<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT02212457</url>
  </required_header>
  <id_info>
    <org_study_id>205215</org_study_id>
    <secondary_id>V102_15</secondary_id>
    <secondary_id>2013-002451-15</secondary_id>
    <nct_id>NCT02212457</nct_id>
  </id_info>
  <brief_title>Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents</brief_title>
  <official_title>A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of GSK Meningococcal ABCWY Vaccine Administered at Different Schedules Compared to GSK Meningococcal Group B Vaccine, in Healthy Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      The main purposes for conducting the study are firstly to assess immunological&#xD;
      non-inferiority of the MenABCWY vaccine, administered according to 0, 2 month schedule to&#xD;
      healthy adolescents 10 to 18 years of age, to those of the licensed rMenB+OMV vaccine&#xD;
      (Bexsero™) in terms of hSBA GMTs at one month after the second vaccination, secondly to give&#xD;
      the flexibility for the national vaccination program by showing the safety and immunogenicity&#xD;
      of MenABCWY administrated according to four different vaccination schedules and additionally&#xD;
      to evaluate a potential benefit of the 3-dose vaccination series.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 21, 2014</start_date>
  <completion_date type="Actual">March 3, 2016</completion_date>
  <primary_completion_date type="Actual">May 22, 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Human Serum Bactericidal Assay (hSBA) Geometric Mean Titers (GMTs) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.</measure>
    <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3)</time_frame>
    <description>The non-inferiority of the Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant (MenABCWY) vaccine to Meningococcal (group B) multicomponent recombinant adsorbed (Bexsero) vaccine, administered according to 0, 2 month schedule, as measured by hSBA GMTs against N.meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, is reported. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the rMenB_0_2 and ABCWY_ 0_2 Groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.</measure>
    <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3 for ABCWY_ 0_2 Group and Month 7 for ABCWY_0_2_6 Group)</time_frame>
    <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 2 months schedule, as measured by hSBA GMTs against N. meningitidis serogroup B test strains and serogroups A,C, W and Y at 1 month after the last meningococcal vaccination. The B test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the ABCWY_ 0_2 and ABCWY_0_2_6 Groups. 1 month post last meningococcal vaccination corresponds to Month 3 for ABCWY_0_2 Group and Month 7 for ABCWY_0_2_6 Group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ Against N. Meningitidis Serogroups A, C, W and y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.</measure>
    <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3 for ABCWY_ 0_2 Group and Month 7 for ABCWY_0_2_6 Group)</time_frame>
    <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 2 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hSBA GMTs Against Each of N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0, 11 Month Schedule.</measure>
    <time_frame>At 1 Month after the last vaccination (Month 2 for ABCWY_0_1 Group, Month 3 for ABCWY_0_2 Group, Month 7 for ABCWY_0_6 Group and Month 13 for ABCWY_0_11 Group)</time_frame>
    <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2 months schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.</measure>
    <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3)</time_frame>
    <description>A sufficient immune response following Bexsero vaccine, administered according to 0, 2 month schedule, as measured by the percentage of subjects with hSBA titers ≥ Lower Limit of Quantitation (LLQ) against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, was to be demonstrated. Criterion: the immune response was to be considered sufficient if the lower limit of the two-sided 95% CI for the percentage of subjects with hSBA titers ≥ LLQ was greater than 75% for each of the four serogroup B test strains. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.</measure>
    <time_frame>At 1 month after last vaccination (Month 7)</time_frame>
    <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 6 months schedule, as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.</measure>
    <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 7)</time_frame>
    <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 6 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥ LLQ Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0_11 Month Schedule.</measure>
    <time_frame>At 1 month after second vaccination (Month 2 for ABCWY_0_1 Group, Month 3 for ABCWY_0_2 Group , Month 7 for ABCWY_0_6 Group and Month 13 for ABCWY_0_11 Group)</time_frame>
    <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2 month schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hSBA GMTs Against Serogroups A, C, W and Y and Serogroup B Test Strains at All the Relevant Time Points for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the adjusted hSBA GMTs against serogroups A,C, W and Y and serogroup B test strains was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against NZ98/254 B Strain for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against NZ98/254 B strain was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M14459 B Strain for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M14459 B strain was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M07-0241084 B Strain for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M07-0241084 B strain was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against 96217 B Strain for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against 96217 B strain was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against A Human Serogroup for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against A human serogroup was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against C Human Serogroup for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against C human serogroup was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against W Human Serogroup for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against W human serogroup was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against Y Human Serogroup for All Schedules.</measure>
    <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
    <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against Y human serogroup was assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With Two-, Three- and Four-fold Titer Rise Against Serogroups A, C, W and Y and Serogroup B Test Strains for All Schedules.</measure>
    <time_frame>At Month 2, Month 3, Month 7 and Month 13</time_frame>
    <description>The kinetic of immune response (at Months 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with two-, three- and four-fold titer rise against serogroups A, C, W and Y and serogroup B test strains was assessed. The two/three/four fold titer rise is defined as: a) for subjects with prevaccination hSBA titers ≤ LLQ, a postvaccination hSBA ≥ 2/3/4 LLQ; b) for subjects with a prevaccination hSBA titers ≥ LLQ, an increase of at least 2/3/4 times of the prevaccination hSBA titer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Area Under the Curve (AUC) for Percentage of Subjects With hSBA Titers ≥LLQ for All Serogroups and Strains.</measure>
    <time_frame>From Month 0 to Month 13</time_frame>
    <description>The area under the curve for percentage of subjects with hSBA titers ≥ LLQ for all serogroups (A, C, W and Y) and for all serogroup B test strains (M14459, 96217, NZ98/254 and M07-0241084) was summarized overall (from Month 0 to Month 13) and by period (from Month 0 to Month 2, Month 2 to Month 3, Month 3 to Month 7 and Month 7 to Month 13) by vaccine groups. It was computed as the sum of the trapezoidal areas and the time unit used was the month. AUC 0_13 = (r0+r2)(2-0)/2 + (r2+r3)(3-2)/2 + (r3+r7)(7-3)/2 + (r7+r13)(13-7)/2 with ri = percentages of subjects with both hSBA titers &gt;= LLQ against N. meningitis for all serogroups A, C, W and Y and for all serogroup B test strains at Month 1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Any Solicited Local or Systemic AEs and Other Indicators of Reactogenicity Within 30 Minutes After Vaccination.</measure>
    <time_frame>Within 30 minutes after vaccination</time_frame>
    <description>Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity within 30 minutes after each vaccination. Assessed solicited symptoms were Pain, erythema and induration. Assessed solicited systemic symptoms were Fatigue, headache, myalgia, arthralgia, loss of appetite, nausea, chills, and fever (body temperature ≥38.0°C).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Any Unsolicited AEs Within 30 Minutes After Vaccination.</measure>
    <time_frame>Within 30 minutes after vaccination</time_frame>
    <description>An unsolicited adverse event is an adverse event that was not solicited and that was spontaneously communicated by a participant and/or parent/legal guardian who has signed the informed consent. Number of participants reporting any unsolicited AE within 30 minutes after each vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Unsolicited AEs From Day 1 to Day 30 After Any Vaccination.</measure>
    <time_frame>Day 1 through Day 30 after any vaccination</time_frame>
    <description>The number of participants reporting unsolicited AEs and possibly or probably related unsolicited AEs were assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Any Solicited Local or Systemic Adverse Events (AEs) and Other Indicators of Reactogenicity From Day 1 to Day 7.</measure>
    <time_frame>At Day 1 (6 hours) to Day 7 after vaccination</time_frame>
    <description>Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity from Day 1 (6 hours) to Day 7 after any meningococcal vaccination is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Any Serious AE (SAE), Medically Attended AEs (MAAEs), AEs Leading to Premature Withdrawal</measure>
    <time_frame>During the entire study period (Month 0 to Month 13)</time_frame>
    <description>The number of participants reporting any SAE, possibly or probably related SAE(s), medically-attended AEs, AEs leading to premature withdrawal, AEs leading to death, AEs leading to hospitalization and AEs leading to dose reduction, interruption and delay in study vaccination during the entire study period is reported.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">1063</enrollment>
  <condition>Infections, Meningococcal</condition>
  <arm_group>
    <arm_group_label>rMenB_0_2 Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCWY_ 0_2 Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCWY_0_1 Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCWY_0_6 Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCWY_0_11 Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCWY_0_2_6 Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bexsero</intervention_name>
    <description>Two doses administered intramuscularly into the deltoid area at Months 0 and 2 in rMenB_0_2 Group.</description>
    <arm_group_label>rMenB_0_2 Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline Placebo</intervention_name>
    <description>One dose administered intramusculary in the deltoid muscle at Month 1 in ABCWY_ 0_2 Group and rMenB_0_2 Group, Month 2 in ABCWY_0_6 Group and ABCWY_0_11 Group and Month 6 in ABCWY_0_1 Group.</description>
    <arm_group_label>ABCWY_ 0_2 Group</arm_group_label>
    <arm_group_label>ABCWY_0_1 Group</arm_group_label>
    <arm_group_label>ABCWY_0_11 Group</arm_group_label>
    <arm_group_label>ABCWY_0_6 Group</arm_group_label>
    <arm_group_label>rMenB_0_2 Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Havrix</intervention_name>
    <description>Two doses administered in the deltoid muscle at Month 2 and 12 in ABCWY_0_1 Group, Month 1 and 12 in Group ABCWY_0_6 Group and ABCWY_0_2_6 Group , Month 0 and 6 in ABCWY_0_11 Group and Month 6 and 12 in ABCWY_ 0_2 Group and rMenB_0_2 Group.</description>
    <arm_group_label>ABCWY_ 0_2 Group</arm_group_label>
    <arm_group_label>ABCWY_0_1 Group</arm_group_label>
    <arm_group_label>ABCWY_0_11 Group</arm_group_label>
    <arm_group_label>ABCWY_0_2_6 Group</arm_group_label>
    <arm_group_label>ABCWY_0_6 Group</arm_group_label>
    <arm_group_label>rMenB_0_2 Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MenABCWY</intervention_name>
    <description>Two to three doses administered in the deltoid muscle at Month 0 and 1 in ABCWY_0_1 Group, Month 0 and 6 in ABCWY_0_6 Group, Month 1 and 12 in ABCWY_0_11 Group, Month 0, 2 and 6 in ABCWY_0_2_6 Group, Month 0 and 2 in ABCWY_ 0_2 Group and rMenB_0_2 Group.</description>
    <arm_group_label>ABCWY_ 0_2 Group</arm_group_label>
    <arm_group_label>ABCWY_0_1 Group</arm_group_label>
    <arm_group_label>ABCWY_0_11 Group</arm_group_label>
    <arm_group_label>ABCWY_0_2_6 Group</arm_group_label>
    <arm_group_label>ABCWY_0_6 Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adolecents from 10-18 yearsof age, generally in good health, and available for all&#xD;
             study visits, and who/whose legally acceptable representative has given written&#xD;
             informed consent at the time of enrollment.&#xD;
&#xD;
          2. Individuals of who the investigator believes can and will comply with the requirements&#xD;
             of the protocol (e.g. use of an eDiary, return for follow-up visits, available for&#xD;
             phone contacts).&#xD;
&#xD;
          3. Female subjects of childbearing potential must have a negative urine preganancy test.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Serious, acute, or chronic illness. Previous or suspected disease caused by N.&#xD;
             meningitidis. Previous immunization with any menincococcal or Hepatitis A vaccines.&#xD;
&#xD;
          2. Exposure to individuals with clicically proven meningococcal disease or clinical&#xD;
             bacterial meningitis without further microbiologic characteriszation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32934</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Augusta</city>
        <state>Kansas</state>
        <zip>67010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Niles</city>
        <state>Michigan</state>
        <zip>49120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bellevue</city>
        <state>Nebraska</state>
        <zip>68005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Binghamton</city>
        <state>New York</state>
        <zip>13901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Espoo</city>
        <zip>02230</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Helsinki</city>
        <zip>00100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Helsinki</city>
        <zip>00930</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jarvenpaa</city>
        <zip>04400</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kokkola</city>
        <zip>67100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oulu</city>
        <zip>90200</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pori</city>
        <zip>28100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seinajoki</city>
        <zip>60100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tampere</city>
        <zip>33100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vantaa</city>
        <zip>01300</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Debica</city>
        <zip>39200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80 542</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80-546</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>91347</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Osielsko</city>
        <zip>86031</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Siemianowice Slaskie</city>
        <zip>41 103</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>01809</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>50368</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Poland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 6, 2014</study_first_submitted>
  <study_first_submitted_qc>August 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2014</study_first_posted>
  <results_first_submitted>March 2, 2017</results_first_submitted>
  <results_first_submitted_qc>June 22, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 21, 2017</results_first_posted>
  <disposition_first_submitted>May 29, 2015</disposition_first_submitted>
  <disposition_first_submitted_qc>May 29, 2015</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">June 26, 2015</disposition_first_posted>
  <last_update_submitted>June 13, 2019</last_update_submitted>
  <last_update_submitted_qc>June 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningococcal Infections</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited from 32 centers from Finland, Poland and United States.</recruitment_details>
      <pre_assignment_details>All subjects were included in the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>rMenB_0_2 Group</title>
          <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
        </group>
        <group group_id="P2">
          <title>ABCWY_ 0_2 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
        </group>
        <group group_id="P3">
          <title>ABCWY_0_1 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
        </group>
        <group group_id="P4">
          <title>ABCWY_0_6 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
        </group>
        <group group_id="P5">
          <title>ABCWY_0_11 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
        </group>
        <group group_id="P6">
          <title>ABCWY_0_2_6 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="228"/>
                <participants group_id="P2" count="232"/>
                <participants group_id="P3" count="157"/>
                <participants group_id="P4" count="134"/>
                <participants group_id="P5" count="152"/>
                <participants group_id="P6" count="160"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="209"/>
                <participants group_id="P2" count="211"/>
                <participants group_id="P3" count="141"/>
                <participants group_id="P4" count="123"/>
                <participants group_id="P5" count="137"/>
                <participants group_id="P6" count="147"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="16"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>rMenB_0_2 Group</title>
          <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
        </group>
        <group group_id="B2">
          <title>ABCWY_ 0_2 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
        </group>
        <group group_id="B3">
          <title>ABCWY_0_1 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
        </group>
        <group group_id="B4">
          <title>ABCWY_0_6 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
        </group>
        <group group_id="B5">
          <title>ABCWY_0_11 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
        </group>
        <group group_id="B6">
          <title>ABCWY_0_2_6 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="228"/>
            <count group_id="B2" value="232"/>
            <count group_id="B3" value="157"/>
            <count group_id="B4" value="134"/>
            <count group_id="B5" value="152"/>
            <count group_id="B6" value="160"/>
            <count group_id="B7" value="1063"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.5" spread="3.09"/>
                    <measurement group_id="B2" value="14.2" spread="3.17"/>
                    <measurement group_id="B3" value="14.4" spread="3.01"/>
                    <measurement group_id="B4" value="14.4" spread="3.06"/>
                    <measurement group_id="B5" value="14.5" spread="3.1"/>
                    <measurement group_id="B6" value="14.3" spread="3.16"/>
                    <measurement group_id="B7" value="14.4" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="101"/>
                    <measurement group_id="B4" value="76"/>
                    <measurement group_id="B5" value="89"/>
                    <measurement group_id="B6" value="96"/>
                    <measurement group_id="B7" value="611"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="98"/>
                    <measurement group_id="B2" value="113"/>
                    <measurement group_id="B3" value="56"/>
                    <measurement group_id="B4" value="58"/>
                    <measurement group_id="B5" value="63"/>
                    <measurement group_id="B6" value="64"/>
                    <measurement group_id="B7" value="452"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Human Serum Bactericidal Assay (hSBA) Geometric Mean Titers (GMTs) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.</title>
        <description>The non-inferiority of the Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant (MenABCWY) vaccine to Meningococcal (group B) multicomponent recombinant adsorbed (Bexsero) vaccine, administered according to 0, 2 month schedule, as measured by hSBA GMTs against N.meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, is reported. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the rMenB_0_2 and ABCWY_ 0_2 Groups.</description>
        <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3)</time_frame>
        <population>Analysis was done on Per Protocol Set (PPS)-Month 3, which included all screened subjects who received a study vaccination, provided evaluable serum samples at pre- &amp; post-vaccination, with results available for at least 1 serogroup B test strain &amp; who was not excluded due to protocol deviations/other reasons defined before unblinding/analysis</population>
        <group_list>
          <group group_id="O1">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
        </group_list>
        <measure>
          <title>Human Serum Bactericidal Assay (hSBA) Geometric Mean Titers (GMTs) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.</title>
          <description>The non-inferiority of the Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant (MenABCWY) vaccine to Meningococcal (group B) multicomponent recombinant adsorbed (Bexsero) vaccine, administered according to 0, 2 month schedule, as measured by hSBA GMTs against N.meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, is reported. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the rMenB_0_2 and ABCWY_ 0_2 Groups.</description>
          <population>Analysis was done on Per Protocol Set (PPS)-Month 3, which included all screened subjects who received a study vaccination, provided evaluable serum samples at pre- &amp; post-vaccination, with results available for at least 1 serogroup B test strain &amp; who was not excluded due to protocol deviations/other reasons defined before unblinding/analysis</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>M14459 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="155"/>
                    <count group_id="O2" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" lower_limit="1.07" upper_limit="1.53"/>
                    <measurement group_id="O2" value="1.31" lower_limit="1.09" upper_limit="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="158"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.64" lower_limit="8.61" upper_limit="16"/>
                    <measurement group_id="O2" value="15.78" lower_limit="12" upper_limit="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="151"/>
                    <count group_id="O2" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.12" lower_limit="1.60" upper_limit="2.82"/>
                    <measurement group_id="O2" value="2.16" lower_limit="1.61" upper_limit="2.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="154"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.19" lower_limit="6.31" upper_limit="11"/>
                    <measurement group_id="O2" value="11.56" lower_limit="8.86" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="152"/>
                    <count group_id="O2" value="143"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.93" lower_limit="2.13" upper_limit="4.03"/>
                    <measurement group_id="O2" value="2.36" lower_limit="1.70" upper_limit="3.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="156"/>
                    <count group_id="O2" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150.82" lower_limit="118" upper_limit="192"/>
                    <measurement group_id="O2" value="229.29" lower_limit="179" upper_limit="294"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="154"/>
                    <count group_id="O2" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.27" lower_limit="1.06" upper_limit="1.53"/>
                    <measurement group_id="O2" value="1.15" lower_limit="0.95" upper_limit="1.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="157"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.95" lower_limit="9.10" upper_limit="16"/>
                    <measurement group_id="O2" value="24.31" lower_limit="18" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority response against N. meningitidis serogroup B test strain M14459 of the MenABCWY vaccine to that of the Bexsero vaccine, administered according to 0, 2 month schedule.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was concluded when, at 1 month after the second meningococcal vaccination (Visit Month 3), the lower limit of the two-sided 95% confidence interval for the between-group ratios of GMTs (ABCWY_0_2 versus rMenB_0_2) was greater than 0.5 for each of the four serogroup B test strains.</non_inferiority_desc>
            <param_type>Geometric Mean Ratio</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.53</ci_lower_limit>
            <ci_upper_limit>1.02</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority response against N. meningitidis serogroup B test strain M07-0241084 of the MenABCWY vaccine to that of the Bexsero vaccine, administered according to 0, 2 month schedule.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was concluded when, at 1 month after the second meningococcal vaccination (Visit Month 3), the lower limit of the two-sided 95% confidence interval for the between-group ratios of GMTs (ABCWY_0_2 versus rMenB_0_2) was greater than 0.5 for each of the four serogroup B test strains.</non_inferiority_desc>
            <param_type>Geometric Mean Ratio</param_type>
            <param_value>0.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.54</ci_lower_limit>
            <ci_upper_limit>0.94</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority response against N. meningitidis serogroup B test strain 96217 of the MenABCWY vaccine to that of the Bexsero vaccine, administered according to 0, 2 month schedule.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was concluded when, at 1 month after the second meningococcal vaccination (Visit Month 3), the lower limit of the two-sided 95% confidence interval for the between-group ratios of GMTs (ABCWY_0_2 versus rMenB_0_2) was greater than 0.5 for each of the four serogroup B test strains.</non_inferiority_desc>
            <param_type>Geometric Mean Ratio</param_type>
            <param_value>0.66</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.51</ci_lower_limit>
            <ci_upper_limit>0.85</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority response against N. meningitidis serogroup B test strain NZ98/254 of the MenABCWY vaccine to that of the Bexsero vaccine, administered according to 0, 2 month schedule.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was concluded when, at 1 month after the second meningococcal vaccination (Visit Month 3), the lower limit of the two-sided 95% confidence interval for the between-group ratios of GMTs (ABCWY_0_2 versus rMenB_0_2) was greater than 0.5 for each of the four serogroup B test strains.</non_inferiority_desc>
            <param_type>Geometric Mean Ratio</param_type>
            <param_value>0.49</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.37</ci_lower_limit>
            <ci_upper_limit>0.66</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.</title>
        <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 2 months schedule, as measured by hSBA GMTs against N. meningitidis serogroup B test strains and serogroups A,C, W and Y at 1 month after the last meningococcal vaccination. The B test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the ABCWY_ 0_2 and ABCWY_0_2_6 Groups. 1 month post last meningococcal vaccination corresponds to Month 3 for ABCWY_0_2 Group and Month 7 for ABCWY_0_2_6 Group.</description>
        <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3 for ABCWY_ 0_2 Group and Month 7 for ABCWY_0_2_6 Group)</time_frame>
        <population>Analysis was done on the FAS-1 month after the last meningococcal vaccination.All subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at pre- &amp; at one month after the last meningococcal vaccination whose result is available for at least one A,C,W,or Y serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.</title>
          <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 2 months schedule, as measured by hSBA GMTs against N. meningitidis serogroup B test strains and serogroups A,C, W and Y at 1 month after the last meningococcal vaccination. The B test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the ABCWY_ 0_2 and ABCWY_0_2_6 Groups. 1 month post last meningococcal vaccination corresponds to Month 3 for ABCWY_0_2 Group and Month 7 for ABCWY_0_2_6 Group.</description>
          <population>Analysis was done on the FAS-1 month after the last meningococcal vaccination.All subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at pre- &amp; at one month after the last meningococcal vaccination whose result is available for at least one A,C,W,or Y serogroup or serogroup B test strain.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="213"/>
                <count group_id="O2" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>M14459 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" lower_limit="1.07" upper_limit="1.37"/>
                    <measurement group_id="O2" value="1.12" lower_limit="0.98" upper_limit="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 3/Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.17" lower_limit="9.60" upper_limit="15"/>
                    <measurement group_id="O2" value="27.09" lower_limit="21" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="201"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.36" lower_limit="1.85" upper_limit="3.01"/>
                    <measurement group_id="O2" value="2.05" lower_limit="1.58" upper_limit="2.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 3/Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.91" lower_limit="7.10" upper_limit="11"/>
                    <measurement group_id="O2" value="18.03" lower_limit="14" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="205"/>
                    <count group_id="O2" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.31" lower_limit="1.75" upper_limit="3.06"/>
                    <measurement group_id="O2" value="2.28" lower_limit="1.68" upper_limit="3.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 3/Month7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="174.27" lower_limit="142" upper_limit="215"/>
                    <measurement group_id="O2" value="298.76" lower_limit="239" upper_limit="374"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="208"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.24" lower_limit="1.09" upper_limit="1.41"/>
                    <measurement group_id="O2" value="1.07" lower_limit="0.93" upper_limit="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 3/Month7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.57" lower_limit="9.81" upper_limit="16"/>
                    <measurement group_id="O2" value="17.55" lower_limit="13" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human serogroup (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.19" lower_limit="1.04" upper_limit="1.36"/>
                    <measurement group_id="O2" value="1.10" lower_limit="0.95" upper_limit="1.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human serogroup (Month 3/Month7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.73" lower_limit="54" upper_limit="83"/>
                    <measurement group_id="O2" value="125.45" lower_limit="99" upper_limit="159"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human serogroup (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.59" lower_limit="2.85" upper_limit="4.53"/>
                    <measurement group_id="O2" value="3.19" lower_limit="2.48" upper_limit="4.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human serogroup (Month 3/Month7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="158.8" lower_limit="127" upper_limit="199"/>
                    <measurement group_id="O2" value="376.44" lower_limit="295" upper_limit="481"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human serogroup (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.20" lower_limit="3.56" upper_limit="7.59"/>
                    <measurement group_id="O2" value="4.64" lower_limit="3.05" upper_limit="7.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human serogroup (Month 3/Month7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="208"/>
                    <count group_id="O2" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="206.62" lower_limit="175" upper_limit="244"/>
                    <measurement group_id="O2" value="295.9" lower_limit="246" upper_limit="356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human serogroup (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="202"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" lower_limit="1.10" upper_limit="1.60"/>
                    <measurement group_id="O2" value="1.26" lower_limit="1.03" upper_limit="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human serogroup (Month 3/Month7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.84" lower_limit="62" upper_limit="103"/>
                    <measurement group_id="O2" value="163.69" lower_limit="124" upper_limit="216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ Against N. Meningitidis Serogroups A, C, W and y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.</title>
        <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 2 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
        <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3 for ABCWY_ 0_2 Group and Month 7 for ABCWY_0_2_6 Group)</time_frame>
        <population>Analysis was done on the FAS-1 month after the last meningococcal vaccination.All subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at pre- &amp; at one month after the last meningococcal vaccination whose result is available for at least one A,C,W,or Y serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ Against N. Meningitidis Serogroups A, C, W and y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.</title>
          <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 2 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
          <population>Analysis was done on the FAS-1 month after the last meningococcal vaccination.All subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at pre- &amp; at one month after the last meningococcal vaccination whose result is available for at least one A,C,W,or Y serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="213"/>
                <count group_id="O2" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="208"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="3.37" upper_limit="10.45"/>
                    <measurement group_id="O2" value="2" lower_limit="0.41" upper_limit="5.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 3/7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="55.85" upper_limit="69.26"/>
                    <measurement group_id="O2" value="74" lower_limit="65.72" upper_limit="80.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.68" upper_limit="9.31"/>
                    <measurement group_id="O2" value="2" lower_limit="0.41" upper_limit="5.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 3/Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="63.48" upper_limit="76.23"/>
                    <measurement group_id="O2" value="89" lower_limit="83.36" upper_limit="93.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="201"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="13.30" upper_limit="24.47"/>
                    <measurement group_id="O2" value="18" lower_limit="12.06" upper_limit="25.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 3/7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="41.54" upper_limit="55.59"/>
                    <measurement group_id="O2" value="72" lower_limit="64.35" upper_limit="79.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="205"/>
                    <count group_id="O2" value="144"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="22.24" upper_limit="34.99"/>
                    <measurement group_id="O2" value="27" lower_limit="20.02" upper_limit="35.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 3/7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.25" upper_limit="98.65"/>
                    <measurement group_id="O2" value="99" lower_limit="96.34" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.08" upper_limit="6.23"/>
                    <measurement group_id="O2" value="1" lower_limit="0.02" upper_limit="3.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (Month 3/7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="83.01" upper_limit="92.18"/>
                    <measurement group_id="O2" value="95" lower_limit="89.56" upper_limit="97.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="37.28" upper_limit="51.24"/>
                    <measurement group_id="O2" value="41" lower_limit="32.62" upper_limit="49.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (Month 3/7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="96.63" upper_limit="99.89"/>
                    <measurement group_id="O2" value="100" lower_limit="97.55" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="21.20" upper_limit="34.04"/>
                    <measurement group_id="O2" value="22" lower_limit="15.17" upper_limit="29.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (Month 3/7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="208"/>
                    <count group_id="O2" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.19" upper_limit="98.64"/>
                    <measurement group_id="O2" value="99" lower_limit="96.08" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="202"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.37" upper_limit="13.72"/>
                    <measurement group_id="O2" value="6" lower_limit="2.78" upper_limit="11.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (Month 3/7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="86.97" upper_limit="94.91"/>
                    <measurement group_id="O2" value="97" lower_limit="93.31" upper_limit="99.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>hSBA GMTs Against Each of N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0, 11 Month Schedule.</title>
        <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2 months schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.</description>
        <time_frame>At 1 Month after the last vaccination (Month 2 for ABCWY_0_1 Group, Month 3 for ABCWY_0_2 Group, Month 7 for ABCWY_0_6 Group and Month 13 for ABCWY_0_11 Group)</time_frame>
        <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strain</population>
        <group_list>
          <group group_id="O1">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
        </group_list>
        <measure>
          <title>hSBA GMTs Against Each of N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0, 11 Month Schedule.</title>
          <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2 months schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.</description>
          <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strain</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="213"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="121"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.32" lower_limit="9.82" upper_limit="15"/>
                    <measurement group_id="O2" value="6.33" lower_limit="4.86" upper_limit="8.23"/>
                    <measurement group_id="O3" value="13.64" lower_limit="10" upper_limit="18"/>
                    <measurement group_id="O4" value="15.87" lower_limit="12" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="140"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="133"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.72" lower_limit="10" upper_limit="16"/>
                    <measurement group_id="O2" value="9.19" lower_limit="7.11" upper_limit="12"/>
                    <measurement group_id="O3" value="26.48" lower_limit="20" upper_limit="35"/>
                    <measurement group_id="O4" value="29.57" lower_limit="23" upper_limit="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="140"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.15" lower_limit="7.52" upper_limit="11"/>
                    <measurement group_id="O2" value="6.59" lower_limit="5.25" upper_limit="8.27"/>
                    <measurement group_id="O3" value="15.04" lower_limit="12" upper_limit="19"/>
                    <measurement group_id="O4" value="16.22" lower_limit="13" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                    <count group_id="O2" value="143"/>
                    <count group_id="O3" value="121"/>
                    <count group_id="O4" value="133"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="165.47" lower_limit="133" upper_limit="206"/>
                    <measurement group_id="O2" value="117.28" lower_limit="91" upper_limit="151"/>
                    <measurement group_id="O3" value="237.89" lower_limit="182" upper_limit="310"/>
                    <measurement group_id="O4" value="244.97" lower_limit="189" upper_limit="317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human serogroup</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="133"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.61" lower_limit="56" upper_limit="87"/>
                    <measurement group_id="O2" value="79.87" lower_limit="62" upper_limit="103"/>
                    <measurement group_id="O3" value="140.76" lower_limit="108" upper_limit="184"/>
                    <measurement group_id="O4" value="162.76" lower_limit="126" upper_limit="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human serogroup</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162.57" lower_limit="132" upper_limit="201"/>
                    <measurement group_id="O2" value="145.73" lower_limit="114" upper_limit="186"/>
                    <measurement group_id="O3" value="225.00" lower_limit="174" upper_limit="290"/>
                    <measurement group_id="O4" value="292.61" lower_limit="227" upper_limit="376"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human serogroup</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="208"/>
                    <count group_id="O2" value="143"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="215.72" lower_limit="182" upper_limit="256"/>
                    <measurement group_id="O2" value="197.69" lower_limit="162" upper_limit="241"/>
                    <measurement group_id="O3" value="376.03" lower_limit="306" upper_limit="462"/>
                    <measurement group_id="O4" value="531.79" lower_limit="434" upper_limit="652"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human serogroup</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="132"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.66" lower_limit="55" upper_limit="93"/>
                    <measurement group_id="O2" value="57.45" lower_limit="42" upper_limit="78"/>
                    <measurement group_id="O3" value="120.76" lower_limit="88" upper_limit="166"/>
                    <measurement group_id="O4" value="209.53" lower_limit="153" upper_limit="286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.</title>
        <description>A sufficient immune response following Bexsero vaccine, administered according to 0, 2 month schedule, as measured by the percentage of subjects with hSBA titers ≥ Lower Limit of Quantitation (LLQ) against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, was to be demonstrated. Criterion: the immune response was to be considered sufficient if the lower limit of the two-sided 95% CI for the percentage of subjects with hSBA titers ≥ LLQ was greater than 75% for each of the four serogroup B test strains. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab.</description>
        <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3)</time_frame>
        <population>Analysis was done on Full Analysis Set(FAS)- 1 month post meningococcal vaccination. Subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at pre- &amp; at 1 month post last meningococcal vaccination whose result is available for at least one A,C,W or Y serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.</title>
          <description>A sufficient immune response following Bexsero vaccine, administered according to 0, 2 month schedule, as measured by the percentage of subjects with hSBA titers ≥ Lower Limit of Quantitation (LLQ) against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, was to be demonstrated. Criterion: the immune response was to be considered sufficient if the lower limit of the two-sided 95% CI for the percentage of subjects with hSBA titers ≥ LLQ was greater than 75% for each of the four serogroup B test strains. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab.</description>
          <population>Analysis was done on Full Analysis Set(FAS)- 1 month post meningococcal vaccination. Subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at pre- &amp; at 1 month post last meningococcal vaccination whose result is available for at least one A,C,W or Y serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 strain - month 0 (LLQ = 8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.73" upper_limit="11.53"/>
                    <measurement group_id="O2" value="6" lower_limit="3.40" upper_limit="11.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain - month 3 (LLQ = 8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="82.82" upper_limit="92.52"/>
                    <measurement group_id="O2" value="61" lower_limit="53.65" upper_limit="68.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain - month 0 (LLQ = 8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.41" upper_limit="11.11"/>
                    <measurement group_id="O2" value="5" lower_limit="2.32" upper_limit="9.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain - month 3 (LLQ = 8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" lower_limit="75.75" upper_limit="87.32"/>
                    <measurement group_id="O2" value="68" lower_limit="60.21" upper_limit="74.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain - month 0 (LLQ = 8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="15.19" upper_limit="27.25"/>
                    <measurement group_id="O2" value="18" lower_limit="12.78" upper_limit="24.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain - month 3 (LLQ = 8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="59.26" upper_limit="73.19"/>
                    <measurement group_id="O2" value="47" lower_limit="39.60" upper_limit="54.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain - month 0 (LLQ = 8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.26" upper_limit="29.85"/>
                    <measurement group_id="O2" value="29" lower_limit="22.14" upper_limit="35.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain - month 3 (LLQ = 8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="97.04" upper_limit="99.99"/>
                    <measurement group_id="O2" value="97" lower_limit="92.81" upper_limit="98.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.</title>
        <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 6 months schedule, as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
        <time_frame>At 1 month after last vaccination (Month 7)</time_frame>
        <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strains</population>
        <group_list>
          <group group_id="O1">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.</title>
          <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 6 months schedule, as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
          <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strains</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.62" lower_limit="9.98" upper_limit="19"/>
                    <measurement group_id="O2" value="17.13" lower_limit="13" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="122"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.82" lower_limit="21" upper_limit="36"/>
                    <measurement group_id="O2" value="29.27" lower_limit="23" upper_limit="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.43" lower_limit="13" upper_limit="23"/>
                    <measurement group_id="O2" value="20.92" lower_limit="16" upper_limit="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="240.13" lower_limit="186" upper_limit="310"/>
                    <measurement group_id="O2" value="291.63" lower_limit="232" upper_limit="367"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140.14" lower_limit="107" upper_limit="184"/>
                    <measurement group_id="O2" value="128.75" lower_limit="101" upper_limit="164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="246.48" lower_limit="191" upper_limit="318"/>
                    <measurement group_id="O2" value="413.60" lower_limit="328" upper_limit="522"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="341.90" lower_limit="283" upper_limit="413"/>
                    <measurement group_id="O2" value="282.74" lower_limit="237" upper_limit="338"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="123.96" lower_limit="91" upper_limit="169"/>
                    <measurement group_id="O2" value="151.36" lower_limit="115" upper_limit="200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.</title>
        <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 6 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
        <time_frame>At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 7)</time_frame>
        <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strain</population>
        <group_list>
          <group group_id="O1">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.</title>
          <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 6 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.</description>
          <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strain</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 strain - month 0 (LLQ=8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="120"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="1.86" upper_limit="10.57"/>
                    <measurement group_id="O2" value="2" lower_limit="0.41" upper_limit="5.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain - month 7 (LLQ=8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" lower_limit="55.25" upper_limit="72.95"/>
                    <measurement group_id="O2" value="74" lower_limit="65.72" upper_limit="80.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain - month 0 (LLQ=8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="1.84" upper_limit="10.48"/>
                    <measurement group_id="O2" value="2" lower_limit="0.41" upper_limit="5.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain - month 7 (LLQ=8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="122"/>
                    <count group_id="O2" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" lower_limit="79.58" upper_limit="92.31"/>
                    <measurement group_id="O2" value="89" lower_limit="83.36" upper_limit="93.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain - month 0 (LLQ=8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="122"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" lower_limit="8.33" upper_limit="21.37"/>
                    <measurement group_id="O2" value="18" lower_limit="12.06" upper_limit="25.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain - month 7 (LLQ=8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="56.76" upper_limit="74.16"/>
                    <measurement group_id="O2" value="72" lower_limit="64.35" upper_limit="79.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain - month 0 (LLQ=8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="119"/>
                    <count group_id="O2" value="144"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="19.18" upper_limit="35.79"/>
                    <measurement group_id="O2" value="27" lower_limit="20.02" upper_limit="35.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>996217 strain - month 7 (LLQ=8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="92.93" upper_limit="99.49"/>
                    <measurement group_id="O2" value="99" lower_limit="96.34" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human serogroup - month 0 (LLQ=22.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="118"/>
                    <count group_id="O2" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.21" upper_limit="5.99"/>
                    <measurement group_id="O2" value="1" lower_limit="0.02" upper_limit="3.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human serogroup - month 7 (LLQ=22.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="88.63" upper_limit="97.68"/>
                    <measurement group_id="O2" value="95" lower_limit="89.56" upper_limit="97.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human serogroup - month 0 (LLQ=5.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="122"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="32.94" upper_limit="51.07"/>
                    <measurement group_id="O2" value="41" lower_limit="32.62" upper_limit="49.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human serogroup - month 7 (LLQ=5.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="95.55" upper_limit="99.98"/>
                    <measurement group_id="O2" value="100" lower_limit="97.55" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human serogroup - month 0 (LLQ=39.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="119"/>
                    <count group_id="O2" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="13.37" upper_limit="28.51"/>
                    <measurement group_id="O2" value="22" lower_limit="15.17" upper_limit="29.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human serogroup -month 7 (LLQ=39.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="95.55" upper_limit="99.98"/>
                    <measurement group_id="O2" value="99" lower_limit="96.08" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human serogroup - month 0 (LLQ=14.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="120"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="2.92" upper_limit="12.71"/>
                    <measurement group_id="O2" value="6" lower_limit="2.78" upper_limit="11.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human serogroup - month 7 (LLQ=14.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="88.63" upper_limit="97.68"/>
                    <measurement group_id="O2" value="97" lower_limit="93.31" upper_limit="99.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥ LLQ Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0_11 Month Schedule.</title>
        <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2 month schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.</description>
        <time_frame>At 1 month after second vaccination (Month 2 for ABCWY_0_1 Group, Month 3 for ABCWY_0_2 Group , Month 7 for ABCWY_0_6 Group and Month 13 for ABCWY_0_11 Group)</time_frame>
        <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strain</population>
        <group_list>
          <group group_id="O1">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥ LLQ Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0_11 Month Schedule.</title>
          <description>The immunogenicity of MenABCWY vaccine, administered according to 0, 2 month schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.</description>
          <population>Analysis was done on the FAS- 1 month after last meningococcal vaccination, which included all screened subjects who provided informed consent, received a study vaccination &amp; provided evaluable serum samples at 1 month after last vaccination whose results were available for atleast 1 serogroup or B strain</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="213"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 strain (LLQ=8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="121"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="55.85" upper_limit="69.26"/>
                    <measurement group_id="O2" value="44" lower_limit="35.36" upper_limit="52.23"/>
                    <measurement group_id="O3" value="64" lower_limit="55.25" upper_limit="72.95"/>
                    <measurement group_id="O4" value="73" lower_limit="64.85" upper_limit="80.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (LLQ=8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="140"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="133"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="63.48" upper_limit="76.23"/>
                    <measurement group_id="O2" value="62" lower_limit="53.56" upper_limit="70.20"/>
                    <measurement group_id="O3" value="87" lower_limit="79.58" upper_limit="92.31"/>
                    <measurement group_id="O4" value="89" lower_limit="82.08" upper_limit="93.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (LLQ=8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="140"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="41.54" upper_limit="55.59"/>
                    <measurement group_id="O2" value="40" lower_limit="31.82" upper_limit="48.61"/>
                    <measurement group_id="O3" value="66" lower_limit="56.76" upper_limit="74.16"/>
                    <measurement group_id="O4" value="69" lower_limit="60.82" upper_limit="77.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (LLQ=8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                    <count group_id="O2" value="143"/>
                    <count group_id="O3" value="121"/>
                    <count group_id="O4" value="133"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.25" upper_limit="98.65"/>
                    <measurement group_id="O2" value="97" lower_limit="92.99" upper_limit="99.23"/>
                    <measurement group_id="O3" value="98" lower_limit="92.93" upper_limit="99.49"/>
                    <measurement group_id="O4" value="98" lower_limit="93.55" upper_limit="99.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (LLQ=22.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="133"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="83.01" upper_limit="92.18"/>
                    <measurement group_id="O2" value="92" lower_limit="85.70" upper_limit="95.56"/>
                    <measurement group_id="O3" value="94" lower_limit="88.63" upper_limit="97.68"/>
                    <measurement group_id="O4" value="94" lower_limit="88.49" upper_limit="97.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (LLQ=5.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="96.63" upper_limit="99.89"/>
                    <measurement group_id="O2" value="100" lower_limit="97.44" upper_limit="100"/>
                    <measurement group_id="O3" value="99" lower_limit="95.55" upper_limit="99.99"/>
                    <measurement group_id="O4" value="100" lower_limit="97.22" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (LLQ=39.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="208"/>
                    <count group_id="O2" value="143"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.19" upper_limit="98.64"/>
                    <measurement group_id="O2" value="96" lower_limit="91.09" upper_limit="98.44"/>
                    <measurement group_id="O3" value="99" lower_limit="95.55" upper_limit="99.98"/>
                    <measurement group_id="O4" value="98" lower_limit="93.45" upper_limit="99.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (LLQ=14.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="123"/>
                    <count group_id="O4" value="132"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="86.97" upper_limit="94.91"/>
                    <measurement group_id="O2" value="85" lower_limit="78.29" upper_limit="90.61"/>
                    <measurement group_id="O3" value="94" lower_limit="88.63" upper_limit="97.68"/>
                    <measurement group_id="O4" value="97" lower_limit="92.42" upper_limit="99.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>hSBA GMTs Against Serogroups A, C, W and Y and Serogroup B Test Strains at All the Relevant Time Points for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the adjusted hSBA GMTs against serogroups A,C, W and Y and serogroup B test strains was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>hSBA GMTs Against Serogroups A, C, W and Y and Serogroup B Test Strains at All the Relevant Time Points for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the adjusted hSBA GMTs against serogroups A,C, W and Y and serogroup B test strains was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="185"/>
                <count group_id="O3" value="122"/>
                <count group_id="O4" value="114"/>
                <count group_id="O5" value="128"/>
                <count group_id="O6" value="137"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="126"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.22" lower_limit="1.08" upper_limit="1.38"/>
                    <measurement group_id="O2" value="1.22" lower_limit="1.08" upper_limit="1.38"/>
                    <measurement group_id="O3" value="1.21" lower_limit="1.04" upper_limit="1.40"/>
                    <measurement group_id="O4" value="1.13" lower_limit="0.97" upper_limit="1.31"/>
                    <measurement group_id="O5" value="1.12" lower_limit="0.97" upper_limit="1.29"/>
                    <measurement group_id="O6" value="1.06" lower_limit="0.93" upper_limit="1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="126"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.67" lower_limit="2.14" upper_limit="3.34"/>
                    <measurement group_id="O2" value="2.27" lower_limit="1.82" upper_limit="2.84"/>
                    <measurement group_id="O3" value="6.50" lower_limit="4.98" upper_limit="8.48"/>
                    <measurement group_id="O4" value="1.92" lower_limit="1.46" upper_limit="2.51"/>
                    <measurement group_id="O5" value="3.87" lower_limit="2.98" upper_limit="5.01"/>
                    <measurement group_id="O6" value="2.20" lower_limit="1.71" upper_limit="2.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="126"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.17" lower_limit="22" upper_limit="34"/>
                    <measurement group_id="O2" value="11.46" lower_limit="9.28" upper_limit="14"/>
                    <measurement group_id="O3" value="3.15" lower_limit="2.44" upper_limit="4.05"/>
                    <measurement group_id="O4" value="1.69" lower_limit="1.31" upper_limit="2.19"/>
                    <measurement group_id="O5" value="2.38" lower_limit="1.86" upper_limit="3.05"/>
                    <measurement group_id="O6" value="12.80" lower_limit="10" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="126"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.00" lower_limit="2.44" upper_limit="3.67"/>
                    <measurement group_id="O2" value="2.41" lower_limit="1.97" upper_limit="2.95"/>
                    <measurement group_id="O3" value="1.88" lower_limit="1.47" upper_limit="2.40"/>
                    <measurement group_id="O4" value="14.30" lower_limit="11" upper_limit="18"/>
                    <measurement group_id="O5" value="1.75" lower_limit="1.38" upper_limit="2.22"/>
                    <measurement group_id="O6" value="18.24" lower_limit="14" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 strain (Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="126"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.33" lower_limit="1.92" upper_limit="2.83"/>
                    <measurement group_id="O2" value="1.93" lower_limit="1.59" upper_limit="2.33"/>
                    <measurement group_id="O3" value="1.81" lower_limit="1.44" upper_limit="2.27"/>
                    <measurement group_id="O4" value="2.57" lower_limit="2.04" upper_limit="3.25"/>
                    <measurement group_id="O5" value="17.08" lower_limit="14" upper_limit="21"/>
                    <measurement group_id="O6" value="2.82" lower_limit="2.28" upper_limit="3.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain(Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.37" lower_limit="1.21" upper_limit="1.56"/>
                    <measurement group_id="O2" value="1.22" lower_limit="1.08" upper_limit="1.39"/>
                    <measurement group_id="O3" value="1.22" lower_limit="1.04" upper_limit="1.42"/>
                    <measurement group_id="O4" value="1.21" lower_limit="1.04" upper_limit="1.41"/>
                    <measurement group_id="O5" value="1.34" lower_limit="1.15" upper_limit="1.55"/>
                    <measurement group_id="O6" value="1.17" lower_limit="1.02" upper_limit="1.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" lower_limit="2.31" upper_limit="3.46"/>
                    <measurement group_id="O2" value="2.55" lower_limit="2.08" upper_limit="3.13"/>
                    <measurement group_id="O3" value="9.23" lower_limit="7.21" upper_limit="12"/>
                    <measurement group_id="O4" value="2.34" lower_limit="1.82" upper_limit="2.99"/>
                    <measurement group_id="O5" value="3.94" lower_limit="3.11" upper_limit="4.98"/>
                    <measurement group_id="O6" value="2.40" lower_limit="1.92" upper_limit="3.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.29" lower_limit="15" upper_limit="23"/>
                    <measurement group_id="O2" value="12.85" lower_limit="10" upper_limit="16"/>
                    <measurement group_id="O3" value="5.30" lower_limit="4.04" upper_limit="6.93"/>
                    <measurement group_id="O4" value="2.15" lower_limit="1.64" upper_limit="2.82"/>
                    <measurement group_id="O5" value="3.11" lower_limit="2.40" upper_limit="4.02"/>
                    <measurement group_id="O6" value="15.24" lower_limit="12" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.52" lower_limit="2.91" upper_limit="4.26"/>
                    <measurement group_id="O2" value="3.24" lower_limit="2.68" upper_limit="3.93"/>
                    <measurement group_id="O3" value="2.19" lower_limit="1.74" upper_limit="2.77"/>
                    <measurement group_id="O4" value="27.47" lower_limit="22" upper_limit="35"/>
                    <measurement group_id="O5" value="1.95" lower_limit="1.56" upper_limit="2.43"/>
                    <measurement group_id="O6" value="28.56" lower_limit="23" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 strain (Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.46" lower_limit="2.03" upper_limit="2.97"/>
                    <measurement group_id="O2" value="2.29" lower_limit="1.89" upper_limit="2.78"/>
                    <measurement group_id="O3" value="1.95" lower_limit="1.54" upper_limit="2.45"/>
                    <measurement group_id="O4" value="3.22" lower_limit="2.55" upper_limit="4.06"/>
                    <measurement group_id="O5" value="29.01" lower_limit="23" upper_limit="36"/>
                    <measurement group_id="O6" value="3.17" lower_limit="2.57" upper_limit="3.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.26" lower_limit="1.81" upper_limit="2.82"/>
                    <measurement group_id="O2" value="2.07" lower_limit="1.65" upper_limit="2.59"/>
                    <measurement group_id="O3" value="2.01" lower_limit="1.53" upper_limit="2.63"/>
                    <measurement group_id="O4" value="2.06" lower_limit="1.57" upper_limit="2.71"/>
                    <measurement group_id="O5" value="2.59" lower_limit="1.99" upper_limit="3.37"/>
                    <measurement group_id="O6" value="1.83" lower_limit="1.42" upper_limit="2.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.09" lower_limit="4.26" upper_limit="6.07"/>
                    <measurement group_id="O2" value="4.30" lower_limit="3.59" upper_limit="5.14"/>
                    <measurement group_id="O3" value="6.73" lower_limit="5.44" upper_limit="8.34"/>
                    <measurement group_id="O4" value="3.51" lower_limit="2.83" upper_limit="4.35"/>
                    <measurement group_id="O5" value="4.90" lower_limit="3.97" upper_limit="6.04"/>
                    <measurement group_id="O6" value="4.20" lower_limit="3.43" upper_limit="5.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain(Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.91" lower_limit="12" upper_limit="17"/>
                    <measurement group_id="O2" value="8.82" lower_limit="7.29" upper_limit="11"/>
                    <measurement group_id="O3" value="4.39" lower_limit="3.49" upper_limit="5.50"/>
                    <measurement group_id="O4" value="3.30" lower_limit="2.62" upper_limit="4.15"/>
                    <measurement group_id="O5" value="3.55" lower_limit="2.84" upper_limit="4.43"/>
                    <measurement group_id="O6" value="9.29" lower_limit="7.49" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.42" lower_limit="4.51" upper_limit="6.51"/>
                    <measurement group_id="O2" value="4.68" lower_limit="3.88" upper_limit="5.63"/>
                    <measurement group_id="O3" value="3.36" lower_limit="2.69" upper_limit="4.20"/>
                    <measurement group_id="O4" value="15.70" lower_limit="13" upper_limit="20"/>
                    <measurement group_id="O5" value="2.96" lower_limit="2.38" upper_limit="3.67"/>
                    <measurement group_id="O6" value="19.18" lower_limit="16" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 strain(Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.45" lower_limit="3.71" upper_limit="5.35"/>
                    <measurement group_id="O2" value="4.01" lower_limit="3.34" upper_limit="4.83"/>
                    <measurement group_id="O3" value="3.07" lower_limit="2.46" upper_limit="3.83"/>
                    <measurement group_id="O4" value="5.42" lower_limit="4.33" upper_limit="6.77"/>
                    <measurement group_id="O5" value="15.68" lower_limit="13" upper_limit="19"/>
                    <measurement group_id="O6" value="5.80" lower_limit="4.70" upper_limit="7.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.32" lower_limit="1.82" upper_limit="2.95"/>
                    <measurement group_id="O2" value="2.84" lower_limit="2.23" upper_limit="3.62"/>
                    <measurement group_id="O3" value="2.88" lower_limit="2.16" upper_limit="3.83"/>
                    <measurement group_id="O4" value="2.39" lower_limit="1.78" upper_limit="3.21"/>
                    <measurement group_id="O5" value="2.78" lower_limit="2.11" upper_limit="3.68"/>
                    <measurement group_id="O6" value="2.57" lower_limit="1.94" upper_limit="3.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain(Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.48" lower_limit="13" upper_limit="21"/>
                    <measurement group_id="O2" value="11.62" lower_limit="8.96" upper_limit="15"/>
                    <measurement group_id="O3" value="124.75" lower_limit="92" upper_limit="169"/>
                    <measurement group_id="O4" value="11.61" lower_limit="8.49" upper_limit="16"/>
                    <measurement group_id="O5" value="11.94" lower_limit="8.87" upper_limit="16"/>
                    <measurement group_id="O6" value="8.54" lower_limit="6.33" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain(Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263.56" lower_limit="211" upper_limit="329"/>
                    <measurement group_id="O2" value="169.65" lower_limit="136" upper_limit="212"/>
                    <measurement group_id="O3" value="82.23" lower_limit="63" upper_limit="107"/>
                    <measurement group_id="O4" value="8.61" lower_limit="6.57" upper_limit="11"/>
                    <measurement group_id="O5" value="7.72" lower_limit="5.97" upper_limit="9.99"/>
                    <measurement group_id="O6" value="162.27" lower_limit="125" upper_limit="210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.46" lower_limit="50" upper_limit="75"/>
                    <measurement group_id="O2" value="43.01" lower_limit="35" upper_limit="53"/>
                    <measurement group_id="O3" value="37.26" lower_limit="29" upper_limit="47"/>
                    <measurement group_id="O4" value="264.85" lower_limit="207" upper_limit="340"/>
                    <measurement group_id="O5" value="5.19" lower_limit="4.10" upper_limit="6.58"/>
                    <measurement group_id="O6" value="306.14" lower_limit="242" upper_limit="388"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 strain (Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.07" lower_limit="27" upper_limit="41"/>
                    <measurement group_id="O2" value="22.48" lower_limit="18" upper_limit="28"/>
                    <measurement group_id="O3" value="24.00" lower_limit="18" upper_limit="31"/>
                    <measurement group_id="O4" value="42.27" lower_limit="32" upper_limit="55"/>
                    <measurement group_id="O5" value="264.32" lower_limit="205" upper_limit="341"/>
                    <measurement group_id="O6" value="47.22" lower_limit="37" upper_limit="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.37" lower_limit="1.18" upper_limit="1.59"/>
                    <measurement group_id="O2" value="1.17" lower_limit="1.02" upper_limit="1.36"/>
                    <measurement group_id="O3" value="1.38" lower_limit="1.15" upper_limit="1.65"/>
                    <measurement group_id="O4" value="1.08" lower_limit="0.90" upper_limit="1.30"/>
                    <measurement group_id="O5" value="1.19" lower_limit="1.00" upper_limit="1.41"/>
                    <measurement group_id="O6" value="1.06" lower_limit="0.90" upper_limit="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.05" lower_limit="2.97" upper_limit="5.54"/>
                    <measurement group_id="O2" value="8.35" lower_limit="6.14" upper_limit="11"/>
                    <measurement group_id="O3" value="85.49" lower_limit="59" upper_limit="125"/>
                    <measurement group_id="O4" value="7.64" lower_limit="5.22" upper_limit="11"/>
                    <measurement group_id="O5" value="22.54" lower_limit="16" upper_limit="32"/>
                    <measurement group_id="O6" value="5.18" lower_limit="3.65" upper_limit="7.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.70" lower_limit="82" upper_limit="139"/>
                    <measurement group_id="O2" value="68.85" lower_limit="53" upper_limit="89"/>
                    <measurement group_id="O3" value="52.42" lower_limit="38" upper_limit="72"/>
                    <measurement group_id="O4" value="5.31" lower_limit="3.86" upper_limit="7.31"/>
                    <measurement group_id="O5" value="8.77" lower_limit="6.49" upper_limit="12"/>
                    <measurement group_id="O6" value="78.30" lower_limit="58" upper_limit="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.15" lower_limit="11" upper_limit="19"/>
                    <measurement group_id="O2" value="11.49" lower_limit="8.71" upper_limit="15"/>
                    <measurement group_id="O3" value="9.88" lower_limit="7.04" upper_limit="14"/>
                    <measurement group_id="O4" value="165.14" lower_limit="117" upper_limit="233"/>
                    <measurement group_id="O5" value="3.25" lower_limit="2.35" upper_limit="4.49"/>
                    <measurement group_id="O6" value="140.73" lower_limit="103" upper_limit="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A (Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.80" lower_limit="4.30" upper_limit="7.82"/>
                    <measurement group_id="O2" value="4.64" lower_limit="3.45" upper_limit="6.23"/>
                    <measurement group_id="O3" value="5.90" lower_limit="4.11" upper_limit="8.46"/>
                    <measurement group_id="O4" value="15.20" lower_limit="11" upper_limit="22"/>
                    <measurement group_id="O5" value="168.23" lower_limit="119" upper_limit="238"/>
                    <measurement group_id="O6" value="13.32" lower_limit="9.52" upper_limit="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.46" lower_limit="2.76" upper_limit="4.33"/>
                    <measurement group_id="O2" value="3.38" lower_limit="2.71" upper_limit="4.23"/>
                    <measurement group_id="O3" value="3.87" lower_limit="2.96" upper_limit="5.04"/>
                    <measurement group_id="O4" value="3.36" lower_limit="2.56" upper_limit="4.40"/>
                    <measurement group_id="O5" value="3.80" lower_limit="2.92" upper_limit="4.94"/>
                    <measurement group_id="O6" value="2.99" lower_limit="2.32" upper_limit="3.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.47" lower_limit="7.18" upper_limit="13"/>
                    <measurement group_id="O2" value="31.56" lower_limit="24" upper_limit="42"/>
                    <measurement group_id="O3" value="163.28" lower_limit="118" upper_limit="227"/>
                    <measurement group_id="O4" value="37.24" lower_limit="27" upper_limit="52"/>
                    <measurement group_id="O5" value="54.75" lower_limit="40" upper_limit="76"/>
                    <measurement group_id="O6" value="40.29" lower_limit="29" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.25" lower_limit="32" upper_limit="52"/>
                    <measurement group_id="O2" value="184.05" lower_limit="145" upper_limit="234"/>
                    <measurement group_id="O3" value="119.71" lower_limit="90" upper_limit="159"/>
                    <measurement group_id="O4" value="31.50" lower_limit="24" upper_limit="42"/>
                    <measurement group_id="O5" value="41.15" lower_limit="31" upper_limit="54"/>
                    <measurement group_id="O6" value="236.97" lower_limit="180" upper_limit="312"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.03" lower_limit="8.81" upper_limit="14"/>
                    <measurement group_id="O2" value="80.70" lower_limit="65" upper_limit="101"/>
                    <measurement group_id="O3" value="76.97" lower_limit="59" upper_limit="100"/>
                    <measurement group_id="O4" value="260.57" lower_limit="199" upper_limit="342"/>
                    <measurement group_id="O5" value="24.59" lower_limit="19" upper_limit="32"/>
                    <measurement group_id="O6" value="476.44" lower_limit="369" upper_limit="615"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C (Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.45" lower_limit="6.79" upper_limit="11"/>
                    <measurement group_id="O2" value="37.45" lower_limit="30" upper_limit="47"/>
                    <measurement group_id="O3" value="38.42" lower_limit="30" upper_limit="50"/>
                    <measurement group_id="O4" value="57.48" lower_limit="44" upper_limit="75"/>
                    <measurement group_id="O5" value="303.63" lower_limit="235" upper_limit="392"/>
                    <measurement group_id="O6" value="113.72" lower_limit="89" upper_limit="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.43" lower_limit="4.46" upper_limit="9.27"/>
                    <measurement group_id="O2" value="4.75" lower_limit="3.35" upper_limit="6.73"/>
                    <measurement group_id="O3" value="4.54" lower_limit="2.98" upper_limit="6.90"/>
                    <measurement group_id="O4" value="4.29" lower_limit="2.80" upper_limit="6.58"/>
                    <measurement group_id="O5" value="4.95" lower_limit="3.30" upper_limit="7.44"/>
                    <measurement group_id="O6" value="4.46" lower_limit="2.97" upper_limit="6.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.43" lower_limit="13" upper_limit="23"/>
                    <measurement group_id="O2" value="50.71" lower_limit="39" upper_limit="66"/>
                    <measurement group_id="O3" value="175.57" lower_limit="128" upper_limit="241"/>
                    <measurement group_id="O4" value="59.37" lower_limit="43" upper_limit="82"/>
                    <measurement group_id="O5" value="94.34" lower_limit="69" upper_limit="128"/>
                    <measurement group_id="O6" value="47.54" lower_limit="35" upper_limit="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="138.43" lower_limit="111" upper_limit="173"/>
                    <measurement group_id="O2" value="214.70" lower_limit="173" upper_limit="266"/>
                    <measurement group_id="O3" value="125.70" lower_limit="97" upper_limit="162"/>
                    <measurement group_id="O4" value="59.26" lower_limit="46" upper_limit="77"/>
                    <measurement group_id="O5" value="86.66" lower_limit="68" upper_limit="111"/>
                    <measurement group_id="O6" value="200.91" lower_limit="157" upper_limit="258"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.53" lower_limit="18" upper_limit="29"/>
                    <measurement group_id="O2" value="79.96" lower_limit="63" upper_limit="101"/>
                    <measurement group_id="O3" value="74.84" lower_limit="57" upper_limit="99"/>
                    <measurement group_id="O4" value="340.85" lower_limit="256" upper_limit="453"/>
                    <measurement group_id="O5" value="58.19" lower_limit="44" upper_limit="76"/>
                    <measurement group_id="O6" value="270.12" lower_limit="206" upper_limit="354"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W (Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.63" lower_limit="9.86" upper_limit="16"/>
                    <measurement group_id="O2" value="45.63" lower_limit="36" upper_limit="58"/>
                    <measurement group_id="O3" value="46.83" lower_limit="35" upper_limit="62"/>
                    <measurement group_id="O4" value="96.43" lower_limit="72" upper_limit="129"/>
                    <measurement group_id="O5" value="478.73" lower_limit="363" upper_limit="631"/>
                    <measurement group_id="O6" value="95.90" lower_limit="73" upper_limit="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (Month 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.72" lower_limit="1.41" upper_limit="2.10"/>
                    <measurement group_id="O2" value="1.40" lower_limit="1.14" upper_limit="1.71"/>
                    <measurement group_id="O3" value="1.68" lower_limit="1.32" upper_limit="2.13"/>
                    <measurement group_id="O4" value="1.24" lower_limit="0.97" upper_limit="1.59"/>
                    <measurement group_id="O5" value="1.79" lower_limit="1.42" upper_limit="2.25"/>
                    <measurement group_id="O6" value="1.34" lower_limit="1.07" upper_limit="1.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.36" lower_limit="1.72" upper_limit="3.23"/>
                    <measurement group_id="O2" value="19.43" lower_limit="14" upper_limit="27"/>
                    <measurement group_id="O3" value="63.45" lower_limit="44" upper_limit="93"/>
                    <measurement group_id="O4" value="16.41" lower_limit="11" upper_limit="24"/>
                    <measurement group_id="O5" value="27.00" lower_limit="19" upper_limit="39"/>
                    <measurement group_id="O6" value="19.82" lower_limit="14" upper_limit="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.12" lower_limit="2.34" upper_limit="4.17"/>
                    <measurement group_id="O2" value="90.61" lower_limit="68" upper_limit="121"/>
                    <measurement group_id="O3" value="42.97" lower_limit="30" upper_limit="61"/>
                    <measurement group_id="O4" value="15.95" lower_limit="11" upper_limit="23"/>
                    <measurement group_id="O5" value="18.76" lower_limit="13" upper_limit="26"/>
                    <measurement group_id="O6" value="97.12" lower_limit="70" upper_limit="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.44" lower_limit="1.87" upper_limit="3.17"/>
                    <measurement group_id="O2" value="34.27" lower_limit="26" upper_limit="45"/>
                    <measurement group_id="O3" value="27.86" lower_limit="20" upper_limit="38"/>
                    <measurement group_id="O4" value="152.73" lower_limit="111" upper_limit="211"/>
                    <measurement group_id="O5" value="14.29" lower_limit="11" upper_limit="19"/>
                    <measurement group_id="O6" value="180.33" lower_limit="135" upper_limit="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y (Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.28" lower_limit="1.75" upper_limit="2.96"/>
                    <measurement group_id="O2" value="18.13" lower_limit="14" upper_limit="24"/>
                    <measurement group_id="O3" value="15.19" lower_limit="11" upper_limit="21"/>
                    <measurement group_id="O4" value="42.14" lower_limit="31" upper_limit="58"/>
                    <measurement group_id="O5" value="231.39" lower_limit="171" upper_limit="313"/>
                    <measurement group_id="O6" value="53.78" lower_limit="40" upper_limit="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against NZ98/254 B Strain for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against NZ98/254 B strain was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against NZ98/254 B Strain for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against NZ98/254 B strain was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="185"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="112"/>
                <count group_id="O5" value="126"/>
                <count group_id="O6" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 Strain (At Month 0) ≥ LLQ (8.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.73" upper_limit="11.53"/>
                    <measurement group_id="O2" value="6" lower_limit="3.40" upper_limit="11.06"/>
                    <measurement group_id="O3" value="6" lower_limit="2.38" upper_limit="11.65"/>
                    <measurement group_id="O4" value="5" lower_limit="1.99" upper_limit="11.30"/>
                    <measurement group_id="O5" value="4" lower_limit="1.30" upper_limit="9.02"/>
                    <measurement group_id="O6" value="2" lower_limit="0.46" upper_limit="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="4.94" upper_limit="13.45"/>
                    <measurement group_id="O2" value="7" lower_limit="3.79" upper_limit="11.72"/>
                    <measurement group_id="O3" value="7" lower_limit="2.92" upper_limit="12.71"/>
                    <measurement group_id="O4" value="5" lower_limit="1.99" upper_limit="11.30"/>
                    <measurement group_id="O5" value="6" lower_limit="2.26" upper_limit="11.11"/>
                    <measurement group_id="O6" value="3" lower_limit="0.82" upper_limit="7.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="4.13" upper_limit="12.18"/>
                    <measurement group_id="O2" value="6" lower_limit="3.40" upper_limit="11.06"/>
                    <measurement group_id="O3" value="6" lower_limit="2.38" upper_limit="11.65"/>
                    <measurement group_id="O4" value="5" lower_limit="1.99" upper_limit="11.30"/>
                    <measurement group_id="O5" value="4" lower_limit="1.30" upper_limit="9.02"/>
                    <measurement group_id="O6" value="2" lower_limit="0.46" upper_limit="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.85" upper_limit="8.21"/>
                    <measurement group_id="O2" value="5" lower_limit="2.62" upper_limit="9.72"/>
                    <measurement group_id="O3" value="4" lower_limit="1.37" upper_limit="9.46"/>
                    <measurement group_id="O4" value="4" lower_limit="0.98" upper_limit="8.89"/>
                    <measurement group_id="O5" value="2" lower_limit="0.19" upper_limit="5.62"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.33" upper_limit="4.59"/>
                    <measurement group_id="O2" value="3" lower_limit="0.88" upper_limit="6.19"/>
                    <measurement group_id="O3" value="3" lower_limit="0.52" upper_limit="7.13"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.87"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="2.89"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.94"/>
                    <measurement group_id="O2" value="3" lower_limit="0.34" upper_limit="4.67"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="3.03"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.87"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="2.89"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.94"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="1.97"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="3.03"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.24"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="2.89"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 2) ≥ LLQ (8.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.55" upper_limit="30.12"/>
                    <measurement group_id="O2" value="20" lower_limit="14.49" upper_limit="26.50"/>
                    <measurement group_id="O3" value="43" lower_limit="33.53" upper_limit="51.85"/>
                    <measurement group_id="O4" value="17" lower_limit="10.53" upper_limit="25.22"/>
                    <measurement group_id="O5" value="27" lower_limit="19.47" upper_limit="35.62"/>
                    <measurement group_id="O6" value="18" lower_limit="11.83" upper_limit="25.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="22.86" upper_limit="36.32"/>
                    <measurement group_id="O2" value="24" lower_limit="18.33" upper_limit="31.16"/>
                    <measurement group_id="O3" value="58" lower_limit="48.98" upper_limit="67.26"/>
                    <measurement group_id="O4" value="18" lower_limit="11.26" upper_limit="26.22"/>
                    <measurement group_id="O5" value="36" lower_limit="27.38" upper_limit="44.74"/>
                    <measurement group_id="O6" value="20" lower_limit="13.72" upper_limit="27.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.55" upper_limit="30.12"/>
                    <measurement group_id="O2" value="20" lower_limit="14.49" upper_limit="26.50"/>
                    <measurement group_id="O3" value="43" lower_limit="33.53" upper_limit="51.85"/>
                    <measurement group_id="O4" value="17" lower_limit="10.53" upper_limit="25.22"/>
                    <measurement group_id="O5" value="28" lower_limit="20.17" upper_limit="36.46"/>
                    <measurement group_id="O6" value="18" lower_limit="11.83" upper_limit="25.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.79" upper_limit="25.51"/>
                    <measurement group_id="O2" value="15" lower_limit="10.30" upper_limit="21.13"/>
                    <measurement group_id="O3" value="28" lower_limit="20.49" upper_limit="37.28"/>
                    <measurement group_id="O4" value="11" lower_limit="5.66" upper_limit="17.97"/>
                    <measurement group_id="O5" value="23" lower_limit="15.99" upper_limit="31.35"/>
                    <measurement group_id="O6" value="13" lower_limit="7.57" upper_limit="19.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10.13" upper_limit="20.80"/>
                    <measurement group_id="O2" value="10" lower_limit="5.87" upper_limit="14.94"/>
                    <measurement group_id="O3" value="20" lower_limit="13.25" upper_limit="28.28"/>
                    <measurement group_id="O4" value="9" lower_limit="4.36" upper_limit="15.81"/>
                    <measurement group_id="O5" value="17" lower_limit="10.62" upper_limit="24.34"/>
                    <measurement group_id="O6" value="7" lower_limit="3.64" upper_limit="13.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="4.94" upper_limit="13.45"/>
                    <measurement group_id="O2" value="7" lower_limit="3.79" upper_limit="11.72"/>
                    <measurement group_id="O3" value="12" lower_limit="6.53" upper_limit="18.80"/>
                    <measurement group_id="O4" value="4" lower_limit="0.98" upper_limit="8.89"/>
                    <measurement group_id="O5" value="13" lower_limit="7.44" upper_limit="19.80"/>
                    <measurement group_id="O6" value="2" lower_limit="0.46" upper_limit="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.33" upper_limit="4.59"/>
                    <measurement group_id="O2" value="5" lower_limit="2.25" upper_limit="9.03"/>
                    <measurement group_id="O3" value="5" lower_limit="1.86" upper_limit="10.57"/>
                    <measurement group_id="O4" value="3" lower_limit="0.56" upper_limit="7.63"/>
                    <measurement group_id="O5" value="6" lower_limit="2.78" upper_limit="12.13"/>
                    <measurement group_id="O6" value="1" lower_limit="0.18" upper_limit="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 3) ≥ LLQ (8.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="82.82" upper_limit="92.52"/>
                    <measurement group_id="O2" value="61" lower_limit="53.65" upper_limit="68.15"/>
                    <measurement group_id="O3" value="30" lower_limit="21.98" upper_limit="39.04"/>
                    <measurement group_id="O4" value="14" lower_limit="8.39" upper_limit="22.16"/>
                    <measurement group_id="O5" value="20" lower_limit="13.27" upper_limit="27.88"/>
                    <measurement group_id="O6" value="68" lower_limit="59.30" upper_limit="75.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="89.12" upper_limit="96.66"/>
                    <measurement group_id="O2" value="76" lower_limit="68.84" upper_limit="81.67"/>
                    <measurement group_id="O3" value="38" lower_limit="29.61" upper_limit="47.65"/>
                    <measurement group_id="O4" value="17" lower_limit="10.53" upper_limit="25.22"/>
                    <measurement group_id="O5" value="27" lower_limit="19.47" upper_limit="35.62"/>
                    <measurement group_id="O6" value="78" lower_limit="70.42" upper_limit="85.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="82.82" upper_limit="92.52"/>
                    <measurement group_id="O2" value="63" lower_limit="55.30" upper_limit="69.69"/>
                    <measurement group_id="O3" value="30" lower_limit="21.98" upper_limit="39.04"/>
                    <measurement group_id="O4" value="14" lower_limit="8.39" upper_limit="22.16"/>
                    <measurement group_id="O5" value="21" lower_limit="13.94" upper_limit="28.75"/>
                    <measurement group_id="O6" value="69" lower_limit="60.86" upper_limit="77.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74" lower_limit="67.05" upper_limit="80.05"/>
                    <measurement group_id="O2" value="44" lower_limit="37.04" upper_limit="51.79"/>
                    <measurement group_id="O3" value="18" lower_limit="11.86" upper_limit="26.43"/>
                    <measurement group_id="O4" value="11" lower_limit="5.66" upper_limit="17.97"/>
                    <measurement group_id="O5" value="14" lower_limit="8.69" upper_limit="21.63"/>
                    <measurement group_id="O6" value="46" lower_limit="37.62" upper_limit="55.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" lower_limit="42.64" upper_limit="57.36"/>
                    <measurement group_id="O2" value="23" lower_limit="17.36" upper_limit="30.00"/>
                    <measurement group_id="O3" value="13" lower_limit="7.17" upper_limit="19.78"/>
                    <measurement group_id="O4" value="5" lower_limit="1.99" upper_limit="11.30"/>
                    <measurement group_id="O5" value="10" lower_limit="5.02" upper_limit="16.05"/>
                    <measurement group_id="O6" value="19" lower_limit="12.45" upper_limit="26.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="22.86" upper_limit="36.32"/>
                    <measurement group_id="O2" value="12" lower_limit="7.60" upper_limit="17.45"/>
                    <measurement group_id="O3" value="6" lower_limit="2.38" upper_limit="11.65"/>
                    <measurement group_id="O4" value="4" lower_limit="0.98" upper_limit="8.89"/>
                    <measurement group_id="O5" value="6" lower_limit="2.26" upper_limit="11.11"/>
                    <measurement group_id="O6" value="14" lower_limit="8.76" upper_limit="21.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="7.48" upper_limit="17.18"/>
                    <measurement group_id="O2" value="6" lower_limit="3.40" upper_limit="11.06"/>
                    <measurement group_id="O3" value="4" lower_limit="1.37" upper_limit="9.46"/>
                    <measurement group_id="O4" value="2" lower_limit="0.22" upper_limit="6.30"/>
                    <measurement group_id="O5" value="4" lower_limit="1.30" upper_limit="9.02"/>
                    <measurement group_id="O6" value="4" lower_limit="1.66" upper_limit="9.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 7) ≥ LLQ (8.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="20.43" upper_limit="33.52"/>
                    <measurement group_id="O2" value="19" lower_limit="14.02" upper_limit="25.91"/>
                    <measurement group_id="O3" value="14" lower_limit="8.47" upper_limit="21.71"/>
                    <measurement group_id="O4" value="63" lower_limit="53.76" upper_limit="72.29"/>
                    <measurement group_id="O5" value="13" lower_limit="7.44" upper_limit="19.80"/>
                    <measurement group_id="O6" value="72" lower_limit="64.00" upper_limit="79.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" lower_limit="26.31" upper_limit="40.19"/>
                    <measurement group_id="O2" value="27" lower_limit="20.77" upper_limit="34.03"/>
                    <measurement group_id="O3" value="18" lower_limit="11.86" upper_limit="26.43"/>
                    <measurement group_id="O4" value="80" lower_limit="71.78" upper_limit="87.26"/>
                    <measurement group_id="O5" value="17" lower_limit="11.28" upper_limit="25.23"/>
                    <measurement group_id="O6" value="82" lower_limit="74.53" upper_limit="88.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="20.43" upper_limit="33.52"/>
                    <measurement group_id="O2" value="20" lower_limit="14.49" upper_limit="26.50"/>
                    <measurement group_id="O3" value="14" lower_limit="8.47" upper_limit="21.71"/>
                    <measurement group_id="O4" value="69" lower_limit="59.30" upper_limit="77.17"/>
                    <measurement group_id="O5" value="13" lower_limit="7.44" upper_limit="19.80"/>
                    <measurement group_id="O6" value="74" lower_limit="65.59" upper_limit="81.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="15.19" upper_limit="27.25"/>
                    <measurement group_id="O2" value="14" lower_limit="9.39" upper_limit="19.91"/>
                    <measurement group_id="O3" value="12" lower_limit="6.53" upper_limit="18.80"/>
                    <measurement group_id="O4" value="46" lower_limit="36.10" upper_limit="55.22"/>
                    <measurement group_id="O5" value="10" lower_limit="5.02" upper_limit="16.05"/>
                    <measurement group_id="O6" value="55" lower_limit="46.40" upper_limit="63.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="7.92" upper_limit="17.79"/>
                    <measurement group_id="O2" value="10" lower_limit="6.30" upper_limit="15.57"/>
                    <measurement group_id="O3" value="9" lower_limit="4.67" upper_limit="15.81"/>
                    <measurement group_id="O4" value="26" lower_limit="18.08" upper_limit="35.03"/>
                    <measurement group_id="O5" value="4" lower_limit="1.30" upper_limit="9.02"/>
                    <measurement group_id="O6" value="34" lower_limit="25.66" upper_limit="42.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="3.34" upper_limit="10.88"/>
                    <measurement group_id="O2" value="6" lower_limit="3.40" upper_limit="11.06"/>
                    <measurement group_id="O3" value="6" lower_limit="2.38" upper_limit="11.65"/>
                    <measurement group_id="O4" value="13" lower_limit="7.69" upper_limit="21.13"/>
                    <measurement group_id="O5" value="2" lower_limit="0.19" upper_limit="5.62"/>
                    <measurement group_id="O6" value="16" lower_limit="10.58" upper_limit="23.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.33" upper_limit="4.59"/>
                    <measurement group_id="O2" value="4" lower_limit="1.53" upper_limit="7.64"/>
                    <measurement group_id="O3" value="5" lower_limit="1.86" upper_limit="10.57"/>
                    <measurement group_id="O4" value="7" lower_limit="3.13" upper_limit="13.59"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.34"/>
                    <measurement group_id="O6" value="5" lower_limit="2.13" upper_limit="10.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 13) ≥ LLQ (8.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="15.19" upper_limit="27.25"/>
                    <measurement group_id="O2" value="16" lower_limit="11.22" upper_limit="22.33"/>
                    <measurement group_id="O3" value="15" lower_limit="9.14" upper_limit="22.67"/>
                    <measurement group_id="O4" value="18" lower_limit="11.26" upper_limit="26.22"/>
                    <measurement group_id="O5" value="73" lower_limit="64.38" upper_limit="80.53"/>
                    <measurement group_id="O6" value="19" lower_limit="13.08" upper_limit="27.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="20.43" upper_limit="33.52"/>
                    <measurement group_id="O2" value="19" lower_limit="14.02" upper_limit="25.91"/>
                    <measurement group_id="O3" value="16" lower_limit="9.81" upper_limit="23.62"/>
                    <measurement group_id="O4" value="28" lower_limit="19.64" upper_limit="36.93"/>
                    <measurement group_id="O5" value="85" lower_limit="77.46" upper_limit="90.67"/>
                    <measurement group_id="O6" value="25" lower_limit="17.60" upper_limit="32.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="15.19" upper_limit="27.25"/>
                    <measurement group_id="O2" value="16" lower_limit="11.22" upper_limit="22.33"/>
                    <measurement group_id="O3" value="15" lower_limit="9.14" upper_limit="22.67"/>
                    <measurement group_id="O4" value="18" lower_limit="11.26" upper_limit="26.22"/>
                    <measurement group_id="O5" value="74" lower_limit="65.23" upper_limit="81.24"/>
                    <measurement group_id="O6" value="19" lower_limit="13.08" upper_limit="27.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10.13" upper_limit="20.80"/>
                    <measurement group_id="O2" value="12" lower_limit="8.05" upper_limit="18.07"/>
                    <measurement group_id="O3" value="8" lower_limit="4.07" upper_limit="14.79"/>
                    <measurement group_id="O4" value="12" lower_limit="6.33" upper_limit="19.03"/>
                    <measurement group_id="O5" value="49" lower_limit="40.19" upper_limit="58.26"/>
                    <measurement group_id="O6" value="14" lower_limit="8.76" upper_limit="21.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="4.13" upper_limit="12.18"/>
                    <measurement group_id="O2" value="7" lower_limit="3.79" upper_limit="11.72"/>
                    <measurement group_id="O3" value="8" lower_limit="3.49" upper_limit="13.76"/>
                    <measurement group_id="O4" value="8" lower_limit="3.74" upper_limit="14.71"/>
                    <measurement group_id="O5" value="30" lower_limit="22.31" upper_limit="38.97"/>
                    <measurement group_id="O6" value="4" lower_limit="1.66" upper_limit="9.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0.87" upper_limit="6.10"/>
                    <measurement group_id="O2" value="5" lower_limit="2.25" upper_limit="9.03"/>
                    <measurement group_id="O3" value="5" lower_limit="1.86" upper_limit="10.57"/>
                    <measurement group_id="O4" value="5" lower_limit="1.99" upper_limit="11.30"/>
                    <measurement group_id="O5" value="13" lower_limit="8.06" upper_limit="20.72"/>
                    <measurement group_id="O6" value="3" lower_limit="0.82" upper_limit="7.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.33" upper_limit="4.59"/>
                    <measurement group_id="O2" value="3" lower_limit="0.88" upper_limit="6.19"/>
                    <measurement group_id="O3" value="3" lower_limit="0.92" upper_limit="8.31"/>
                    <measurement group_id="O4" value="3" lower_limit="0.56" upper_limit="7.63"/>
                    <measurement group_id="O5" value="6" lower_limit="2.78" upper_limit="12.13"/>
                    <measurement group_id="O6" value="2" lower_limit="0.46" upper_limit="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M14459 B Strain for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M14459 B strain was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M14459 B Strain for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M14459 B strain was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="184"/>
                <count group_id="O2" value="179"/>
                <count group_id="O3" value="112"/>
                <count group_id="O4" value="108"/>
                <count group_id="O5" value="123"/>
                <count group_id="O6" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>M14459 Strain (At Month 0) ≥ LLQ (8.0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.41" upper_limit="11.11"/>
                    <measurement group_id="O2" value="5" lower_limit="2.32" upper_limit="9.33"/>
                    <measurement group_id="O3" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O4" value="4" lower_limit="1.02" upper_limit="9.21"/>
                    <measurement group_id="O5" value="7" lower_limit="2.85" upper_limit="12.41"/>
                    <measurement group_id="O6" value="2" lower_limit="0.46" upper_limit="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="7.65" upper_limit="17.54"/>
                    <measurement group_id="O2" value="7" lower_limit="3.92" upper_limit="12.10"/>
                    <measurement group_id="O3" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O4" value="6" lower_limit="2.65" upper_limit="12.90"/>
                    <measurement group_id="O5" value="11" lower_limit="6.36" upper_limit="18.36"/>
                    <measurement group_id="O6" value="4" lower_limit="1.22" upper_limit="8.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.41" upper_limit="11.11"/>
                    <measurement group_id="O2" value="5" lower_limit="2.32" upper_limit="9.33"/>
                    <measurement group_id="O3" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O4" value="4" lower_limit="1.02" upper_limit="9.21"/>
                    <measurement group_id="O5" value="7" lower_limit="2.85" upper_limit="12.41"/>
                    <measurement group_id="O6" value="2" lower_limit="0.46" upper_limit="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0.89" upper_limit="6.23"/>
                    <measurement group_id="O2" value="2" lower_limit="0.35" upper_limit="4.82"/>
                    <measurement group_id="O3" value="2" lower_limit="0.22" upper_limit="6.30"/>
                    <measurement group_id="O4" value="3" lower_limit="0.58" upper_limit="7.90"/>
                    <measurement group_id="O5" value="2" lower_limit="0.51" upper_limit="6.96"/>
                    <measurement group_id="O6" value="1" lower_limit="0.18" upper_limit="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.34" upper_limit="4.69"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2.04"/>
                    <measurement group_id="O3" value="1" lower_limit="0.02" upper_limit="4.87"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.05"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="2.95"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.13" upper_limit="3.87"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2.04"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="3.24"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.36"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="2.95"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.98"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2.04"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="3.24"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.36"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="2.95"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 2) ≥ LLQ (8.0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="21.88" upper_limit="35.35"/>
                    <measurement group_id="O2" value="24" lower_limit="17.96" upper_limit="30.96"/>
                    <measurement group_id="O3" value="61" lower_limit="51.04" upper_limit="69.81"/>
                    <measurement group_id="O4" value="17" lower_limit="10.19" upper_limit="25.06"/>
                    <measurement group_id="O5" value="34" lower_limit="25.84" upper_limit="43.24"/>
                    <measurement group_id="O6" value="17" lower_limit="11.20" upper_limit="24.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" lower_limit="30.49" upper_limit="44.92"/>
                    <measurement group_id="O2" value="30" lower_limit="23.03" upper_limit="36.88"/>
                    <measurement group_id="O3" value="75" lower_limit="65.93" upper_limit="82.70"/>
                    <measurement group_id="O4" value="26" lower_limit="17.97" upper_limit="35.25"/>
                    <measurement group_id="O5" value="42" lower_limit="33.42" upper_limit="51.51"/>
                    <measurement group_id="O6" value="22" lower_limit="15.64" upper_limit="30.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="21.88" upper_limit="35.35"/>
                    <measurement group_id="O2" value="24" lower_limit="17.96" upper_limit="30.96"/>
                    <measurement group_id="O3" value="61" lower_limit="51.04" upper_limit="69.81"/>
                    <measurement group_id="O4" value="17" lower_limit="10.19" upper_limit="25.06"/>
                    <measurement group_id="O5" value="34" lower_limit="25.84" upper_limit="43.24"/>
                    <measurement group_id="O6" value="17" lower_limit="11.20" upper_limit="24.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="11.74" upper_limit="23.05"/>
                    <measurement group_id="O2" value="13" lower_limit="8.32" upper_limit="18.65"/>
                    <measurement group_id="O3" value="34" lower_limit="25.25" upper_limit="43.48"/>
                    <measurement group_id="O4" value="11" lower_limit="5.87" upper_limit="18.06"/>
                    <measurement group_id="O5" value="25" lower_limit="17.81" upper_limit="33.83"/>
                    <measurement group_id="O6" value="12" lower_limit="6.98" upper_limit="18.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.05" upper_limit="13.74"/>
                    <measurement group_id="O2" value="6" lower_limit="3.11" upper_limit="10.73"/>
                    <measurement group_id="O3" value="19" lower_limit="12.00" upper_limit="27.22"/>
                    <measurement group_id="O4" value="6" lower_limit="2.07" upper_limit="11.70"/>
                    <measurement group_id="O5" value="13" lower_limit="7.62" upper_limit="20.26"/>
                    <measurement group_id="O6" value="5" lower_limit="2.13" upper_limit="10.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.90" upper_limit="8.39"/>
                    <measurement group_id="O2" value="2" lower_limit="0.61" upper_limit="5.62"/>
                    <measurement group_id="O3" value="4" lower_limit="0.98" upper_limit="8.89"/>
                    <measurement group_id="O4" value="2" lower_limit="0.23" upper_limit="6.53"/>
                    <measurement group_id="O5" value="8" lower_limit="3.97" upper_limit="14.44"/>
                    <measurement group_id="O6" value="2" lower_limit="0.46" upper_limit="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.01" upper_limit="2.99"/>
                    <measurement group_id="O2" value="2" lower_limit="0.35" upper_limit="4.82"/>
                    <measurement group_id="O3" value="2" lower_limit="0.22" upper_limit="6.30"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.05"/>
                    <measurement group_id="O5" value="5" lower_limit="1.81" upper_limit="10.32"/>
                    <measurement group_id="O6" value="1" lower_limit="0.18" upper_limit="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 3) ≥ LLQ (8.0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" lower_limit="75.75" upper_limit="87.32"/>
                    <measurement group_id="O2" value="68" lower_limit="60.21" upper_limit="74.39"/>
                    <measurement group_id="O3" value="44" lower_limit="34.39" upper_limit="53.44"/>
                    <measurement group_id="O4" value="16" lower_limit="9.45" upper_limit="24.00"/>
                    <measurement group_id="O5" value="28" lower_limit="20.69" upper_limit="37.29"/>
                    <measurement group_id="O6" value="73" lower_limit="64.80" upper_limit="80.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" lower_limit="78.16" upper_limit="89.18"/>
                    <measurement group_id="O2" value="74" lower_limit="66.66" upper_limit="80.03"/>
                    <measurement group_id="O3" value="54" lower_limit="44.78" upper_limit="63.90"/>
                    <measurement group_id="O4" value="20" lower_limit="13.23" upper_limit="29.20"/>
                    <measurement group_id="O5" value="35" lower_limit="26.58" upper_limit="44.08"/>
                    <measurement group_id="O6" value="80" lower_limit="72.05" upper_limit="86.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" lower_limit="75.75" upper_limit="87.32"/>
                    <measurement group_id="O2" value="68" lower_limit="60.21" upper_limit="74.39"/>
                    <measurement group_id="O3" value="44" lower_limit="34.39" upper_limit="53.44"/>
                    <measurement group_id="O4" value="16" lower_limit="9.45" upper_limit="24.00"/>
                    <measurement group_id="O5" value="28" lower_limit="20.69" upper_limit="37.29"/>
                    <measurement group_id="O6" value="73" lower_limit="64.80" upper_limit="80.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="58.98" upper_limit="73.09"/>
                    <measurement group_id="O2" value="51" lower_limit="43.83" upper_limit="58.92"/>
                    <measurement group_id="O3" value="24" lower_limit="16.53" upper_limit="33.10"/>
                    <measurement group_id="O4" value="9" lower_limit="4.53" upper_limit="16.37"/>
                    <measurement group_id="O5" value="18" lower_limit="11.56" upper_limit="25.82"/>
                    <measurement group_id="O6" value="51" lower_limit="41.98" upper_limit="59.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39" lower_limit="32.03" upper_limit="46.58"/>
                    <measurement group_id="O2" value="30" lower_limit="23.54" upper_limit="37.46"/>
                    <measurement group_id="O3" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O4" value="4" lower_limit="1.02" upper_limit="9.21"/>
                    <measurement group_id="O5" value="9" lower_limit="4.55" upper_limit="15.44"/>
                    <measurement group_id="O6" value="28" lower_limit="20.91" upper_limit="36.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="12.68" upper_limit="24.25"/>
                    <measurement group_id="O2" value="11" lower_limit="6.51" upper_limit="16.08"/>
                    <measurement group_id="O3" value="3" lower_limit="0.56" upper_limit="7.63"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.05"/>
                    <measurement group_id="O5" value="4" lower_limit="1.33" upper_limit="9.23"/>
                    <measurement group_id="O6" value="10" lower_limit="5.83" upper_limit="16.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.41" upper_limit="11.11"/>
                    <measurement group_id="O2" value="2" lower_limit="0.61" upper_limit="5.62"/>
                    <measurement group_id="O3" value="2" lower_limit="0.22" upper_limit="6.30"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.05"/>
                    <measurement group_id="O5" value="3" lower_limit="0.89" upper_limit="8.12"/>
                    <measurement group_id="O6" value="3" lower_limit="0.82" upper_limit="7.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 7) ≥ LLQ (8.0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" lower_limit="26.91" upper_limit="41.02"/>
                    <measurement group_id="O2" value="30" lower_limit="23.03" upper_limit="36.88"/>
                    <measurement group_id="O3" value="17" lower_limit="10.53" upper_limit="25.22"/>
                    <measurement group_id="O4" value="86" lower_limit="78.13" upper_limit="92.01"/>
                    <measurement group_id="O5" value="15" lower_limit="9.56" upper_limit="23.07"/>
                    <measurement group_id="O6" value="89" lower_limit="82.21" upper_limit="93.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="36.73" upper_limit="51.51"/>
                    <measurement group_id="O2" value="35" lower_limit="28.22" upper_limit="42.67"/>
                    <measurement group_id="O3" value="21" lower_limit="14.24" upper_limit="30.19"/>
                    <measurement group_id="O4" value="92" lower_limit="84.77" upper_limit="96.12"/>
                    <measurement group_id="O5" value="20" lower_limit="12.92" upper_limit="27.63"/>
                    <measurement group_id="O6" value="93" lower_limit="87.63" upper_limit="96.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" lower_limit="26.91" upper_limit="41.02"/>
                    <measurement group_id="O2" value="30" lower_limit="23.03" upper_limit="36.88"/>
                    <measurement group_id="O3" value="17" lower_limit="10.53" upper_limit="25.22"/>
                    <measurement group_id="O4" value="86" lower_limit="78.13" upper_limit="92.01"/>
                    <measurement group_id="O5" value="15" lower_limit="9.56" upper_limit="23.07"/>
                    <measurement group_id="O6" value="89" lower_limit="82.21" upper_limit="93.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.62" upper_limit="25.45"/>
                    <measurement group_id="O2" value="14" lower_limit="9.25" upper_limit="19.92"/>
                    <measurement group_id="O3" value="10" lower_limit="5.01" upper_limit="16.89"/>
                    <measurement group_id="O4" value="69" lower_limit="59.84" upper_limit="77.95"/>
                    <measurement group_id="O5" value="8" lower_limit="3.97" upper_limit="14.44"/>
                    <measurement group_id="O6" value="72" lower_limit="63.21" upper_limit="79.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="7.21" upper_limit="16.92"/>
                    <measurement group_id="O2" value="7" lower_limit="3.51" upper_limit="11.42"/>
                    <measurement group_id="O3" value="5" lower_limit="1.99" upper_limit="11.30"/>
                    <measurement group_id="O4" value="50" lower_limit="40.22" upper_limit="59.78"/>
                    <measurement group_id="O5" value="6" lower_limit="2.32" upper_limit="11.37"/>
                    <measurement group_id="O6" value="49" lower_limit="40.52" upper_limit="58.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.21" upper_limit="6.96"/>
                    <measurement group_id="O2" value="4" lower_limit="1.59" upper_limit="7.89"/>
                    <measurement group_id="O3" value="3" lower_limit="0.56" upper_limit="7.63"/>
                    <measurement group_id="O4" value="23" lower_limit="15.57" upper_limit="32.25"/>
                    <measurement group_id="O5" value="4" lower_limit="1.33" upper_limit="9.23"/>
                    <measurement group_id="O6" value="22" lower_limit="15.64" upper_limit="30.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.98"/>
                    <measurement group_id="O2" value="1" lower_limit="0.01" upper_limit="3.07"/>
                    <measurement group_id="O3" value="1" lower_limit="0.02" upper_limit="4.87"/>
                    <measurement group_id="O4" value="10" lower_limit="5.20" upper_limit="17.49"/>
                    <measurement group_id="O5" value="2" lower_limit="0.20" upper_limit="5.75"/>
                    <measurement group_id="O6" value="7" lower_limit="3.12" upper_limit="12.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 13) ≥ LLQ (8.0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.46" upper_limit="30.16"/>
                    <measurement group_id="O2" value="20" lower_limit="14.01" upper_limit="26.13"/>
                    <measurement group_id="O3" value="13" lower_limit="7.01" upper_limit="20.08"/>
                    <measurement group_id="O4" value="23" lower_limit="15.57" upper_limit="32.25"/>
                    <measurement group_id="O5" value="89" lower_limit="81.64" upper_limit="93.64"/>
                    <measurement group_id="O6" value="27" lower_limit="19.58" upper_limit="35.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="23.88" upper_limit="37.63"/>
                    <measurement group_id="O2" value="26" lower_limit="19.47" upper_limit="32.75"/>
                    <measurement group_id="O3" value="20" lower_limit="12.74" upper_limit="28.22"/>
                    <measurement group_id="O4" value="37" lower_limit="27.94" upper_limit="46.86"/>
                    <measurement group_id="O5" value="93" lower_limit="86.56" upper_limit="96.60"/>
                    <measurement group_id="O6" value="38" lower_limit="29.82" upper_limit="46.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.46" upper_limit="30.16"/>
                    <measurement group_id="O2" value="20" lower_limit="14.01" upper_limit="26.13"/>
                    <measurement group_id="O3" value="13" lower_limit="7.01" upper_limit="20.08"/>
                    <measurement group_id="O4" value="23" lower_limit="15.57" upper_limit="32.25"/>
                    <measurement group_id="O5" value="89" lower_limit="81.64" upper_limit="93.64"/>
                    <measurement group_id="O6" value="27" lower_limit="19.58" upper_limit="35.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="9.90" upper_limit="20.63"/>
                    <measurement group_id="O2" value="9" lower_limit="5.63" upper_limit="14.77"/>
                    <measurement group_id="O3" value="7" lower_limit="3.13" upper_limit="13.59"/>
                    <measurement group_id="O4" value="13" lower_limit="7.27" upper_limit="20.79"/>
                    <measurement group_id="O5" value="76" lower_limit="67.05" upper_limit="82.90"/>
                    <measurement group_id="O6" value="13" lower_limit="7.57" upper_limit="19.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.64" upper_limit="9.77"/>
                    <measurement group_id="O2" value="4" lower_limit="1.95" upper_limit="8.62"/>
                    <measurement group_id="O3" value="4" lower_limit="0.98" upper_limit="8.89"/>
                    <measurement group_id="O4" value="7" lower_limit="3.25" upper_limit="14.07"/>
                    <measurement group_id="O5" value="54" lower_limit="45.25" upper_limit="63.47"/>
                    <measurement group_id="O6" value="6" lower_limit="2.61" upper_limit="11.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.34" upper_limit="4.69"/>
                    <measurement group_id="O2" value="2" lower_limit="0.61" upper_limit="5.62"/>
                    <measurement group_id="O3" value="3" lower_limit="0.56" upper_limit="7.63"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.05"/>
                    <measurement group_id="O5" value="29" lower_limit="21.41" upper_limit="38.15"/>
                    <measurement group_id="O6" value="1" lower_limit="0.18" upper_limit="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.98"/>
                    <measurement group_id="O2" value="1" lower_limit="0.01" upper_limit="3.07"/>
                    <measurement group_id="O3" value="2" lower_limit="0.22" upper_limit="6.30"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.05"/>
                    <measurement group_id="O5" value="11" lower_limit="5.75" upper_limit="17.40"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M07-0241084 B Strain for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M07-0241084 B strain was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M07-0241084 B Strain for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M07-0241084 B strain was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="176"/>
                <count group_id="O3" value="117"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="121"/>
                <count group_id="O6" value="128"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>M07-0241084 Strain (At Month 0) ≥ LLQ (8.9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="15.19" upper_limit="27.25"/>
                    <measurement group_id="O2" value="18" lower_limit="12.78" upper_limit="24.69"/>
                    <measurement group_id="O3" value="17" lower_limit="10.77" upper_limit="25.16"/>
                    <measurement group_id="O4" value="14" lower_limit="8.32" upper_limit="21.97"/>
                    <measurement group_id="O5" value="21" lower_limit="14.54" upper_limit="29.88"/>
                    <measurement group_id="O6" value="19" lower_limit="12.40" upper_limit="26.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="23.35" upper_limit="36.87"/>
                    <measurement group_id="O2" value="28" lower_limit="21.36" upper_limit="35.08"/>
                    <measurement group_id="O3" value="25" lower_limit="17.27" upper_limit="33.62"/>
                    <measurement group_id="O4" value="27" lower_limit="19.46" upper_limit="36.63"/>
                    <measurement group_id="O5" value="30" lower_limit="21.79" upper_limit="38.74"/>
                    <measurement group_id="O6" value="21" lower_limit="14.38" upper_limit="29.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="16.13" upper_limit="28.40"/>
                    <measurement group_id="O2" value="20" lower_limit="14.26" upper_limit="26.56"/>
                    <measurement group_id="O3" value="18" lower_limit="11.47" upper_limit="26.12"/>
                    <measurement group_id="O4" value="19" lower_limit="12.62" upper_limit="27.98"/>
                    <measurement group_id="O5" value="24" lower_limit="16.68" upper_limit="32.57"/>
                    <measurement group_id="O6" value="20" lower_limit="13.72" upper_limit="28.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="8.79" upper_limit="19.00"/>
                    <measurement group_id="O2" value="14" lower_limit="9.41" upper_limit="20.25"/>
                    <measurement group_id="O3" value="12" lower_limit="6.70" upper_limit="19.26"/>
                    <measurement group_id="O4" value="6" lower_limit="2.53" upper_limit="12.35"/>
                    <measurement group_id="O5" value="16" lower_limit="9.73" upper_limit="23.43"/>
                    <measurement group_id="O6" value="15" lower_limit="9.18" upper_limit="22.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4.53" upper_limit="12.82"/>
                    <measurement group_id="O2" value="6" lower_limit="3.16" upper_limit="10.91"/>
                    <measurement group_id="O3" value="7" lower_limit="3.00" upper_limit="13.03"/>
                    <measurement group_id="O4" value="4" lower_limit="0.97" upper_limit="8.82"/>
                    <measurement group_id="O5" value="9" lower_limit="4.63" upper_limit="15.68"/>
                    <measurement group_id="O6" value="6" lower_limit="2.74" upper_limit="11.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.18" upper_limit="6.82"/>
                    <measurement group_id="O2" value="2" lower_limit="0.35" upper_limit="4.90"/>
                    <measurement group_id="O3" value="3" lower_limit="0.53" upper_limit="7.31"/>
                    <measurement group_id="O4" value="2" lower_limit="0.22" upper_limit="6.25"/>
                    <measurement group_id="O5" value="3" lower_limit="0.91" upper_limit="8.25"/>
                    <measurement group_id="O6" value="3" lower_limit="0.86" upper_limit="7.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.94"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2.07"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="3.10"/>
                    <measurement group_id="O4" value="2" lower_limit="0.22" upper_limit="6.25"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.52"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 2) ≥ LLQ (8.9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" lower_limit="30.81" upper_limit="45.11"/>
                    <measurement group_id="O2" value="29" lower_limit="22.40" upper_limit="36.28"/>
                    <measurement group_id="O3" value="37" lower_limit="28.03" upper_limit="46.16"/>
                    <measurement group_id="O4" value="28" lower_limit="20.24" upper_limit="37.57"/>
                    <measurement group_id="O5" value="39" lower_limit="30.12" upper_limit="48.13"/>
                    <measurement group_id="O6" value="30" lower_limit="22.65" upper_limit="39.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="40.03" upper_limit="54.74"/>
                    <measurement group_id="O2" value="43" lower_limit="35.75" upper_limit="50.85"/>
                    <measurement group_id="O3" value="54" lower_limit="44.39" upper_limit="63.10"/>
                    <measurement group_id="O4" value="40" lower_limit="30.73" upper_limit="49.46"/>
                    <measurement group_id="O5" value="54" lower_limit="44.43" upper_limit="62.83"/>
                    <measurement group_id="O6" value="41" lower_limit="32.04" upper_limit="49.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="34.88" upper_limit="49.42"/>
                    <measurement group_id="O2" value="32" lower_limit="25.54" upper_limit="39.84"/>
                    <measurement group_id="O3" value="43" lower_limit="33.63" upper_limit="52.21"/>
                    <measurement group_id="O4" value="31" lower_limit="22.61" upper_limit="40.36"/>
                    <measurement group_id="O5" value="43" lower_limit="34.01" upper_limit="52.29"/>
                    <measurement group_id="O6" value="35" lower_limit="26.93" upper_limit="44.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31" lower_limit="24.33" upper_limit="37.98"/>
                    <measurement group_id="O2" value="22" lower_limit="16.26" upper_limit="29.02"/>
                    <measurement group_id="O3" value="29" lower_limit="21.04" upper_limit="38.17"/>
                    <measurement group_id="O4" value="16" lower_limit="9.72" upper_limit="24.00"/>
                    <measurement group_id="O5" value="30" lower_limit="21.79" upper_limit="38.74"/>
                    <measurement group_id="O6" value="19" lower_limit="12.40" upper_limit="26.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="14.72" upper_limit="26.67"/>
                    <measurement group_id="O2" value="15" lower_limit="10.36" upper_limit="21.53"/>
                    <measurement group_id="O3" value="17" lower_limit="10.77" upper_limit="25.16"/>
                    <measurement group_id="O4" value="7" lower_limit="3.11" upper_limit="13.47"/>
                    <measurement group_id="O5" value="19" lower_limit="12.45" upper_limit="27.14"/>
                    <measurement group_id="O6" value="9" lower_limit="4.37" upper_limit="14.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="5.77" upper_limit="14.71"/>
                    <measurement group_id="O2" value="7" lower_limit="3.99" upper_limit="12.30"/>
                    <measurement group_id="O3" value="9" lower_limit="4.17" upper_limit="15.16"/>
                    <measurement group_id="O4" value="2" lower_limit="0.22" upper_limit="6.25"/>
                    <measurement group_id="O5" value="9" lower_limit="4.63" upper_limit="15.68"/>
                    <measurement group_id="O6" value="5" lower_limit="1.74" upper_limit="9.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.18" upper_limit="6.82"/>
                    <measurement group_id="O2" value="2" lower_limit="0.35" upper_limit="4.90"/>
                    <measurement group_id="O3" value="3" lower_limit="0.53" upper_limit="7.31"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.83"/>
                    <measurement group_id="O5" value="5" lower_limit="1.84" upper_limit="10.48"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 3) ≥ LLQ (8.9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="59.26" upper_limit="73.19"/>
                    <measurement group_id="O2" value="47" lower_limit="39.60" upper_limit="54.81"/>
                    <measurement group_id="O3" value="28" lower_limit="20.28" upper_limit="37.27"/>
                    <measurement group_id="O4" value="28" lower_limit="20.24" upper_limit="37.57"/>
                    <measurement group_id="O5" value="30" lower_limit="21.79" upper_limit="38.74"/>
                    <measurement group_id="O6" value="53" lower_limit="44.11" upper_limit="62.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="72.75" upper_limit="84.81"/>
                    <measurement group_id="O2" value="69" lower_limit="61.94" upper_limit="76.04"/>
                    <measurement group_id="O3" value="43" lower_limit="33.63" upper_limit="52.21"/>
                    <measurement group_id="O4" value="40" lower_limit="30.73" upper_limit="49.46"/>
                    <measurement group_id="O5" value="43" lower_limit="34.01" upper_limit="52.29"/>
                    <measurement group_id="O6" value="62" lower_limit="52.72" upper_limit="70.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" lower_limit="62.02" upper_limit="75.67"/>
                    <measurement group_id="O2" value="55" lower_limit="47.45" upper_limit="62.60"/>
                    <measurement group_id="O3" value="34" lower_limit="25.67" upper_limit="43.53"/>
                    <measurement group_id="O4" value="31" lower_limit="22.61" upper_limit="40.36"/>
                    <measurement group_id="O5" value="34" lower_limit="25.53" upper_limit="43.05"/>
                    <measurement group_id="O6" value="56" lower_limit="47.21" upper_limit="65.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52" lower_limit="44.74" upper_limit="59.45"/>
                    <measurement group_id="O2" value="33" lower_limit="26.07" upper_limit="40.43"/>
                    <measurement group_id="O3" value="21" lower_limit="14.33" upper_limit="29.91"/>
                    <measurement group_id="O4" value="12" lower_limit="6.27" upper_limit="18.87"/>
                    <measurement group_id="O5" value="21" lower_limit="14.54" upper_limit="29.88"/>
                    <measurement group_id="O6" value="40" lower_limit="31.30" upper_limit="48.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" lower_limit="26.31" upper_limit="40.19"/>
                    <measurement group_id="O2" value="18" lower_limit="12.78" upper_limit="24.69"/>
                    <measurement group_id="O3" value="15" lower_limit="9.38" upper_limit="23.22"/>
                    <measurement group_id="O4" value="5" lower_limit="1.97" upper_limit="11.20"/>
                    <measurement group_id="O5" value="15" lower_limit="9.06" upper_limit="22.49"/>
                    <measurement group_id="O6" value="23" lower_limit="15.73" upper_limit="30.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="12.40" upper_limit="23.76"/>
                    <measurement group_id="O2" value="11" lower_limit="7.08" upper_limit="17.00"/>
                    <measurement group_id="O3" value="5" lower_limit="1.90" upper_limit="10.83"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.83"/>
                    <measurement group_id="O5" value="4" lower_limit="1.36" upper_limit="9.38"/>
                    <measurement group_id="O6" value="13" lower_limit="7.32" upper_limit="19.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.21" upper_limit="8.89"/>
                    <measurement group_id="O2" value="3" lower_limit="0.93" upper_limit="6.50"/>
                    <measurement group_id="O3" value="3" lower_limit="0.53" upper_limit="7.31"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.83"/>
                    <measurement group_id="O5" value="2" lower_limit="0.51" upper_limit="7.07"/>
                    <measurement group_id="O6" value="2" lower_limit="0.49" upper_limit="6.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 7) ≥ LLQ (8.9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40" lower_limit="32.84" upper_limit="47.27"/>
                    <measurement group_id="O2" value="30" lower_limit="22.92" upper_limit="36.88"/>
                    <measurement group_id="O3" value="26" lower_limit="18.02" upper_limit="34.54"/>
                    <measurement group_id="O4" value="66" lower_limit="56.88" upper_limit="74.99"/>
                    <measurement group_id="O5" value="26" lower_limit="18.12" upper_limit="34.35"/>
                    <measurement group_id="O6" value="70" lower_limit="61.60" upper_limit="78.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" lower_limit="42.64" upper_limit="57.36"/>
                    <measurement group_id="O2" value="44" lower_limit="36.30" upper_limit="51.42"/>
                    <measurement group_id="O3" value="32" lower_limit="24.11" upper_limit="41.76"/>
                    <measurement group_id="O4" value="83" lower_limit="74.99" upper_limit="89.56"/>
                    <measurement group_id="O5" value="36" lower_limit="27.81" upper_limit="45.60"/>
                    <measurement group_id="O6" value="80" lower_limit="72.53" upper_limit="86.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="34.88" upper_limit="49.42"/>
                    <measurement group_id="O2" value="32" lower_limit="25.54" upper_limit="39.84"/>
                    <measurement group_id="O3" value="27" lower_limit="19.52" upper_limit="36.36"/>
                    <measurement group_id="O4" value="70" lower_limit="60.57" upper_limit="78.18"/>
                    <measurement group_id="O5" value="28" lower_limit="20.31" upper_limit="36.99"/>
                    <measurement group_id="O6" value="77" lower_limit="68.26" upper_limit="83.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="22.37" upper_limit="35.76"/>
                    <measurement group_id="O2" value="24" lower_limit="18.28" upper_limit="31.47"/>
                    <measurement group_id="O3" value="19" lower_limit="12.18" upper_limit="27.07"/>
                    <measurement group_id="O4" value="53" lower_limit="43.48" upper_limit="62.55"/>
                    <measurement group_id="O5" value="18" lower_limit="11.76" upper_limit="26.22"/>
                    <measurement group_id="O6" value="58" lower_limit="48.77" upper_limit="66.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="15.19" upper_limit="27.25"/>
                    <measurement group_id="O2" value="14" lower_limit="8.94" upper_limit="19.61"/>
                    <measurement group_id="O3" value="9" lower_limit="4.79" upper_limit="16.20"/>
                    <measurement group_id="O4" value="28" lower_limit="20.24" upper_limit="37.57"/>
                    <measurement group_id="O5" value="8" lower_limit="4.03" upper_limit="14.67"/>
                    <measurement group_id="O6" value="34" lower_limit="25.49" upper_limit="42.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="2.96" upper_limit="10.23"/>
                    <measurement group_id="O2" value="8" lower_limit="4.42" upper_limit="12.99"/>
                    <measurement group_id="O3" value="6" lower_limit="2.44" upper_limit="11.94"/>
                    <measurement group_id="O4" value="10" lower_limit="4.96" upper_limit="16.75"/>
                    <measurement group_id="O5" value="4" lower_limit="1.36" upper_limit="9.38"/>
                    <measurement group_id="O6" value="17" lower_limit="11.10" upper_limit="24.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.01" upper_limit="2.93"/>
                    <measurement group_id="O2" value="2" lower_limit="0.35" upper_limit="4.90"/>
                    <measurement group_id="O3" value="1" lower_limit="0.02" upper_limit="4.67"/>
                    <measurement group_id="O4" value="3" lower_limit="0.55" upper_limit="7.56"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.52"/>
                    <measurement group_id="O6" value="4" lower_limit="1.28" upper_limit="8.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 13) ≥ LLQ (8.9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" lower_limit="26.81" upper_limit="40.74"/>
                    <measurement group_id="O2" value="27" lower_limit="20.84" upper_limit="34.48"/>
                    <measurement group_id="O3" value="23" lower_limit="15.79" upper_limit="31.77"/>
                    <measurement group_id="O4" value="34" lower_limit="25.01" upper_limit="43.12"/>
                    <measurement group_id="O5" value="69" lower_limit="59.53" upper_limit="76.73"/>
                    <measurement group_id="O6" value="37" lower_limit="28.38" upper_limit="45.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" lower_limit="38.48" upper_limit="53.15"/>
                    <measurement group_id="O2" value="39" lower_limit="31.95" upper_limit="46.83"/>
                    <measurement group_id="O3" value="36" lower_limit="27.24" upper_limit="45.29"/>
                    <measurement group_id="O4" value="57" lower_limit="46.99" upper_limit="65.93"/>
                    <measurement group_id="O5" value="82" lower_limit="73.78" upper_limit="88.24"/>
                    <measurement group_id="O6" value="51" lower_limit="41.80" upper_limit="59.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37" lower_limit="29.81" upper_limit="44.02"/>
                    <measurement group_id="O2" value="34" lower_limit="26.60" upper_limit="41.01"/>
                    <measurement group_id="O3" value="27" lower_limit="19.52" upper_limit="36.36"/>
                    <measurement group_id="O4" value="39" lower_limit="29.91" upper_limit="48.56"/>
                    <measurement group_id="O5" value="74" lower_limit="64.76" upper_limit="81.16"/>
                    <measurement group_id="O6" value="42" lower_limit="33.51" upper_limit="51.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.46" upper_limit="32.39"/>
                    <measurement group_id="O2" value="23" lower_limit="16.76" upper_limit="29.64"/>
                    <measurement group_id="O3" value="17" lower_limit="10.77" upper_limit="25.16"/>
                    <measurement group_id="O4" value="19" lower_limit="12.62" upper_limit="27.98"/>
                    <measurement group_id="O5" value="55" lower_limit="45.24" upper_limit="63.62"/>
                    <measurement group_id="O6" value="26" lower_limit="18.46" upper_limit="34.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="11.03" upper_limit="21.99"/>
                    <measurement group_id="O2" value="13" lower_limit="8.47" upper_limit="18.96"/>
                    <measurement group_id="O3" value="11" lower_limit="6.05" upper_limit="18.25"/>
                    <measurement group_id="O4" value="12" lower_limit="6.27" upper_limit="18.87"/>
                    <measurement group_id="O5" value="35" lower_limit="26.29" upper_limit="43.90"/>
                    <measurement group_id="O6" value="12" lower_limit="6.71" upper_limit="18.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="3.34" upper_limit="10.88"/>
                    <measurement group_id="O2" value="3" lower_limit="1.26" upper_limit="7.27"/>
                    <measurement group_id="O3" value="4" lower_limit="1.40" upper_limit="9.69"/>
                    <measurement group_id="O4" value="5" lower_limit="1.97" upper_limit="11.20"/>
                    <measurement group_id="O5" value="20" lower_limit="13.14" upper_limit="28.06"/>
                    <measurement group_id="O6" value="5" lower_limit="1.74" upper_limit="9.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.58" upper_limit="5.36"/>
                    <measurement group_id="O2" value="1" lower_limit="0.01" upper_limit="3.12"/>
                    <measurement group_id="O3" value="2" lower_limit="0.21" upper_limit="6.04"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.83"/>
                    <measurement group_id="O5" value="9" lower_limit="4.63" upper_limit="15.68"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against 96217 B Strain for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against 96217 B strain was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against 96217 B Strain for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against 96217 B strain was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="178"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="112"/>
                <count group_id="O5" value="128"/>
                <count group_id="O6" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>96217 Strain (At Month 0) ≥ LLQ (8.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.26" upper_limit="29.85"/>
                    <measurement group_id="O2" value="29" lower_limit="22.14" upper_limit="35.89"/>
                    <measurement group_id="O3" value="29" lower_limit="21.23" upper_limit="38.16"/>
                    <measurement group_id="O4" value="28" lower_limit="19.64" upper_limit="36.93"/>
                    <measurement group_id="O5" value="25" lower_limit="17.77" upper_limit="33.42"/>
                    <measurement group_id="O6" value="27" lower_limit="19.57" upper_limit="36.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.68" upper_limit="32.72"/>
                    <measurement group_id="O2" value="35" lower_limit="28.38" upper_limit="42.90"/>
                    <measurement group_id="O3" value="35" lower_limit="26.52" upper_limit="44.24"/>
                    <measurement group_id="O4" value="29" lower_limit="21.23" upper_limit="38.82"/>
                    <measurement group_id="O5" value="35" lower_limit="26.93" upper_limit="44.09"/>
                    <measurement group_id="O6" value="29" lower_limit="21.05" upper_limit="37.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="18.23" upper_limit="31.00"/>
                    <measurement group_id="O2" value="30" lower_limit="23.68" upper_limit="37.66"/>
                    <measurement group_id="O3" value="31" lower_limit="22.73" upper_limit="39.91"/>
                    <measurement group_id="O4" value="28" lower_limit="19.64" upper_limit="36.93"/>
                    <measurement group_id="O5" value="25" lower_limit="17.77" upper_limit="33.42"/>
                    <measurement group_id="O6" value="27" lower_limit="19.57" upper_limit="36.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="11.15" upper_limit="22.22"/>
                    <measurement group_id="O2" value="17" lower_limit="11.67" upper_limit="23.18"/>
                    <measurement group_id="O3" value="22" lower_limit="14.67" upper_limit="30.11"/>
                    <measurement group_id="O4" value="19" lower_limit="12.00" upper_limit="27.22"/>
                    <measurement group_id="O5" value="18" lower_limit="11.74" upper_limit="25.73"/>
                    <measurement group_id="O6" value="16" lower_limit="9.73" upper_limit="23.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="3.38" upper_limit="11.00"/>
                    <measurement group_id="O2" value="8" lower_limit="4.37" upper_limit="12.84"/>
                    <measurement group_id="O3" value="8" lower_limit="4.07" upper_limit="14.79"/>
                    <measurement group_id="O4" value="4" lower_limit="1.47" upper_limit="10.11"/>
                    <measurement group_id="O5" value="8" lower_limit="3.81" upper_limit="13.90"/>
                    <measurement group_id="O6" value="7" lower_limit="2.90" upper_limit="12.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.33" upper_limit="4.64"/>
                    <measurement group_id="O2" value="2" lower_limit="0.62" upper_limit="5.65"/>
                    <measurement group_id="O3" value="3" lower_limit="0.52" upper_limit="7.13"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.24"/>
                    <measurement group_id="O5" value="2" lower_limit="0.49" upper_limit="6.70"/>
                    <measurement group_id="O6" value="5" lower_limit="1.84" upper_limit="10.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.01" upper_limit="2.96"/>
                    <measurement group_id="O2" value="1" lower_limit="0.14" upper_limit="4.00"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="3.03"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.24"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.28"/>
                    <measurement group_id="O6" value="2" lower_limit="0.20" upper_limit="5.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 2) ≥ LLQ (8.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" lower_limit="61.63" upper_limit="75.39"/>
                    <measurement group_id="O2" value="64" lower_limit="56.53" upper_limit="71.09"/>
                    <measurement group_id="O3" value="97" lower_limit="91.69" upper_limit="99.08"/>
                    <measurement group_id="O4" value="62" lower_limit="51.94" upper_limit="70.64"/>
                    <measurement group_id="O5" value="58" lower_limit="48.77" upper_limit="66.49"/>
                    <measurement group_id="O6" value="50" lower_limit="40.37" upper_limit="58.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75" lower_limit="68.42" upper_limit="81.29"/>
                    <measurement group_id="O2" value="67" lower_limit="60.00" upper_limit="74.24"/>
                    <measurement group_id="O3" value="97" lower_limit="91.69" upper_limit="99.08"/>
                    <measurement group_id="O4" value="66" lower_limit="56.52" upper_limit="74.75"/>
                    <measurement group_id="O5" value="66" lower_limit="56.72" upper_limit="73.79"/>
                    <measurement group_id="O6" value="53" lower_limit="43.61" upper_limit="62.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="63.31" upper_limit="76.88"/>
                    <measurement group_id="O2" value="64" lower_limit="56.53" upper_limit="71.09"/>
                    <measurement group_id="O3" value="97" lower_limit="91.69" upper_limit="99.08"/>
                    <measurement group_id="O4" value="63" lower_limit="53.76" upper_limit="72.29"/>
                    <measurement group_id="O5" value="59" lower_limit="50.34" upper_limit="67.96"/>
                    <measurement group_id="O6" value="51" lower_limit="41.99" upper_limit="60.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="41.01" upper_limit="55.81"/>
                    <measurement group_id="O2" value="48" lower_limit="40.78" upper_limit="55.91"/>
                    <measurement group_id="O3" value="94" lower_limit="88.35" upper_limit="97.62"/>
                    <measurement group_id="O4" value="48" lower_limit="38.67" upper_limit="57.85"/>
                    <measurement group_id="O5" value="42" lower_limit="33.51" upper_limit="51.23"/>
                    <measurement group_id="O6" value="39" lower_limit="30.12" upper_limit="48.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="21.15" upper_limit="34.43"/>
                    <measurement group_id="O2" value="21" lower_limit="15.57" upper_limit="28.10"/>
                    <measurement group_id="O3" value="84" lower_limit="76.38" upper_limit="90.19"/>
                    <measurement group_id="O4" value="20" lower_limit="12.74" upper_limit="28.22"/>
                    <measurement group_id="O5" value="26" lower_limit="18.46" upper_limit="34.26"/>
                    <measurement group_id="O6" value="24" lower_limit="16.68" upper_limit="32.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="6.69" upper_limit="16.12"/>
                    <measurement group_id="O2" value="15" lower_limit="9.77" upper_limit="20.67"/>
                    <measurement group_id="O3" value="73" lower_limit="63.60" upper_limit="80.25"/>
                    <measurement group_id="O4" value="9" lower_limit="4.36" upper_limit="15.81"/>
                    <measurement group_id="O5" value="14" lower_limit="8.55" upper_limit="21.31"/>
                    <measurement group_id="O6" value="12" lower_limit="6.47" upper_limit="18.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.77" upper_limit="11.66"/>
                    <measurement group_id="O2" value="4" lower_limit="1.96" upper_limit="8.66"/>
                    <measurement group_id="O3" value="45" lower_limit="35.91" upper_limit="54.35"/>
                    <measurement group_id="O4" value="4" lower_limit="1.47" upper_limit="10.11"/>
                    <measurement group_id="O5" value="9" lower_limit="4.94" upper_limit="15.80"/>
                    <measurement group_id="O6" value="7" lower_limit="3.46" upper_limit="13.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 3) ≥ LLQ (8.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="97.04" upper_limit="99.99"/>
                    <measurement group_id="O2" value="97" lower_limit="92.81" upper_limit="98.75"/>
                    <measurement group_id="O3" value="94" lower_limit="88.35" upper_limit="97.62"/>
                    <measurement group_id="O4" value="58" lower_limit="48.34" upper_limit="67.30"/>
                    <measurement group_id="O5" value="47" lower_limit="38.00" upper_limit="55.89"/>
                    <measurement group_id="O6" value="97" lower_limit="91.75" upper_limit="99.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="97.04" upper_limit="99.99"/>
                    <measurement group_id="O2" value="97" lower_limit="93.57" upper_limit="99.08"/>
                    <measurement group_id="O3" value="96" lower_limit="90.54" upper_limit="98.53"/>
                    <measurement group_id="O4" value="61" lower_limit="51.04" upper_limit="69.81"/>
                    <measurement group_id="O5" value="56" lower_limit="47.21" upper_limit="65.00"/>
                    <measurement group_id="O6" value="98" lower_limit="92.93" upper_limit="99.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="97.04" upper_limit="99.99"/>
                    <measurement group_id="O2" value="97" lower_limit="92.81" upper_limit="98.75"/>
                    <measurement group_id="O3" value="95" lower_limit="89.43" upper_limit="98.14"/>
                    <measurement group_id="O4" value="58" lower_limit="48.34" upper_limit="67.30"/>
                    <measurement group_id="O5" value="52" lower_limit="43.34" upper_limit="61.24"/>
                    <measurement group_id="O6" value="97" lower_limit="91.75" upper_limit="99.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="97.04" upper_limit="99.99"/>
                    <measurement group_id="O2" value="95" lower_limit="90.62" upper_limit="97.66"/>
                    <measurement group_id="O3" value="91" lower_limit="84.19" upper_limit="95.33"/>
                    <measurement group_id="O4" value="40" lower_limit="31.03" upper_limit="49.86"/>
                    <measurement group_id="O5" value="36" lower_limit="27.65" upper_limit="44.89"/>
                    <measurement group_id="O6" value="95" lower_limit="89.52" upper_limit="98.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="95.36" upper_limit="99.67"/>
                    <measurement group_id="O2" value="89" lower_limit="83.83" upper_limit="93.45"/>
                    <measurement group_id="O3" value="83" lower_limit="75.44" upper_limit="89.51"/>
                    <measurement group_id="O4" value="21" lower_limit="13.49" upper_limit="29.20"/>
                    <measurement group_id="O5" value="23" lower_limit="15.73" upper_limit="30.89"/>
                    <measurement group_id="O6" value="92" lower_limit="85.33" upper_limit="95.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90" lower_limit="84.51" upper_limit="93.74"/>
                    <measurement group_id="O2" value="81" lower_limit="74.34" upper_limit="86.39"/>
                    <measurement group_id="O3" value="62" lower_limit="52.35" upper_limit="70.39"/>
                    <measurement group_id="O4" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O5" value="11" lower_limit="6.11" upper_limit="17.67"/>
                    <measurement group_id="O6" value="84" lower_limit="76.57" upper_limit="90.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74" lower_limit="67.28" upper_limit="80.32"/>
                    <measurement group_id="O2" value="63" lower_limit="55.38" upper_limit="70.03"/>
                    <measurement group_id="O3" value="34" lower_limit="25.76" upper_limit="43.38"/>
                    <measurement group_id="O4" value="4" lower_limit="1.47" upper_limit="10.11"/>
                    <measurement group_id="O5" value="4" lower_limit="1.28" upper_limit="8.88"/>
                    <measurement group_id="O6" value="60" lower_limit="51.04" upper_limit="69.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 7) ≥ LLQ (8.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="91.01" upper_limit="97.76"/>
                    <measurement group_id="O2" value="91" lower_limit="85.81" upper_limit="94.77"/>
                    <measurement group_id="O3" value="88" lower_limit="80.22" upper_limit="92.83"/>
                    <measurement group_id="O4" value="97" lower_limit="92.37" upper_limit="99.44"/>
                    <measurement group_id="O5" value="39" lower_limit="30.56" upper_limit="48.08"/>
                    <measurement group_id="O6" value="99" lower_limit="95.48" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="92.40" upper_limit="98.47"/>
                    <measurement group_id="O2" value="93" lower_limit="87.83" upper_limit="96.05"/>
                    <measurement group_id="O3" value="91" lower_limit="84.19" upper_limit="95.33"/>
                    <measurement group_id="O4" value="97" lower_limit="92.37" upper_limit="99.44"/>
                    <measurement group_id="O5" value="44" lower_limit="35.00" upper_limit="52.79"/>
                    <measurement group_id="O6" value="99" lower_limit="95.48" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="91.01" upper_limit="97.76"/>
                    <measurement group_id="O2" value="91" lower_limit="85.81" upper_limit="94.77"/>
                    <measurement group_id="O3" value="88" lower_limit="80.22" upper_limit="92.83"/>
                    <measurement group_id="O4" value="97" lower_limit="92.37" upper_limit="99.44"/>
                    <measurement group_id="O5" value="40" lower_limit="31.30" upper_limit="48.87"/>
                    <measurement group_id="O6" value="99" lower_limit="95.48" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="88.34" upper_limit="96.23"/>
                    <measurement group_id="O2" value="85" lower_limit="79.33" upper_limit="90.23"/>
                    <measurement group_id="O3" value="76" lower_limit="67.17" upper_limit="83.18"/>
                    <measurement group_id="O4" value="96" lower_limit="91.11" upper_limit="99.02"/>
                    <measurement group_id="O5" value="30" lower_limit="22.65" upper_limit="39.22"/>
                    <measurement group_id="O6" value="99" lower_limit="95.48" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75" lower_limit="67.85" upper_limit="80.80"/>
                    <measurement group_id="O2" value="65" lower_limit="57.68" upper_limit="72.14"/>
                    <measurement group_id="O3" value="57" lower_limit="47.31" upper_limit="65.68"/>
                    <measurement group_id="O4" value="96" lower_limit="89.89" upper_limit="98.53"/>
                    <measurement group_id="O5" value="18" lower_limit="11.74" upper_limit="25.73"/>
                    <measurement group_id="O6" value="98" lower_limit="94.16" upper_limit="99.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43" lower_limit="35.79" upper_limit="50.46"/>
                    <measurement group_id="O2" value="34" lower_limit="26.81" upper_limit="41.16"/>
                    <measurement group_id="O3" value="32" lower_limit="23.48" upper_limit="40.78"/>
                    <measurement group_id="O4" value="87" lower_limit="78.87" upper_limit="92.31"/>
                    <measurement group_id="O5" value="7" lower_limit="3.27" upper_limit="12.93"/>
                    <measurement group_id="O6" value="98" lower_limit="92.93" upper_limit="99.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="7.13" upper_limit="16.74"/>
                    <measurement group_id="O2" value="7" lower_limit="3.53" upper_limit="11.48"/>
                    <measurement group_id="O3" value="12" lower_limit="6.53" upper_limit="18.80"/>
                    <measurement group_id="O4" value="73" lower_limit="64.02" upper_limit="81.14"/>
                    <measurement group_id="O5" value="2" lower_limit="0.49" upper_limit="6.70"/>
                    <measurement group_id="O6" value="85" lower_limit="77.51" upper_limit="90.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 13) ≥ LLQ (8.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" lower_limit="81.41" upper_limit="91.55"/>
                    <measurement group_id="O2" value="83" lower_limit="76.20" upper_limit="87.85"/>
                    <measurement group_id="O3" value="81" lower_limit="72.64" upper_limit="87.44"/>
                    <measurement group_id="O4" value="90" lower_limit="83.11" upper_limit="94.99"/>
                    <measurement group_id="O5" value="98" lower_limit="93.30" upper_limit="99.51"/>
                    <measurement group_id="O6" value="93" lower_limit="87.39" upper_limit="97.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90" lower_limit="85.14" upper_limit="94.16"/>
                    <measurement group_id="O2" value="85" lower_limit="78.70" upper_limit="89.76"/>
                    <measurement group_id="O3" value="83" lower_limit="75.44" upper_limit="89.51"/>
                    <measurement group_id="O4" value="92" lower_limit="85.29" upper_limit="96.26"/>
                    <measurement group_id="O5" value="98" lower_limit="94.47" upper_limit="99.81"/>
                    <measurement group_id="O6" value="93" lower_limit="87.39" upper_limit="97.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="82.03" upper_limit="92.00"/>
                    <measurement group_id="O2" value="83" lower_limit="76.82" upper_limit="88.33"/>
                    <measurement group_id="O3" value="81" lower_limit="72.64" upper_limit="87.44"/>
                    <measurement group_id="O4" value="90" lower_limit="83.11" upper_limit="94.99"/>
                    <measurement group_id="O5" value="98" lower_limit="94.47" upper_limit="99.81"/>
                    <measurement group_id="O6" value="93" lower_limit="87.39" upper_limit="97.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76" lower_limit="69.00" upper_limit="81.77"/>
                    <measurement group_id="O2" value="69" lower_limit="61.75" upper_limit="75.80"/>
                    <measurement group_id="O3" value="66" lower_limit="56.62" upper_limit="74.24"/>
                    <measurement group_id="O4" value="79" lower_limit="70.80" upper_limit="86.51"/>
                    <measurement group_id="O5" value="98" lower_limit="93.30" upper_limit="99.51"/>
                    <measurement group_id="O6" value="88" lower_limit="80.38" upper_limit="92.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52" lower_limit="44.72" upper_limit="59.51"/>
                    <measurement group_id="O2" value="40" lower_limit="32.64" upper_limit="47.48"/>
                    <measurement group_id="O3" value="41" lower_limit="31.95" upper_limit="50.18"/>
                    <measurement group_id="O4" value="57" lower_limit="47.45" upper_limit="66.45"/>
                    <measurement group_id="O5" value="96" lower_limit="91.12" upper_limit="98.72"/>
                    <measurement group_id="O6" value="64" lower_limit="55.25" upper_limit="72.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.26" upper_limit="29.85"/>
                    <measurement group_id="O2" value="13" lower_limit="8.37" upper_limit="18.76"/>
                    <measurement group_id="O3" value="23" lower_limit="15.38" upper_limit="31.02"/>
                    <measurement group_id="O4" value="30" lower_limit="22.02" upper_limit="39.76"/>
                    <measurement group_id="O5" value="85" lower_limit="77.79" upper_limit="90.82"/>
                    <measurement group_id="O6" value="36" lower_limit="27.81" upper_limit="45.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.87" upper_limit="8.30"/>
                    <measurement group_id="O2" value="3" lower_limit="0.92" upper_limit="6.43"/>
                    <measurement group_id="O3" value="8" lower_limit="3.49" upper_limit="13.76"/>
                    <measurement group_id="O4" value="13" lower_limit="7.69" upper_limit="21.13"/>
                    <measurement group_id="O5" value="73" lower_limit="64.08" upper_limit="80.16"/>
                    <measurement group_id="O6" value="12" lower_limit="7.11" upper_limit="19.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against A Human Serogroup for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against A human serogroup was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against A Human Serogroup for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against A human serogroup was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="172"/>
                <count group_id="O2" value="178"/>
                <count group_id="O3" value="107"/>
                <count group_id="O4" value="105"/>
                <count group_id="O5" value="120"/>
                <count group_id="O6" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>A human Serogroup (At Month 0) ≥ LLQ (22.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="2.82" upper_limit="10.43"/>
                    <measurement group_id="O2" value="3" lower_limit="1.25" upper_limit="7.19"/>
                    <measurement group_id="O3" value="5" lower_limit="1.53" upper_limit="10.57"/>
                    <measurement group_id="O4" value="2" lower_limit="0.23" upper_limit="6.71"/>
                    <measurement group_id="O5" value="3" lower_limit="0.52" upper_limit="7.13"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="6.32" upper_limit="16.03"/>
                    <measurement group_id="O2" value="6" lower_limit="3.12" upper_limit="10.79"/>
                    <measurement group_id="O3" value="10" lower_limit="5.24" upper_limit="17.65"/>
                    <measurement group_id="O4" value="4" lower_limit="1.05" upper_limit="9.47"/>
                    <measurement group_id="O5" value="8" lower_limit="3.49" upper_limit="13.76"/>
                    <measurement group_id="O6" value="3" lower_limit="0.86" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="5.86" upper_limit="15.35"/>
                    <measurement group_id="O2" value="6" lower_limit="2.73" upper_limit="10.09"/>
                    <measurement group_id="O3" value="10" lower_limit="5.24" upper_limit="17.65"/>
                    <measurement group_id="O4" value="3" lower_limit="0.59" upper_limit="8.12"/>
                    <measurement group_id="O5" value="5" lower_limit="1.86" upper_limit="10.57"/>
                    <measurement group_id="O6" value="2" lower_limit="0.49" upper_limit="6.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.66" upper_limit="11.87"/>
                    <measurement group_id="O2" value="4" lower_limit="1.96" upper_limit="8.66"/>
                    <measurement group_id="O3" value="7" lower_limit="3.28" upper_limit="14.20"/>
                    <measurement group_id="O4" value="2" lower_limit="0.23" upper_limit="6.71"/>
                    <measurement group_id="O5" value="4" lower_limit="1.37" upper_limit="9.46"/>
                    <measurement group_id="O6" value="2" lower_limit="0.19" upper_limit="5.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.65" upper_limit="8.21"/>
                    <measurement group_id="O2" value="2" lower_limit="0.62" upper_limit="5.65"/>
                    <measurement group_id="O3" value="3" lower_limit="0.58" upper_limit="7.98"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.19"/>
                    <measurement group_id="O5" value="2" lower_limit="0.20" upper_limit="5.89"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.14" upper_limit="4.14"/>
                    <measurement group_id="O2" value="1" lower_limit="0.14" upper_limit="4.00"/>
                    <measurement group_id="O3" value="2" lower_limit="0.23" upper_limit="6.59"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="5.19"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="3.03"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.01" upper_limit="3.20"/>
                    <measurement group_id="O2" value="1" lower_limit="0.01" upper_limit="3.09"/>
                    <measurement group_id="O3" value="1" lower_limit="0.02" upper_limit="5.10"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.45"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="3.03"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 2) ≥ LLQ (22.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="16.13" upper_limit="29.04"/>
                    <measurement group_id="O2" value="35" lower_limit="27.86" upper_limit="42.32"/>
                    <measurement group_id="O3" value="93" lower_limit="85.80" upper_limit="96.72"/>
                    <measurement group_id="O4" value="33" lower_limit="24.43" upper_limit="43.20"/>
                    <measurement group_id="O5" value="54" lower_limit="44.83" upper_limit="63.29"/>
                    <measurement group_id="O6" value="28" lower_limit="20.01" upper_limit="36.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37" lower_limit="29.97" upper_limit="44.89"/>
                    <measurement group_id="O2" value="53" lower_limit="45.76" upper_limit="60.87"/>
                    <measurement group_id="O3" value="95" lower_limit="89.43" upper_limit="98.47"/>
                    <measurement group_id="O4" value="48" lower_limit="37.78" upper_limit="57.59"/>
                    <measurement group_id="O5" value="75" lower_limit="66.27" upper_limit="82.45"/>
                    <measurement group_id="O6" value="39" lower_limit="30.08" upper_limit="47.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37" lower_limit="29.43" upper_limit="44.30"/>
                    <measurement group_id="O2" value="51" lower_limit="42.98" upper_limit="58.12"/>
                    <measurement group_id="O3" value="94" lower_limit="88.19" upper_limit="97.91"/>
                    <measurement group_id="O4" value="46" lower_limit="35.96" upper_limit="55.72"/>
                    <measurement group_id="O5" value="74" lower_limit="65.38" upper_limit="81.72"/>
                    <measurement group_id="O6" value="38" lower_limit="29.35" upper_limit="46.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="21.35" upper_limit="35.24"/>
                    <measurement group_id="O2" value="44" lower_limit="36.41" upper_limit="51.44"/>
                    <measurement group_id="O3" value="93" lower_limit="86.98" upper_limit="97.33"/>
                    <measurement group_id="O4" value="41" lower_limit="31.45" upper_limit="50.98"/>
                    <measurement group_id="O5" value="67" lower_limit="57.48" upper_limit="75.01"/>
                    <measurement group_id="O6" value="31" lower_limit="22.83" upper_limit="39.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.09" upper_limit="25.24"/>
                    <measurement group_id="O2" value="33" lower_limit="26.28" upper_limit="40.58"/>
                    <measurement group_id="O3" value="88" lower_limit="80.12" upper_limit="93.37"/>
                    <measurement group_id="O4" value="30" lower_limit="21.02" upper_limit="39.22"/>
                    <measurement group_id="O5" value="42" lower_limit="32.74" upper_limit="51.02"/>
                    <measurement group_id="O6" value="22" lower_limit="15.18" upper_limit="30.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="7.72" upper_limit="18.06"/>
                    <measurement group_id="O2" value="19" lower_limit="13.12" upper_limit="25.04"/>
                    <measurement group_id="O3" value="69" lower_limit="59.50" upper_limit="77.73"/>
                    <measurement group_id="O4" value="18" lower_limit="11.26" upper_limit="26.81"/>
                    <measurement group_id="O5" value="33" lower_limit="24.23" upper_limit="41.65"/>
                    <measurement group_id="O6" value="14" lower_limit="8.62" upper_limit="21.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.65" upper_limit="8.21"/>
                    <measurement group_id="O2" value="10" lower_limit="5.66" upper_limit="14.85"/>
                    <measurement group_id="O3" value="34" lower_limit="24.80" upper_limit="43.42"/>
                    <measurement group_id="O4" value="9" lower_limit="3.99" upper_limit="15.65"/>
                    <measurement group_id="O5" value="14" lower_limit="8.47" upper_limit="21.71"/>
                    <measurement group_id="O6" value="6" lower_limit="2.76" upper_limit="12.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 3) ≥ LLQ (22.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="89.57" upper_limit="97.18"/>
                    <measurement group_id="O2" value="87" lower_limit="80.61" upper_limit="91.17"/>
                    <measurement group_id="O3" value="80" lower_limit="71.58" upper_limit="87.42"/>
                    <measurement group_id="O4" value="30" lower_limit="21.02" upper_limit="39.22"/>
                    <measurement group_id="O5" value="38" lower_limit="28.83" upper_limit="46.80"/>
                    <measurement group_id="O6" value="92" lower_limit="86.00" upper_limit="96.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.35" upper_limit="99.05"/>
                    <measurement group_id="O2" value="94" lower_limit="89.21" upper_limit="96.88"/>
                    <measurement group_id="O3" value="92" lower_limit="84.63" upper_limit="96.08"/>
                    <measurement group_id="O4" value="40" lower_limit="30.56" upper_limit="50.02"/>
                    <measurement group_id="O5" value="55" lower_limit="45.65" upper_limit="64.09"/>
                    <measurement group_id="O6" value="94" lower_limit="88.97" upper_limit="97.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.35" upper_limit="99.05"/>
                    <measurement group_id="O2" value="93" lower_limit="87.83" upper_limit="96.05"/>
                    <measurement group_id="O3" value="91" lower_limit="83.48" upper_limit="95.43"/>
                    <measurement group_id="O4" value="39" lower_limit="29.67" upper_limit="49.06"/>
                    <measurement group_id="O5" value="53" lower_limit="43.18" upper_limit="61.69"/>
                    <measurement group_id="O6" value="94" lower_limit="87.97" upper_limit="97.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="90.30" upper_limit="97.58"/>
                    <measurement group_id="O2" value="91" lower_limit="85.81" upper_limit="94.77"/>
                    <measurement group_id="O3" value="86" lower_limit="77.93" upper_limit="91.94"/>
                    <measurement group_id="O4" value="33" lower_limit="24.43" upper_limit="43.20"/>
                    <measurement group_id="O5" value="42" lower_limit="32.74" upper_limit="51.02"/>
                    <measurement group_id="O6" value="92" lower_limit="86.00" upper_limit="96.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" lower_limit="85.33" upper_limit="94.59"/>
                    <measurement group_id="O2" value="83" lower_limit="76.20" upper_limit="87.85"/>
                    <measurement group_id="O3" value="74" lower_limit="64.45" upper_limit="81.85"/>
                    <measurement group_id="O4" value="27" lower_limit="18.51" upper_limit="36.19"/>
                    <measurement group_id="O5" value="31" lower_limit="22.73" upper_limit="39.91"/>
                    <measurement group_id="O6" value="90" lower_limit="83.13" upper_limit="94.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" lower_limit="63.53" upper_limit="77.59"/>
                    <measurement group_id="O2" value="57" lower_limit="49.69" upper_limit="64.67"/>
                    <measurement group_id="O3" value="46" lower_limit="36.12" upper_limit="55.70"/>
                    <measurement group_id="O4" value="12" lower_limit="6.76" upper_limit="20.24"/>
                    <measurement group_id="O5" value="19" lower_limit="12.56" upper_limit="27.36"/>
                    <measurement group_id="O6" value="61" lower_limit="51.57" upper_limit="69.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="37.76" upper_limit="53.10"/>
                    <measurement group_id="O2" value="30" lower_limit="23.17" upper_limit="37.07"/>
                    <measurement group_id="O3" value="21" lower_limit="14.14" upper_limit="30.49"/>
                    <measurement group_id="O4" value="6" lower_limit="2.13" upper_limit="12.02"/>
                    <measurement group_id="O5" value="10" lower_limit="5.27" upper_limit="16.82"/>
                    <measurement group_id="O6" value="29" lower_limit="21.41" upper_limit="37.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 7) ≥ LLQ (22.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="45.74" upper_limit="61.12"/>
                    <measurement group_id="O2" value="46" lower_limit="38.04" upper_limit="53.12"/>
                    <measurement group_id="O3" value="41" lower_limit="31.70" upper_limit="51.05"/>
                    <measurement group_id="O4" value="95" lower_limit="89.24" upper_limit="98.44"/>
                    <measurement group_id="O5" value="21" lower_limit="13.96" upper_limit="29.20"/>
                    <measurement group_id="O6" value="94" lower_limit="87.97" upper_limit="97.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="62.31" upper_limit="76.53"/>
                    <measurement group_id="O2" value="62" lower_limit="54.80" upper_limit="69.50"/>
                    <measurement group_id="O3" value="60" lower_limit="49.89" upper_limit="69.18"/>
                    <measurement group_id="O4" value="97" lower_limit="91.88" upper_limit="99.41"/>
                    <measurement group_id="O5" value="29" lower_limit="21.23" upper_limit="38.16"/>
                    <measurement group_id="O6" value="98" lower_limit="93.25" upper_limit="99.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68" lower_limit="60.50" upper_limit="74.92"/>
                    <measurement group_id="O2" value="58" lower_limit="50.82" upper_limit="65.75"/>
                    <measurement group_id="O3" value="58" lower_limit="48.01" upper_limit="67.42"/>
                    <measurement group_id="O4" value="97" lower_limit="91.88" upper_limit="99.41"/>
                    <measurement group_id="O5" value="28" lower_limit="19.75" upper_limit="36.40"/>
                    <measurement group_id="O6" value="98" lower_limit="93.25" upper_limit="99.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="53.33" upper_limit="68.38"/>
                    <measurement group_id="O2" value="51" lower_limit="43.53" upper_limit="58.67"/>
                    <measurement group_id="O3" value="49" lower_limit="38.82" upper_limit="58.46"/>
                    <measurement group_id="O4" value="97" lower_limit="91.88" upper_limit="99.41"/>
                    <measurement group_id="O5" value="22" lower_limit="14.67" upper_limit="30.11"/>
                    <measurement group_id="O6" value="97" lower_limit="92.13" upper_limit="99.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="34.95" upper_limit="50.20"/>
                    <measurement group_id="O2" value="37" lower_limit="29.44" upper_limit="44.05"/>
                    <measurement group_id="O3" value="35" lower_limit="25.65" upper_limit="44.39"/>
                    <measurement group_id="O4" value="91" lower_limit="84.35" upper_limit="96.01"/>
                    <measurement group_id="O5" value="14" lower_limit="8.47" upper_limit="21.71"/>
                    <measurement group_id="O6" value="93" lower_limit="86.97" upper_limit="96.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.59" upper_limit="25.88"/>
                    <measurement group_id="O2" value="19" lower_limit="13.61" upper_limit="25.66"/>
                    <measurement group_id="O3" value="18" lower_limit="11.04" upper_limit="26.33"/>
                    <measurement group_id="O4" value="76" lower_limit="66.89" upper_limit="83.96"/>
                    <measurement group_id="O5" value="7" lower_limit="2.92" upper_limit="12.71"/>
                    <measurement group_id="O6" value="80" lower_limit="72.33" upper_limit="86.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.42" upper_limit="9.70"/>
                    <measurement group_id="O2" value="6" lower_limit="2.73" upper_limit="10.09"/>
                    <measurement group_id="O3" value="10" lower_limit="5.24" upper_limit="17.65"/>
                    <measurement group_id="O4" value="63" lower_limit="52.88" upper_limit="72.09"/>
                    <measurement group_id="O5" value="3" lower_limit="0.52" upper_limit="7.13"/>
                    <measurement group_id="O6" value="54" lower_limit="44.48" upper_limit="62.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 13) ≥ LLQ (22.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" lower_limit="26.16" upper_limit="40.71"/>
                    <measurement group_id="O2" value="26" lower_limit="20.09" upper_limit="33.52"/>
                    <measurement group_id="O3" value="34" lower_limit="24.80" upper_limit="43.42"/>
                    <measurement group_id="O4" value="51" lower_limit="41.47" upper_limit="61.30"/>
                    <measurement group_id="O5" value="93" lower_limit="87.29" upper_limit="97.08"/>
                    <measurement group_id="O6" value="54" lower_limit="45.26" upper_limit="63.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" lower_limit="42.87" upper_limit="58.28"/>
                    <measurement group_id="O2" value="42" lower_limit="34.25" upper_limit="49.18"/>
                    <measurement group_id="O3" value="48" lower_limit="37.92" upper_limit="57.54"/>
                    <measurement group_id="O4" value="68" lower_limit="57.79" upper_limit="76.43"/>
                    <measurement group_id="O5" value="98" lower_limit="92.87" upper_limit="99.48"/>
                    <measurement group_id="O6" value="65" lower_limit="55.59" upper_limit="72.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="40.59" upper_limit="55.99"/>
                    <measurement group_id="O2" value="39" lower_limit="31.57" upper_limit="46.34"/>
                    <measurement group_id="O3" value="47" lower_limit="37.02" upper_limit="56.62"/>
                    <measurement group_id="O4" value="66" lower_limit="55.81" upper_limit="74.70"/>
                    <measurement group_id="O5" value="98" lower_limit="92.87" upper_limit="99.48"/>
                    <measurement group_id="O6" value="64" lower_limit="54.78" upper_limit="72.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" lower_limit="30.52" upper_limit="45.49"/>
                    <measurement group_id="O2" value="30" lower_limit="23.68" upper_limit="37.66"/>
                    <measurement group_id="O3" value="41" lower_limit="31.70" upper_limit="51.05"/>
                    <measurement group_id="O4" value="59" lower_limit="49.02" upper_limit="68.55"/>
                    <measurement group_id="O5" value="95" lower_limit="89.43" upper_limit="98.14"/>
                    <measurement group_id="O6" value="60" lower_limit="50.78" upper_limit="68.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="17.68" upper_limit="30.92"/>
                    <measurement group_id="O2" value="20" lower_limit="14.09" upper_limit="26.27"/>
                    <measurement group_id="O3" value="27" lower_limit="18.96" upper_limit="36.55"/>
                    <measurement group_id="O4" value="44" lower_limit="34.14" upper_limit="53.83"/>
                    <measurement group_id="O5" value="88" lower_limit="81.20" upper_limit="93.47"/>
                    <measurement group_id="O6" value="41" lower_limit="32.30" upper_limit="50.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="8.67" upper_limit="19.39"/>
                    <measurement group_id="O2" value="8" lower_limit="4.79" upper_limit="13.52"/>
                    <measurement group_id="O3" value="13" lower_limit="7.34" upper_limit="20.98"/>
                    <measurement group_id="O4" value="27" lower_limit="18.51" upper_limit="36.19"/>
                    <measurement group_id="O5" value="81" lower_limit="72.64" upper_limit="87.44"/>
                    <measurement group_id="O6" value="16" lower_limit="9.89" upper_limit="23.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.65" upper_limit="8.21"/>
                    <measurement group_id="O2" value="2" lower_limit="0.35" upper_limit="4.85"/>
                    <measurement group_id="O3" value="6" lower_limit="2.09" upper_limit="11.81"/>
                    <measurement group_id="O4" value="8" lower_limit="3.35" upper_limit="14.46"/>
                    <measurement group_id="O5" value="61" lower_limit="51.50" upper_limit="69.61"/>
                    <measurement group_id="O6" value="6" lower_limit="2.24" upper_limit="11.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against C Human Serogroup for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against C human serogroup was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against C Human Serogroup for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against C human serogroup was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
                <count group_id="O3" value="122"/>
                <count group_id="O4" value="114"/>
                <count group_id="O5" value="123"/>
                <count group_id="O6" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C human Serogroup (At Month 0) ≥ LLQ (5.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43" lower_limit="35.79" upper_limit="50.46"/>
                    <measurement group_id="O2" value="45" lower_limit="38.09" upper_limit="52.87"/>
                    <measurement group_id="O3" value="48" lower_limit="38.43" upper_limit="56.78"/>
                    <measurement group_id="O4" value="41" lower_limit="32.09" upper_limit="50.83"/>
                    <measurement group_id="O5" value="48" lower_limit="38.88" upper_limit="57.16"/>
                    <measurement group_id="O6" value="41" lower_limit="32.24" upper_limit="49.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" lower_limit="38.91" upper_limit="53.68"/>
                    <measurement group_id="O2" value="45" lower_limit="38.09" upper_limit="52.87"/>
                    <measurement group_id="O3" value="49" lower_limit="40.02" upper_limit="58.38"/>
                    <measurement group_id="O4" value="43" lower_limit="33.75" upper_limit="52.59"/>
                    <measurement group_id="O5" value="49" lower_limit="39.67" upper_limit="57.95"/>
                    <measurement group_id="O6" value="42" lower_limit="32.97" upper_limit="50.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" lower_limit="27.61" upper_limit="41.71"/>
                    <measurement group_id="O2" value="30" lower_limit="23.75" upper_limit="37.44"/>
                    <measurement group_id="O3" value="36" lower_limit="27.57" upper_limit="45.25"/>
                    <measurement group_id="O4" value="30" lower_limit="21.62" upper_limit="39.11"/>
                    <measurement group_id="O5" value="36" lower_limit="27.33" upper_limit="44.91"/>
                    <measurement group_id="O6" value="30" lower_limit="22.28" upper_limit="38.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.47" upper_limit="25.19"/>
                    <measurement group_id="O2" value="14" lower_limit="8.94" upper_limit="19.30"/>
                    <measurement group_id="O3" value="20" lower_limit="13.03" upper_limit="27.84"/>
                    <measurement group_id="O4" value="14" lower_limit="8.24" upper_limit="21.79"/>
                    <measurement group_id="O5" value="24" lower_limit="17.10" upper_limit="32.95"/>
                    <measurement group_id="O6" value="8" lower_limit="3.75" upper_limit="13.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.61" upper_limit="9.66"/>
                    <measurement group_id="O2" value="6" lower_limit="3.40" upper_limit="11.06"/>
                    <measurement group_id="O3" value="9" lower_limit="4.59" upper_limit="15.56"/>
                    <measurement group_id="O4" value="4" lower_limit="0.96" upper_limit="8.74"/>
                    <measurement group_id="O5" value="7" lower_limit="3.40" upper_limit="13.44"/>
                    <measurement group_id="O6" value="3" lower_limit="0.84" upper_limit="7.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.59" upper_limit="5.41"/>
                    <measurement group_id="O2" value="2" lower_limit="0.34" upper_limit="4.67"/>
                    <measurement group_id="O3" value="2" lower_limit="0.20" upper_limit="5.80"/>
                    <measurement group_id="O4" value="3" lower_limit="0.55" upper_limit="7.50"/>
                    <measurement group_id="O5" value="3" lower_limit="0.89" upper_limit="8.12"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.01" upper_limit="2.96"/>
                    <measurement group_id="O2" value="2" lower_limit="0.34" upper_limit="4.67"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="2.98"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.79"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.45"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="2.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 2) ≥ LLQ (5.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="53.89" upper_limit="68.33"/>
                    <measurement group_id="O2" value="84" lower_limit="78.27" upper_limit="89.24"/>
                    <measurement group_id="O3" value="100" lower_limit="97.02" upper_limit="100"/>
                    <measurement group_id="O4" value="84" lower_limit="76.20" upper_limit="90.37"/>
                    <measurement group_id="O5" value="89" lower_limit="82.60" upper_limit="94.25"/>
                    <measurement group_id="O6" value="88" lower_limit="80.78" upper_limit="92.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" lower_limit="54.98" upper_limit="69.35"/>
                    <measurement group_id="O2" value="84" lower_limit="78.27" upper_limit="89.24"/>
                    <measurement group_id="O3" value="100" lower_limit="97.02" upper_limit="100"/>
                    <measurement group_id="O4" value="84" lower_limit="76.20" upper_limit="90.37"/>
                    <measurement group_id="O5" value="89" lower_limit="82.60" upper_limit="94.25"/>
                    <measurement group_id="O6" value="88" lower_limit="80.78" upper_limit="92.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="45.25" upper_limit="60.04"/>
                    <measurement group_id="O2" value="78" lower_limit="71.16" upper_limit="83.60"/>
                    <measurement group_id="O3" value="98" lower_limit="94.20" upper_limit="99.80"/>
                    <measurement group_id="O4" value="80" lower_limit="71.28" upper_limit="86.76"/>
                    <measurement group_id="O5" value="86" lower_limit="78.80" upper_limit="91.74"/>
                    <measurement group_id="O6" value="78" lower_limit="69.56" upper_limit="84.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="28.62" upper_limit="42.82"/>
                    <measurement group_id="O2" value="65" lower_limit="57.52" upper_limit="71.73"/>
                    <measurement group_id="O3" value="95" lower_limit="89.60" upper_limit="98.17"/>
                    <measurement group_id="O4" value="64" lower_limit="54.51" upper_limit="72.81"/>
                    <measurement group_id="O5" value="72" lower_limit="62.71" upper_limit="79.31"/>
                    <measurement group_id="O6" value="61" lower_limit="51.82" upper_limit="69.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="13.00" upper_limit="24.60"/>
                    <measurement group_id="O2" value="40" lower_limit="32.88" upper_limit="47.44"/>
                    <measurement group_id="O3" value="89" lower_limit="81.50" upper_limit="93.58"/>
                    <measurement group_id="O4" value="44" lower_limit="34.58" upper_limit="53.46"/>
                    <measurement group_id="O5" value="55" lower_limit="46.06" upper_limit="64.25"/>
                    <measurement group_id="O6" value="44" lower_limit="35.16" upper_limit="52.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4.58" upper_limit="12.95"/>
                    <measurement group_id="O2" value="23" lower_limit="17.36" upper_limit="30.00"/>
                    <measurement group_id="O3" value="79" lower_limit="70.35" upper_limit="85.58"/>
                    <measurement group_id="O4" value="29" lower_limit="20.84" upper_limit="38.19"/>
                    <measurement group_id="O5" value="39" lower_limit="30.36" upper_limit="48.23"/>
                    <measurement group_id="O6" value="25" lower_limit="17.49" upper_limit="32.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0.88" upper_limit="6.16"/>
                    <measurement group_id="O2" value="16" lower_limit="10.76" upper_limit="21.73"/>
                    <measurement group_id="O3" value="53" lower_limit="44.03" upper_limit="62.36"/>
                    <measurement group_id="O4" value="17" lower_limit="10.34" upper_limit="24.80"/>
                    <measurement group_id="O5" value="26" lower_limit="18.52" upper_limit="34.70"/>
                    <measurement group_id="O6" value="19" lower_limit="12.85" upper_limit="27.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 3) ≥ LLQ (5.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.84" upper_limit="99.12"/>
                    <measurement group_id="O2" value="99" lower_limit="96.15" upper_limit="99.87"/>
                    <measurement group_id="O3" value="98" lower_limit="94.20" upper_limit="99.80"/>
                    <measurement group_id="O4" value="81" lower_limit="72.25" upper_limit="87.49"/>
                    <measurement group_id="O5" value="88" lower_limit="80.68" upper_limit="93.01"/>
                    <measurement group_id="O6" value="99" lower_limit="95.79" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.84" upper_limit="99.12"/>
                    <measurement group_id="O2" value="99" lower_limit="96.15" upper_limit="99.87"/>
                    <measurement group_id="O3" value="98" lower_limit="94.20" upper_limit="99.80"/>
                    <measurement group_id="O4" value="81" lower_limit="72.25" upper_limit="87.49"/>
                    <measurement group_id="O5" value="88" lower_limit="80.68" upper_limit="93.01"/>
                    <measurement group_id="O6" value="100" lower_limit="97.20" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="89.00" upper_limit="96.62"/>
                    <measurement group_id="O2" value="98" lower_limit="94.56" upper_limit="99.41"/>
                    <measurement group_id="O3" value="98" lower_limit="92.98" upper_limit="99.49"/>
                    <measurement group_id="O4" value="77" lower_limit="68.40" upper_limit="84.53"/>
                    <measurement group_id="O5" value="84" lower_limit="76.01" upper_limit="89.78"/>
                    <measurement group_id="O6" value="99" lower_limit="95.79" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78" lower_limit="71.89" upper_limit="84.17"/>
                    <measurement group_id="O2" value="96" lower_limit="92.36" upper_limit="98.47"/>
                    <measurement group_id="O3" value="95" lower_limit="89.60" upper_limit="98.17"/>
                    <measurement group_id="O4" value="62" lower_limit="52.72" upper_limit="71.19"/>
                    <measurement group_id="O5" value="63" lower_limit="54.25" upper_limit="71.91"/>
                    <measurement group_id="O6" value="98" lower_limit="93.40" upper_limit="99.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56" lower_limit="48.46" upper_limit="63.17"/>
                    <measurement group_id="O2" value="90" lower_limit="84.43" upper_limit="93.70"/>
                    <measurement group_id="O3" value="86" lower_limit="78.63" upper_limit="91.67"/>
                    <measurement group_id="O4" value="43" lower_limit="33.75" upper_limit="52.59"/>
                    <measurement group_id="O5" value="46" lower_limit="36.53" upper_limit="54.75"/>
                    <measurement group_id="O6" value="94" lower_limit="88.23" upper_limit="97.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.68" upper_limit="32.72"/>
                    <measurement group_id="O2" value="78" lower_limit="71.16" upper_limit="83.60"/>
                    <measurement group_id="O3" value="67" lower_limit="58.13" upper_limit="75.44"/>
                    <measurement group_id="O4" value="25" lower_limit="17.75" upper_limit="34.45"/>
                    <measurement group_id="O5" value="30" lower_limit="22.14" upper_limit="39.00"/>
                    <measurement group_id="O6" value="85" lower_limit="77.24" upper_limit="90.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="6.69" upper_limit="16.12"/>
                    <measurement group_id="O2" value="58" lower_limit="50.92" upper_limit="65.57"/>
                    <measurement group_id="O3" value="40" lower_limit="31.39" upper_limit="49.42"/>
                    <measurement group_id="O4" value="18" lower_limit="11.06" upper_limit="25.79"/>
                    <measurement group_id="O5" value="21" lower_limit="14.30" upper_limit="29.42"/>
                    <measurement group_id="O6" value="60" lower_limit="51.05" upper_limit="68.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 7) ≥ LLQ (5.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" lower_limit="61.63" upper_limit="75.39"/>
                    <measurement group_id="O2" value="96" lower_limit="92.36" upper_limit="98.47"/>
                    <measurement group_id="O3" value="97" lower_limit="91.82" upper_limit="99.10"/>
                    <measurement group_id="O4" value="99" lower_limit="95.21" upper_limit="99.98"/>
                    <measurement group_id="O5" value="82" lower_limit="74.18" upper_limit="88.44"/>
                    <measurement group_id="O6" value="100" lower_limit="97.20" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" lower_limit="62.19" upper_limit="75.89"/>
                    <measurement group_id="O2" value="96" lower_limit="92.36" upper_limit="98.47"/>
                    <measurement group_id="O3" value="97" lower_limit="91.82" upper_limit="99.10"/>
                    <measurement group_id="O4" value="99" lower_limit="95.21" upper_limit="99.98"/>
                    <measurement group_id="O5" value="82" lower_limit="74.18" upper_limit="88.44"/>
                    <measurement group_id="O6" value="100" lower_limit="97.20" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58" lower_limit="50.62" upper_limit="65.24"/>
                    <measurement group_id="O2" value="96" lower_limit="92.36" upper_limit="98.47"/>
                    <measurement group_id="O3" value="96" lower_limit="90.69" upper_limit="98.66"/>
                    <measurement group_id="O4" value="99" lower_limit="95.21" upper_limit="99.98"/>
                    <measurement group_id="O5" value="73" lower_limit="64.43" upper_limit="80.76"/>
                    <measurement group_id="O6" value="99" lower_limit="95.79" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" lower_limit="30.65" upper_limit="45.02"/>
                    <measurement group_id="O2" value="90" lower_limit="85.06" upper_limit="94.13"/>
                    <measurement group_id="O3" value="91" lower_limit="84.44" upper_limit="95.41"/>
                    <measurement group_id="O4" value="98" lower_limit="93.81" upper_limit="99.79"/>
                    <measurement group_id="O5" value="55" lower_limit="46.06" upper_limit="64.25"/>
                    <measurement group_id="O6" value="99" lower_limit="95.79" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="16.79" upper_limit="29.27"/>
                    <measurement group_id="O2" value="74" lower_limit="66.54" upper_limit="79.72"/>
                    <measurement group_id="O3" value="77" lower_limit="68.57" upper_limit="84.18"/>
                    <measurement group_id="O4" value="95" lower_limit="88.90" upper_limit="98.04"/>
                    <measurement group_id="O5" value="35" lower_limit="26.58" upper_limit="44.08"/>
                    <measurement group_id="O6" value="98" lower_limit="94.55" upper_limit="99.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.00" upper_limit="13.59"/>
                    <measurement group_id="O2" value="53" lower_limit="45.51" upper_limit="60.34"/>
                    <measurement group_id="O3" value="53" lower_limit="44.03" upper_limit="62.36"/>
                    <measurement group_id="O4" value="86" lower_limit="78.21" upper_limit="91.76"/>
                    <measurement group_id="O5" value="26" lower_limit="18.52" upper_limit="34.70"/>
                    <measurement group_id="O6" value="96" lower_limit="91.25" upper_limit="98.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0.88" upper_limit="6.16"/>
                    <measurement group_id="O2" value="30" lower_limit="23.75" upper_limit="37.44"/>
                    <measurement group_id="O3" value="25" lower_limit="17.96" upper_limit="34.09"/>
                    <measurement group_id="O4" value="74" lower_limit="64.61" upper_limit="81.49"/>
                    <measurement group_id="O5" value="16" lower_limit="10.22" upper_limit="23.99"/>
                    <measurement group_id="O6" value="85" lower_limit="78.12" upper_limit="90.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 13) ≥ LLQ (5.2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="52.25" upper_limit="66.79"/>
                    <measurement group_id="O2" value="92" lower_limit="87.63" upper_limit="95.80"/>
                    <measurement group_id="O3" value="94" lower_limit="88.54" upper_limit="97.66"/>
                    <measurement group_id="O4" value="97" lower_limit="92.50" upper_limit="99.45"/>
                    <measurement group_id="O5" value="100" lower_limit="97.05" upper_limit="100"/>
                    <measurement group_id="O6" value="99" lower_limit="95.79" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="53.34" upper_limit="67.82"/>
                    <measurement group_id="O2" value="92" lower_limit="87.63" upper_limit="95.80"/>
                    <measurement group_id="O3" value="94" lower_limit="88.54" upper_limit="97.66"/>
                    <measurement group_id="O4" value="98" lower_limit="93.81" upper_limit="99.79"/>
                    <measurement group_id="O5" value="100" lower_limit="97.05" upper_limit="100"/>
                    <measurement group_id="O6" value="99" lower_limit="95.79" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="41.01" upper_limit="55.81"/>
                    <measurement group_id="O2" value="88" lower_limit="82.55" upper_limit="92.40"/>
                    <measurement group_id="O3" value="89" lower_limit="82.47" upper_limit="94.20"/>
                    <measurement group_id="O4" value="91" lower_limit="84.46" upper_limit="95.71"/>
                    <measurement group_id="O5" value="98" lower_limit="94.25" upper_limit="99.80"/>
                    <measurement group_id="O6" value="98" lower_limit="93.40" upper_limit="99.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="23.61" upper_limit="37.25"/>
                    <measurement group_id="O2" value="78" lower_limit="71.26" upper_limit="83.60"/>
                    <measurement group_id="O3" value="79" lower_limit="70.35" upper_limit="85.58"/>
                    <measurement group_id="O4" value="83" lower_limit="75.20" upper_limit="89.66"/>
                    <measurement group_id="O5" value="98" lower_limit="93.04" upper_limit="99.49"/>
                    <measurement group_id="O6" value="94" lower_limit="88.23" upper_limit="97.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10.24" upper_limit="21.02"/>
                    <measurement group_id="O2" value="51" lower_limit="43.37" upper_limit="58.22"/>
                    <measurement group_id="O3" value="57" lower_limit="48.10" upper_limit="66.28"/>
                    <measurement group_id="O4" value="61" lower_limit="51.83" upper_limit="70.37"/>
                    <measurement group_id="O5" value="97" lower_limit="91.88" upper_limit="99.11"/>
                    <measurement group_id="O6" value="81" lower_limit="72.93" upper_limit="87.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.00" upper_limit="13.59"/>
                    <measurement group_id="O2" value="28" lower_limit="21.76" upper_limit="35.17"/>
                    <measurement group_id="O3" value="25" lower_limit="17.25" upper_limit="33.21"/>
                    <measurement group_id="O4" value="38" lower_limit="28.81" upper_limit="47.28"/>
                    <measurement group_id="O5" value="93" lower_limit="87.59" upper_limit="97.15"/>
                    <measurement group_id="O6" value="58" lower_limit="49.49" upper_limit="67.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.59" upper_limit="5.41"/>
                    <measurement group_id="O2" value="16" lower_limit="10.76" upper_limit="21.73"/>
                    <measurement group_id="O3" value="16" lower_limit="10.31" upper_limit="24.18"/>
                    <measurement group_id="O4" value="25" lower_limit="16.98" upper_limit="33.51"/>
                    <measurement group_id="O5" value="85" lower_limit="76.93" upper_limit="90.44"/>
                    <measurement group_id="O6" value="40" lower_limit="31.51" upper_limit="48.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against W Human Serogroup for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against W human serogroup was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against W Human Serogroup for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against W human serogroup was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="162"/>
                <count group_id="O2" value="180"/>
                <count group_id="O3" value="119"/>
                <count group_id="O4" value="108"/>
                <count group_id="O5" value="123"/>
                <count group_id="O6" value="123"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>W human Serogroup (At Month 0) ≥ LLQ (39.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="23.29" upper_limit="37.95"/>
                    <measurement group_id="O2" value="26" lower_limit="19.86" upper_limit="33.17"/>
                    <measurement group_id="O3" value="29" lower_limit="21.42" upper_limit="38.46"/>
                    <measurement group_id="O4" value="20" lower_limit="13.23" upper_limit="29.20"/>
                    <measurement group_id="O5" value="29" lower_limit="21.41" upper_limit="38.15"/>
                    <measurement group_id="O6" value="22" lower_limit="14.99" upper_limit="30.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" lower_limit="43.27" upper_limit="59.15"/>
                    <measurement group_id="O2" value="43" lower_limit="35.98" upper_limit="50.91"/>
                    <measurement group_id="O3" value="41" lower_limit="32.24" upper_limit="50.57"/>
                    <measurement group_id="O4" value="42" lower_limit="32.25" upper_limit="51.55"/>
                    <measurement group_id="O5" value="45" lower_limit="35.75" upper_limit="53.94"/>
                    <measurement group_id="O6" value="45" lower_limit="35.75" upper_limit="53.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="41.45" upper_limit="57.34"/>
                    <measurement group_id="O2" value="41" lower_limit="33.85" upper_limit="48.67"/>
                    <measurement group_id="O3" value="40" lower_limit="31.45" upper_limit="49.72"/>
                    <measurement group_id="O4" value="41" lower_limit="31.38" upper_limit="50.62"/>
                    <measurement group_id="O5" value="45" lower_limit="35.75" upper_limit="53.94"/>
                    <measurement group_id="O6" value="43" lower_limit="34.20" upper_limit="52.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="36.05" upper_limit="51.83"/>
                    <measurement group_id="O2" value="39" lower_limit="31.73" upper_limit="46.42"/>
                    <measurement group_id="O3" value="39" lower_limit="30.66" upper_limit="48.87"/>
                    <measurement group_id="O4" value="34" lower_limit="25.40" upper_limit="44.01"/>
                    <measurement group_id="O5" value="41" lower_limit="31.89" upper_limit="49.88"/>
                    <measurement group_id="O6" value="38" lower_limit="29.60" upper_limit="47.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="27.86" upper_limit="43.07"/>
                    <measurement group_id="O2" value="31" lower_limit="24.43" upper_limit="38.42"/>
                    <measurement group_id="O3" value="31" lower_limit="22.93" upper_limit="40.23"/>
                    <measurement group_id="O4" value="24" lower_limit="16.37" upper_limit="33.25"/>
                    <measurement group_id="O5" value="33" lower_limit="25.09" upper_limit="42.40"/>
                    <measurement group_id="O6" value="26" lower_limit="18.52" upper_limit="34.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="14.99" upper_limit="28.07"/>
                    <measurement group_id="O2" value="19" lower_limit="13.45" upper_limit="25.38"/>
                    <measurement group_id="O3" value="20" lower_limit="13.37" upper_limit="28.51"/>
                    <measurement group_id="O4" value="13" lower_limit="7.27" upper_limit="20.79"/>
                    <measurement group_id="O5" value="21" lower_limit="14.30" upper_limit="29.42"/>
                    <measurement group_id="O6" value="12" lower_limit="6.99" upper_limit="19.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4.34" upper_limit="13.33"/>
                    <measurement group_id="O2" value="9" lower_limit="5.17" upper_limit="14.03"/>
                    <measurement group_id="O3" value="10" lower_limit="5.32" upper_limit="16.95"/>
                    <measurement group_id="O4" value="10" lower_limit="5.20" upper_limit="17.49"/>
                    <measurement group_id="O5" value="7" lower_limit="2.85" upper_limit="12.41"/>
                    <measurement group_id="O6" value="4" lower_limit="1.33" upper_limit="9.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 2) ≥ LLQ (39.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="40.24" upper_limit="56.12"/>
                    <measurement group_id="O2" value="65" lower_limit="57.55" upper_limit="71.95"/>
                    <measurement group_id="O3" value="96" lower_limit="90.47" upper_limit="98.62"/>
                    <measurement group_id="O4" value="67" lower_limit="56.95" upper_limit="75.45"/>
                    <measurement group_id="O5" value="77" lower_limit="68.81" upper_limit="84.31"/>
                    <measurement group_id="O6" value="60" lower_limit="50.95" upper_limit="68.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="58.21" upper_limit="73.29"/>
                    <measurement group_id="O2" value="90" lower_limit="84.66" upper_limit="93.96"/>
                    <measurement group_id="O3" value="99" lower_limit="95.41" upper_limit="99.98"/>
                    <measurement group_id="O4" value="92" lower_limit="84.77" upper_limit="96.12"/>
                    <measurement group_id="O5" value="93" lower_limit="86.56" upper_limit="96.60"/>
                    <measurement group_id="O6" value="93" lower_limit="86.56" upper_limit="96.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" lower_limit="56.30" upper_limit="71.57"/>
                    <measurement group_id="O2" value="86" lower_limit="80.18" upper_limit="90.81"/>
                    <measurement group_id="O3" value="99" lower_limit="95.41" upper_limit="99.98"/>
                    <measurement group_id="O4" value="92" lower_limit="84.77" upper_limit="96.12"/>
                    <measurement group_id="O5" value="93" lower_limit="86.56" upper_limit="96.60"/>
                    <measurement group_id="O6" value="89" lower_limit="81.64" upper_limit="93.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="52.52" upper_limit="68.07"/>
                    <measurement group_id="O2" value="82" lower_limit="75.84" upper_limit="87.51"/>
                    <measurement group_id="O3" value="99" lower_limit="95.41" upper_limit="99.98"/>
                    <measurement group_id="O4" value="81" lower_limit="72.86" upper_limit="88.31"/>
                    <measurement group_id="O5" value="89" lower_limit="82.60" upper_limit="94.25"/>
                    <measurement group_id="O6" value="80" lower_limit="72.37" upper_limit="87.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52" lower_limit="44.49" upper_limit="60.36"/>
                    <measurement group_id="O2" value="69" lower_limit="62.16" upper_limit="76.08"/>
                    <measurement group_id="O3" value="98" lower_limit="94.06" upper_limit="99.80"/>
                    <measurement group_id="O4" value="72" lower_limit="62.78" upper_limit="80.41"/>
                    <measurement group_id="O5" value="78" lower_limit="69.69" upper_limit="85.01"/>
                    <measurement group_id="O6" value="65" lower_limit="55.92" upper_limit="73.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="36.05" upper_limit="51.83"/>
                    <measurement group_id="O2" value="50" lower_limit="42.47" upper_limit="57.53"/>
                    <measurement group_id="O3" value="84" lower_limit="76.19" upper_limit="90.10"/>
                    <measurement group_id="O4" value="52" lower_limit="42.03" upper_limit="61.57"/>
                    <measurement group_id="O5" value="67" lower_limit="58.45" upper_limit="75.65"/>
                    <measurement group_id="O6" value="44" lower_limit="34.97" upper_limit="53.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="22.16" upper_limit="36.65"/>
                    <measurement group_id="O2" value="31" lower_limit="23.92" upper_limit="37.84"/>
                    <measurement group_id="O3" value="62" lower_limit="52.84" upper_limit="70.91"/>
                    <measurement group_id="O4" value="33" lower_limit="24.55" upper_limit="43.05"/>
                    <measurement group_id="O5" value="49" lower_limit="39.67" upper_limit="57.95"/>
                    <measurement group_id="O6" value="27" lower_limit="19.24" upper_limit="35.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 3) ≥ LLQ (39.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89" lower_limit="83.01" upper_limit="93.28"/>
                    <measurement group_id="O2" value="97" lower_limit="92.89" upper_limit="98.77"/>
                    <measurement group_id="O3" value="85" lower_limit="77.15" upper_limit="90.78"/>
                    <measurement group_id="O4" value="68" lower_limit="57.91" upper_limit="76.28"/>
                    <measurement group_id="O5" value="77" lower_limit="68.81" upper_limit="84.31"/>
                    <measurement group_id="O6" value="97" lower_limit="91.88" upper_limit="99.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="92.11" upper_limit="98.63"/>
                    <measurement group_id="O2" value="99" lower_limit="96.04" upper_limit="99.87"/>
                    <measurement group_id="O3" value="98" lower_limit="94.06" upper_limit="99.80"/>
                    <measurement group_id="O4" value="94" lower_limit="87.10" upper_limit="97.35"/>
                    <measurement group_id="O5" value="92" lower_limit="85.56" upper_limit="96.03"/>
                    <measurement group_id="O6" value="100" lower_limit="97.05" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="92.11" upper_limit="98.63"/>
                    <measurement group_id="O2" value="99" lower_limit="96.04" upper_limit="99.87"/>
                    <measurement group_id="O3" value="97" lower_limit="92.81" upper_limit="99.48"/>
                    <measurement group_id="O4" value="90" lower_limit="82.51" upper_limit="94.80"/>
                    <measurement group_id="O5" value="90" lower_limit="83.58" upper_limit="94.86"/>
                    <measurement group_id="O6" value="100" lower_limit="97.05" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="91.30" upper_limit="98.25"/>
                    <measurement group_id="O2" value="99" lower_limit="96.04" upper_limit="99.87"/>
                    <measurement group_id="O3" value="96" lower_limit="90.47" upper_limit="98.62"/>
                    <measurement group_id="O4" value="81" lower_limit="71.83" upper_limit="87.54"/>
                    <measurement group_id="O5" value="86" lower_limit="78.80" upper_limit="91.74"/>
                    <measurement group_id="O6" value="99" lower_limit="95.55" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" lower_limit="85.19" upper_limit="94.72"/>
                    <measurement group_id="O2" value="98" lower_limit="94.41" upper_limit="99.39"/>
                    <measurement group_id="O3" value="91" lower_limit="84.06" upper_limit="95.29"/>
                    <measurement group_id="O4" value="73" lower_limit="63.76" upper_limit="81.22"/>
                    <measurement group_id="O5" value="78" lower_limit="69.69" upper_limit="85.01"/>
                    <measurement group_id="O6" value="98" lower_limit="93.04" upper_limit="99.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80" lower_limit="73.27" upper_limit="86.08"/>
                    <measurement group_id="O2" value="93" lower_limit="88.64" upper_limit="96.51"/>
                    <measurement group_id="O3" value="77" lower_limit="68.73" upper_limit="84.48"/>
                    <measurement group_id="O4" value="50" lower_limit="40.22" upper_limit="59.78"/>
                    <measurement group_id="O5" value="64" lower_limit="55.09" upper_limit="72.67"/>
                    <measurement group_id="O6" value="91" lower_limit="84.56" upper_limit="95.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="53.15" upper_limit="68.66"/>
                    <measurement group_id="O2" value="74" lower_limit="66.83" upper_limit="80.14"/>
                    <measurement group_id="O3" value="50" lower_limit="41.11" upper_limit="59.71"/>
                    <measurement group_id="O4" value="33" lower_limit="24.55" upper_limit="43.05"/>
                    <measurement group_id="O5" value="44" lower_limit="34.97" upper_limit="53.13"/>
                    <measurement group_id="O6" value="70" lower_limit="61.00" upper_limit="77.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 7) ≥ LLQ (39.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="51.90" upper_limit="67.49"/>
                    <measurement group_id="O2" value="82" lower_limit="75.23" upper_limit="87.03"/>
                    <measurement group_id="O3" value="79" lower_limit="70.57" upper_limit="85.92"/>
                    <measurement group_id="O4" value="99" lower_limit="94.95" upper_limit="99.98"/>
                    <measurement group_id="O5" value="74" lower_limit="65.30" upper_limit="81.48"/>
                    <measurement group_id="O6" value="99" lower_limit="95.55" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" lower_limit="63.35" upper_limit="77.84"/>
                    <measurement group_id="O2" value="97" lower_limit="92.89" upper_limit="98.77"/>
                    <measurement group_id="O3" value="96" lower_limit="90.47" upper_limit="98.62"/>
                    <measurement group_id="O4" value="100" lower_limit="96.64" upper_limit="100"/>
                    <measurement group_id="O5" value="93" lower_limit="86.56" upper_limit="96.60"/>
                    <measurement group_id="O6" value="100" lower_limit="97.05" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="62.70" upper_limit="77.28"/>
                    <measurement group_id="O2" value="95" lower_limit="90.72" upper_limit="97.69"/>
                    <measurement group_id="O3" value="95" lower_limit="89.35" upper_limit="98.13"/>
                    <measurement group_id="O4" value="100" lower_limit="96.64" upper_limit="100"/>
                    <measurement group_id="O5" value="91" lower_limit="84.56" upper_limit="95.45"/>
                    <measurement group_id="O6" value="100" lower_limit="97.05" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" lower_limit="61.41" upper_limit="76.15"/>
                    <measurement group_id="O2" value="92" lower_limit="87.29" upper_limit="95.68"/>
                    <measurement group_id="O3" value="91" lower_limit="84.06" upper_limit="95.29"/>
                    <measurement group_id="O4" value="100" lower_limit="96.64" upper_limit="100"/>
                    <measurement group_id="O5" value="87" lower_limit="79.74" upper_limit="92.38"/>
                    <measurement group_id="O6" value="100" lower_limit="97.05" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="55.03" upper_limit="70.41"/>
                    <measurement group_id="O2" value="84" lower_limit="78.31" upper_limit="89.41"/>
                    <measurement group_id="O3" value="84" lower_limit="76.19" upper_limit="90.10"/>
                    <measurement group_id="O4" value="100" lower_limit="96.64" upper_limit="100"/>
                    <measurement group_id="O5" value="76" lower_limit="67.93" upper_limit="83.61"/>
                    <measurement group_id="O6" value="99" lower_limit="95.55" upper_limit="99.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="40.85" upper_limit="56.73"/>
                    <measurement group_id="O2" value="68" lower_limit="60.42" upper_limit="74.54"/>
                    <measurement group_id="O3" value="67" lower_limit="58.02" upper_limit="75.55"/>
                    <measurement group_id="O4" value="97" lower_limit="92.10" upper_limit="99.42"/>
                    <measurement group_id="O5" value="59" lower_limit="49.31" upper_limit="67.35"/>
                    <measurement group_id="O6" value="98" lower_limit="93.04" upper_limit="99.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31" lower_limit="23.85" upper_limit="38.59"/>
                    <measurement group_id="O2" value="41" lower_limit="33.31" upper_limit="48.11"/>
                    <measurement group_id="O3" value="34" lower_limit="25.98" upper_limit="43.72"/>
                    <measurement group_id="O4" value="87" lower_limit="79.21" upper_limit="92.73"/>
                    <measurement group_id="O5" value="34" lower_limit="25.84" upper_limit="43.24"/>
                    <measurement group_id="O6" value="82" lower_limit="74.18" upper_limit="88.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 13) ≥ LLQ (39.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="39.04" upper_limit="54.90"/>
                    <measurement group_id="O2" value="64" lower_limit="56.41" upper_limit="70.90"/>
                    <measurement group_id="O3" value="66" lower_limit="56.28" upper_limit="74.02"/>
                    <measurement group_id="O4" value="82" lower_limit="73.90" upper_limit="89.06"/>
                    <measurement group_id="O5" value="98" lower_limit="93.04" upper_limit="99.49"/>
                    <measurement group_id="O6" value="84" lower_limit="76.01" upper_limit="89.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" lower_limit="54.40" upper_limit="69.83"/>
                    <measurement group_id="O2" value="93" lower_limit="87.97" upper_limit="96.10"/>
                    <measurement group_id="O3" value="90" lower_limit="83.05" upper_limit="94.68"/>
                    <measurement group_id="O4" value="99" lower_limit="94.95" upper_limit="99.98"/>
                    <measurement group_id="O5" value="99" lower_limit="95.55" upper_limit="99.98"/>
                    <measurement group_id="O6" value="98" lower_limit="94.25" upper_limit="99.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="52.52" upper_limit="68.07"/>
                    <measurement group_id="O2" value="90" lower_limit="84.66" upper_limit="93.96"/>
                    <measurement group_id="O3" value="90" lower_limit="83.05" upper_limit="94.68"/>
                    <measurement group_id="O4" value="98" lower_limit="93.47" upper_limit="99.77"/>
                    <measurement group_id="O5" value="99" lower_limit="95.55" upper_limit="99.98"/>
                    <measurement group_id="O6" value="98" lower_limit="94.25" upper_limit="99.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57" lower_limit="48.79" upper_limit="64.54"/>
                    <measurement group_id="O2" value="84" lower_limit="77.69" upper_limit="88.94"/>
                    <measurement group_id="O3" value="81" lower_limit="72.42" upper_limit="87.34"/>
                    <measurement group_id="O4" value="94" lower_limit="87.10" upper_limit="97.35"/>
                    <measurement group_id="O5" value="99" lower_limit="95.55" upper_limit="99.98"/>
                    <measurement group_id="O6" value="96" lower_limit="90.77" upper_limit="98.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" lower_limit="42.05" upper_limit="57.95"/>
                    <measurement group_id="O2" value="71" lower_limit="63.90" upper_limit="77.61"/>
                    <measurement group_id="O3" value="72" lower_limit="63.32" upper_limit="80.08"/>
                    <measurement group_id="O4" value="85" lower_limit="77.06" upper_limit="91.29"/>
                    <measurement group_id="O5" value="98" lower_limit="94.25" upper_limit="99.80"/>
                    <measurement group_id="O6" value="89" lower_limit="82.60" upper_limit="94.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="27.28" upper_limit="42.43"/>
                    <measurement group_id="O2" value="44" lower_limit="36.52" upper_limit="51.47"/>
                    <measurement group_id="O3" value="48" lower_limit="38.66" upper_limit="57.25"/>
                    <measurement group_id="O4" value="73" lower_limit="63.76" upper_limit="81.22"/>
                    <measurement group_id="O5" value="98" lower_limit="93.04" upper_limit="99.49"/>
                    <measurement group_id="O6" value="68" lower_limit="59.29" upper_limit="76.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="14.99" upper_limit="28.07"/>
                    <measurement group_id="O2" value="22" lower_limit="16.38" upper_limit="29.01"/>
                    <measurement group_id="O3" value="28" lower_limit="19.92" upper_limit="36.68"/>
                    <measurement group_id="O4" value="43" lower_limit="33.13" upper_limit="52.47"/>
                    <measurement group_id="O5" value="94" lower_limit="88.63" upper_limit="97.68"/>
                    <measurement group_id="O6" value="45" lower_limit="35.75" upper_limit="53.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against Y Human Serogroup for All Schedules.</title>
        <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against Y human serogroup was assessed.</description>
        <time_frame>At Month 0, Month 2, Month 3, Month 7 and Month 13.</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for at least one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against Y Human Serogroup for All Schedules.</title>
          <description>The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against Y human serogroup was assessed.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for at least one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="180"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="110"/>
                <count group_id="O5" value="127"/>
                <count group_id="O6" value="137"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Y human Serogroup (At Month 0) ≥ LLQ (14.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10.13" upper_limit="20.80"/>
                    <measurement group_id="O2" value="10" lower_limit="6.04" upper_limit="15.34"/>
                    <measurement group_id="O3" value="13" lower_limit="7.82" upper_limit="20.75"/>
                    <measurement group_id="O4" value="6" lower_limit="2.60" upper_limit="12.67"/>
                    <measurement group_id="O5" value="13" lower_limit="7.38" upper_limit="19.65"/>
                    <measurement group_id="O6" value="7" lower_limit="3.05" upper_limit="12.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 0) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="11.03" upper_limit="21.99"/>
                    <measurement group_id="O2" value="11" lower_limit="6.92" upper_limit="16.64"/>
                    <measurement group_id="O3" value="15" lower_limit="9.14" upper_limit="22.67"/>
                    <measurement group_id="O4" value="7" lower_limit="3.19" upper_limit="13.83"/>
                    <measurement group_id="O5" value="17" lower_limit="10.54" upper_limit="24.16"/>
                    <measurement group_id="O6" value="9" lower_limit="4.61" upper_limit="14.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 0) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="11.03" upper_limit="21.99"/>
                    <measurement group_id="O2" value="11" lower_limit="6.92" upper_limit="16.64"/>
                    <measurement group_id="O3" value="14" lower_limit="8.47" upper_limit="21.71"/>
                    <measurement group_id="O4" value="7" lower_limit="3.19" upper_limit="13.83"/>
                    <measurement group_id="O5" value="16" lower_limit="9.89" upper_limit="23.27"/>
                    <measurement group_id="O6" value="9" lower_limit="4.61" upper_limit="14.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 0) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10.13" upper_limit="20.80"/>
                    <measurement group_id="O2" value="10" lower_limit="6.04" upper_limit="15.34"/>
                    <measurement group_id="O3" value="13" lower_limit="7.17" upper_limit="19.78"/>
                    <measurement group_id="O4" value="6" lower_limit="2.60" upper_limit="12.67"/>
                    <measurement group_id="O5" value="12" lower_limit="6.76" upper_limit="18.73"/>
                    <measurement group_id="O6" value="6" lower_limit="2.55" upper_limit="11.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 0) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.36" upper_limit="14.08"/>
                    <measurement group_id="O2" value="3" lower_limit="0.91" upper_limit="6.36"/>
                    <measurement group_id="O3" value="8" lower_limit="4.07" upper_limit="14.79"/>
                    <measurement group_id="O4" value="3" lower_limit="0.57" upper_limit="7.76"/>
                    <measurement group_id="O5" value="8" lower_limit="3.84" upper_limit="14.00"/>
                    <measurement group_id="O6" value="4" lower_limit="1.62" upper_limit="9.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 0) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.58" upper_limit="5.36"/>
                    <measurement group_id="O2" value="2" lower_limit="0.35" upper_limit="4.79"/>
                    <measurement group_id="O3" value="4" lower_limit="1.37" upper_limit="9.46"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.30"/>
                    <measurement group_id="O5" value="5" lower_limit="1.75" upper_limit="10.00"/>
                    <measurement group_id="O6" value="3" lower_limit="0.80" upper_limit="7.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 0) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.94"/>
                    <measurement group_id="O2" value="1" lower_limit="0.01" upper_limit="3.06"/>
                    <measurement group_id="O3" value="1" lower_limit="0.02" upper_limit="4.56"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.30"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.31"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 2) ≥ LLQ (14.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="15.19" upper_limit="27.25"/>
                    <measurement group_id="O2" value="66" lower_limit="58.70" upper_limit="72.99"/>
                    <measurement group_id="O3" value="85" lower_limit="77.33" upper_limit="90.86"/>
                    <measurement group_id="O4" value="60" lower_limit="50.22" upper_limit="69.22"/>
                    <measurement group_id="O5" value="72" lower_limit="62.98" upper_limit="79.29"/>
                    <measurement group_id="O6" value="61" lower_limit="52.62" upper_limit="69.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 2) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="20.91" upper_limit="34.08"/>
                    <measurement group_id="O2" value="72" lower_limit="64.48" upper_limit="78.12"/>
                    <measurement group_id="O3" value="90" lower_limit="83.18" upper_limit="94.73"/>
                    <measurement group_id="O4" value="65" lower_limit="55.79" upper_limit="74.26"/>
                    <measurement group_id="O5" value="78" lower_limit="69.74" upper_limit="84.82"/>
                    <measurement group_id="O6" value="65" lower_limit="56.35" upper_limit="72.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 2) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.95" upper_limit="32.95"/>
                    <measurement group_id="O2" value="70" lower_limit="62.74" upper_limit="76.59"/>
                    <measurement group_id="O3" value="89" lower_limit="82.19" upper_limit="94.10"/>
                    <measurement group_id="O4" value="62" lower_limit="52.07" upper_limit="70.92"/>
                    <measurement group_id="O5" value="76" lower_limit="68.03" upper_limit="83.46"/>
                    <measurement group_id="O6" value="64" lower_limit="54.85" upper_limit="71.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 2) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="14.72" upper_limit="26.67"/>
                    <measurement group_id="O2" value="64" lower_limit="56.41" upper_limit="70.90"/>
                    <measurement group_id="O3" value="85" lower_limit="77.33" upper_limit="90.86"/>
                    <measurement group_id="O4" value="58" lower_limit="48.39" upper_limit="67.52"/>
                    <measurement group_id="O5" value="69" lower_limit="60.49" upper_limit="77.17"/>
                    <measurement group_id="O6" value="60" lower_limit="51.14" upper_limit="68.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 2) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="8.35" upper_limit="18.40"/>
                    <measurement group_id="O2" value="47" lower_limit="39.75" upper_limit="54.79"/>
                    <measurement group_id="O3" value="75" lower_limit="66.27" upper_limit="82.45"/>
                    <measurement group_id="O4" value="47" lower_limit="37.68" upper_limit="57.02"/>
                    <measurement group_id="O5" value="54" lower_limit="44.48" upper_limit="62.44"/>
                    <measurement group_id="O6" value="50" lower_limit="41.70" upper_limit="59.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 2) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.21" upper_limit="8.89"/>
                    <measurement group_id="O2" value="31" lower_limit="23.92" upper_limit="37.84"/>
                    <measurement group_id="O3" value="59" lower_limit="49.82" upper_limit="68.05"/>
                    <measurement group_id="O4" value="30" lower_limit="21.63" upper_limit="39.48"/>
                    <measurement group_id="O5" value="39" lower_limit="30.08" upper_limit="47.63"/>
                    <measurement group_id="O6" value="39" lower_limit="31.18" upper_limit="48.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 2) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.13" upper_limit="3.79"/>
                    <measurement group_id="O2" value="14" lower_limit="9.19" upper_limit="19.82"/>
                    <measurement group_id="O3" value="39" lower_limit="30.39" upper_limit="48.50"/>
                    <measurement group_id="O4" value="12" lower_limit="6.45" upper_limit="19.36"/>
                    <measurement group_id="O5" value="23" lower_limit="15.86" upper_limit="31.12"/>
                    <measurement group_id="O6" value="23" lower_limit="16.56" upper_limit="31.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 3) ≥ LLQ (14.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="20.43" upper_limit="33.52"/>
                    <measurement group_id="O2" value="92" lower_limit="87.29" upper_limit="95.68"/>
                    <measurement group_id="O3" value="80" lower_limit="71.72" upper_limit="86.75"/>
                    <measurement group_id="O4" value="58" lower_limit="48.39" upper_limit="67.52"/>
                    <measurement group_id="O5" value="62" lower_limit="53.17" upper_limit="70.65"/>
                    <measurement group_id="O6" value="90" lower_limit="83.45" upper_limit="94.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 3) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" lower_limit="26.31" upper_limit="40.19"/>
                    <measurement group_id="O2" value="94" lower_limit="89.33" upper_limit="96.91"/>
                    <measurement group_id="O3" value="84" lower_limit="76.38" upper_limit="90.19"/>
                    <measurement group_id="O4" value="65" lower_limit="54.85" upper_limit="73.43"/>
                    <measurement group_id="O5" value="70" lower_limit="61.32" upper_limit="77.88"/>
                    <measurement group_id="O6" value="93" lower_limit="86.99" upper_limit="96.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 3) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="23.84" upper_limit="37.43"/>
                    <measurement group_id="O2" value="93" lower_limit="88.64" upper_limit="96.51"/>
                    <measurement group_id="O3" value="83" lower_limit="75.44" upper_limit="89.51"/>
                    <measurement group_id="O4" value="60" lower_limit="50.22" upper_limit="69.22"/>
                    <measurement group_id="O5" value="67" lower_limit="58.03" upper_limit="75.02"/>
                    <measurement group_id="O6" value="93" lower_limit="86.99" upper_limit="96.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 3) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.95" upper_limit="32.95"/>
                    <measurement group_id="O2" value="92" lower_limit="86.63" upper_limit="95.26"/>
                    <measurement group_id="O3" value="79" lower_limit="70.80" upper_limit="86.04"/>
                    <measurement group_id="O4" value="57" lower_limit="47.48" upper_limit="66.66"/>
                    <measurement group_id="O5" value="59" lower_limit="49.98" upper_limit="67.70"/>
                    <measurement group_id="O6" value="90" lower_limit="83.45" upper_limit="94.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 3) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="12.86" upper_limit="24.34"/>
                    <measurement group_id="O2" value="84" lower_limit="77.69" upper_limit="88.94"/>
                    <measurement group_id="O3" value="68" lower_limit="58.35" upper_limit="75.77"/>
                    <measurement group_id="O4" value="44" lower_limit="34.20" upper_limit="53.42"/>
                    <measurement group_id="O5" value="44" lower_limit="35.30" upper_limit="53.17"/>
                    <measurement group_id="O6" value="83" lower_limit="75.88" upper_limit="89.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 3) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="4.94" upper_limit="13.45"/>
                    <measurement group_id="O2" value="68" lower_limit="61.00" upper_limit="75.05"/>
                    <measurement group_id="O3" value="47" lower_limit="37.51" upper_limit="55.99"/>
                    <measurement group_id="O4" value="24" lower_limit="16.06" upper_limit="32.68"/>
                    <measurement group_id="O5" value="31" lower_limit="23.55" upper_limit="40.33"/>
                    <measurement group_id="O6" value="65" lower_limit="56.35" upper_limit="72.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 3) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.58" upper_limit="5.36"/>
                    <measurement group_id="O2" value="39" lower_limit="32.25" upper_limit="46.99"/>
                    <measurement group_id="O3" value="28" lower_limit="19.75" upper_limit="36.40"/>
                    <measurement group_id="O4" value="16" lower_limit="10.00" upper_limit="24.62"/>
                    <measurement group_id="O5" value="23" lower_limit="15.86" upper_limit="31.12"/>
                    <measurement group_id="O6" value="47" lower_limit="38.15" upper_limit="55.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 7) ≥ LLQ (14.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17.07" upper_limit="29.55"/>
                    <measurement group_id="O2" value="78" lower_limit="70.99" upper_limit="83.62"/>
                    <measurement group_id="O3" value="72" lower_limit="62.72" upper_limit="79.51"/>
                    <measurement group_id="O4" value="95" lower_limit="88.51" upper_limit="97.97"/>
                    <measurement group_id="O5" value="54" lower_limit="44.48" upper_limit="62.44"/>
                    <measurement group_id="O6" value="97" lower_limit="92.69" upper_limit="99.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 7) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.95" upper_limit="32.95"/>
                    <measurement group_id="O2" value="86" lower_limit="79.56" upper_limit="90.34"/>
                    <measurement group_id="O3" value="80" lower_limit="71.72" upper_limit="86.75"/>
                    <measurement group_id="O4" value="95" lower_limit="89.71" upper_limit="98.51"/>
                    <measurement group_id="O5" value="69" lower_limit="59.67" upper_limit="76.45"/>
                    <measurement group_id="O6" value="99" lower_limit="94.83" upper_limit="99.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 7) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.46" upper_limit="32.39"/>
                    <measurement group_id="O2" value="84" lower_limit="77.69" upper_limit="88.94"/>
                    <measurement group_id="O3" value="77" lower_limit="68.07" upper_limit="83.90"/>
                    <measurement group_id="O4" value="95" lower_limit="89.71" upper_limit="98.51"/>
                    <measurement group_id="O5" value="64" lower_limit="54.78" upper_limit="72.12"/>
                    <measurement group_id="O6" value="98" lower_limit="93.73" upper_limit="99.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 7) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="16.13" upper_limit="28.40"/>
                    <measurement group_id="O2" value="74" lower_limit="66.83" upper_limit="80.14"/>
                    <measurement group_id="O3" value="69" lower_limit="60.09" upper_limit="77.27"/>
                    <measurement group_id="O4" value="94" lower_limit="87.33" upper_limit="97.40"/>
                    <measurement group_id="O5" value="52" lower_limit="42.93" upper_limit="60.91"/>
                    <measurement group_id="O6" value="97" lower_limit="92.69" upper_limit="99.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 7) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="8.35" upper_limit="18.40"/>
                    <measurement group_id="O2" value="63" lower_limit="55.27" upper_limit="69.85"/>
                    <measurement group_id="O3" value="54" lower_limit="44.83" upper_limit="63.29"/>
                    <measurement group_id="O4" value="87" lower_limit="79.57" upper_limit="92.86"/>
                    <measurement group_id="O5" value="40" lower_limit="31.56" upper_limit="49.22"/>
                    <measurement group_id="O6" value="91" lower_limit="85.20" upper_limit="95.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 7) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0.87" upper_limit="6.10"/>
                    <measurement group_id="O2" value="37" lower_limit="30.15" upper_limit="44.73"/>
                    <measurement group_id="O3" value="35" lower_limit="26.52" upper_limit="44.24"/>
                    <measurement group_id="O4" value="79" lower_limit="70.30" upper_limit="86.26"/>
                    <measurement group_id="O5" value="27" lower_limit="19.31" upper_limit="35.35"/>
                    <measurement group_id="O6" value="75" lower_limit="67.08" upper_limit="82.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 7) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.01" upper_limit="2.93"/>
                    <measurement group_id="O2" value="14" lower_limit="9.66" upper_limit="20.44"/>
                    <measurement group_id="O3" value="22" lower_limit="14.67" upper_limit="30.11"/>
                    <measurement group_id="O4" value="57" lower_limit="47.48" upper_limit="66.66"/>
                    <measurement group_id="O5" value="13" lower_limit="8.00" upper_limit="20.56"/>
                    <measurement group_id="O6" value="57" lower_limit="48.20" upper_limit="65.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 13) ≥ LLQ (14.7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.32" upper_limit="24.93"/>
                    <measurement group_id="O2" value="64" lower_limit="56.41" upper_limit="70.90"/>
                    <measurement group_id="O3" value="58" lower_limit="48.15" upper_limit="66.47"/>
                    <measurement group_id="O4" value="78" lower_limit="69.30" upper_limit="85.49"/>
                    <measurement group_id="O5" value="97" lower_limit="92.13" upper_limit="99.14"/>
                    <measurement group_id="O6" value="82" lower_limit="75.06" upper_limit="88.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 13) ≥ 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" lower_limit="18.98" upper_limit="31.82"/>
                    <measurement group_id="O2" value="76" lower_limit="68.61" upper_limit="81.64"/>
                    <measurement group_id="O3" value="73" lower_limit="64.49" upper_limit="80.99"/>
                    <measurement group_id="O4" value="91" lower_limit="83.92" upper_limit="95.55"/>
                    <measurement group_id="O5" value="97" lower_limit="92.13" upper_limit="99.14"/>
                    <measurement group_id="O6" value="91" lower_limit="85.20" upper_limit="95.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 13) ≥ 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="18.03" upper_limit="30.69"/>
                    <measurement group_id="O2" value="71" lower_limit="63.90" upper_limit="77.61"/>
                    <measurement group_id="O3" value="63" lower_limit="54.05" upper_limit="71.94"/>
                    <measurement group_id="O4" value="84" lower_limit="75.38" upper_limit="90.00"/>
                    <measurement group_id="O5" value="97" lower_limit="92.13" upper_limit="99.14"/>
                    <measurement group_id="O6" value="87" lower_limit="80.03" upper_limit="92.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 13) ≥ 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="12.40" upper_limit="23.76"/>
                    <measurement group_id="O2" value="61" lower_limit="53.58" upper_limit="68.27"/>
                    <measurement group_id="O3" value="55" lower_limit="45.65" upper_limit="64.09"/>
                    <measurement group_id="O4" value="76" lower_limit="67.32" upper_limit="83.94"/>
                    <measurement group_id="O5" value="97" lower_limit="92.13" upper_limit="99.14"/>
                    <measurement group_id="O6" value="81" lower_limit="73.44" upper_limit="87.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 13) ≥ 32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="5.77" upper_limit="14.71"/>
                    <measurement group_id="O2" value="43" lower_limit="35.45" upper_limit="50.35"/>
                    <measurement group_id="O3" value="40" lower_limit="31.17" upper_limit="49.34"/>
                    <measurement group_id="O4" value="60" lower_limit="50.22" upper_limit="69.22"/>
                    <measurement group_id="O5" value="93" lower_limit="86.97" upper_limit="96.71"/>
                    <measurement group_id="O6" value="69" lower_limit="60.13" upper_limit="76.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 13) ≥ 64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.18" upper_limit="6.82"/>
                    <measurement group_id="O2" value="21" lower_limit="15.39" upper_limit="27.81"/>
                    <measurement group_id="O3" value="23" lower_limit="15.38" upper_limit="31.02"/>
                    <measurement group_id="O4" value="41" lower_limit="31.63" upper_limit="50.69"/>
                    <measurement group_id="O5" value="92" lower_limit="86.00" upper_limit="96.16"/>
                    <measurement group_id="O6" value="46" lower_limit="37.44" upper_limit="54.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup (At Month 13) ≥ 128</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0.13" upper_limit="3.79"/>
                    <measurement group_id="O2" value="9" lower_limit="5.17" upper_limit="14.03"/>
                    <measurement group_id="O3" value="11" lower_limit="5.90" upper_limit="17.81"/>
                    <measurement group_id="O4" value="21" lower_limit="13.74" upper_limit="29.70"/>
                    <measurement group_id="O5" value="73" lower_limit="64.65" upper_limit="80.69"/>
                    <measurement group_id="O6" value="28" lower_limit="21.09" upper_limit="36.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With Two-, Three- and Four-fold Titer Rise Against Serogroups A, C, W and Y and Serogroup B Test Strains for All Schedules.</title>
        <description>The kinetic of immune response (at Months 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with two-, three- and four-fold titer rise against serogroups A, C, W and Y and serogroup B test strains was assessed. The two/three/four fold titer rise is defined as: a) for subjects with prevaccination hSBA titers ≤ LLQ, a postvaccination hSBA ≥ 2/3/4 LLQ; b) for subjects with a prevaccination hSBA titers ≥ LLQ, an increase of at least 2/3/4 times of the prevaccination hSBA titer.</description>
        <time_frame>At Month 2, Month 3, Month 7 and Month 13</time_frame>
        <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With Two-, Three- and Four-fold Titer Rise Against Serogroups A, C, W and Y and Serogroup B Test Strains for All Schedules.</title>
          <description>The kinetic of immune response (at Months 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with two-, three- and four-fold titer rise against serogroups A, C, W and Y and serogroup B test strains was assessed. The two/three/four fold titer rise is defined as: a) for subjects with prevaccination hSBA titers ≤ LLQ, a postvaccination hSBA ≥ 2/3/4 LLQ; b) for subjects with a prevaccination hSBA titers ≥ LLQ, an increase of at least 2/3/4 times of the prevaccination hSBA titer.</description>
          <population>Analysis was done on the FAS Month 13 which included all screened subjects who received a study vaccination &amp; provided evaluable serum samples at month 0 and atleast from month 2 to 13 and provided results for atleast one serogroup or serogroup B test strain.</population>
          <units>Percentages of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="185"/>
                <count group_id="O3" value="122"/>
                <count group_id="O4" value="114"/>
                <count group_id="O5" value="128"/>
                <count group_id="O6" value="137"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NZ98/254 Strain ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="12.86" upper_limit="24.34"/>
                    <measurement group_id="O2" value="13" lower_limit="8.49" upper_limit="18.69"/>
                    <measurement group_id="O3" value="28" lower_limit="19.75" upper_limit="36.40"/>
                    <measurement group_id="O4" value="9" lower_limit="4.36" upper_limit="15.81"/>
                    <measurement group_id="O5" value="21" lower_limit="14.62" upper_limit="29.62"/>
                    <measurement group_id="O6" value="12" lower_limit="6.98" upper_limit="18.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" lower_limit="9.24" upper_limit="19.60"/>
                    <measurement group_id="O2" value="9" lower_limit="5.44" upper_limit="14.30"/>
                    <measurement group_id="O3" value="19" lower_limit="12.56" upper_limit="27.36"/>
                    <measurement group_id="O4" value="9" lower_limit="4.36" upper_limit="15.81"/>
                    <measurement group_id="O5" value="17" lower_limit="11.28" upper_limit="25.23"/>
                    <measurement group_id="O6" value="7" lower_limit="3.64" upper_limit="13.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="7.05" upper_limit="16.57"/>
                    <measurement group_id="O2" value="8" lower_limit="4.61" upper_limit="13.02"/>
                    <measurement group_id="O3" value="17" lower_limit="10.49" upper_limit="24.56"/>
                    <measurement group_id="O4" value="7" lower_limit="3.13" upper_limit="13.59"/>
                    <measurement group_id="O5" value="17" lower_limit="10.62" upper_limit="24.34"/>
                    <measurement group_id="O6" value="7" lower_limit="3.12" upper_limit="12.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73" lower_limit="66.48" upper_limit="79.57"/>
                    <measurement group_id="O2" value="42" lower_limit="34.43" upper_limit="49.08"/>
                    <measurement group_id="O3" value="18" lower_limit="11.17" upper_limit="25.50"/>
                    <measurement group_id="O4" value="9" lower_limit="4.36" upper_limit="15.81"/>
                    <measurement group_id="O5" value="13" lower_limit="8.06" upper_limit="20.72"/>
                    <measurement group_id="O6" value="43" lower_limit="34.76" upper_limit="52.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="53.81" upper_limit="68.18"/>
                    <measurement group_id="O2" value="32" lower_limit="25.25" upper_limit="39.13"/>
                    <measurement group_id="O3" value="13" lower_limit="7.17" upper_limit="19.78"/>
                    <measurement group_id="O4" value="5" lower_limit="1.99" upper_limit="11.30"/>
                    <measurement group_id="O5" value="10" lower_limit="5.61" upper_limit="17.00"/>
                    <measurement group_id="O6" value="28" lower_limit="20.91" upper_limit="36.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="39.51" upper_limit="54.21"/>
                    <measurement group_id="O2" value="22" lower_limit="15.92" upper_limit="28.26"/>
                    <measurement group_id="O3" value="9" lower_limit="4.67" upper_limit="15.81"/>
                    <measurement group_id="O4" value="4" lower_limit="0.98" upper_limit="8.89"/>
                    <measurement group_id="O5" value="9" lower_limit="4.44" upper_limit="15.08"/>
                    <measurement group_id="O6" value="19" lower_limit="12.45" upper_limit="26.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.32" upper_limit="24.93"/>
                    <measurement group_id="O2" value="12" lower_limit="8.05" upper_limit="18.07"/>
                    <measurement group_id="O3" value="11" lower_limit="5.90" upper_limit="17.81"/>
                    <measurement group_id="O4" value="45" lower_limit="35.24" upper_limit="54.33"/>
                    <measurement group_id="O5" value="7" lower_limit="3.32" upper_limit="13.13"/>
                    <measurement group_id="O6" value="54" lower_limit="44.92" upper_limit="62.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="7.05" upper_limit="16.57"/>
                    <measurement group_id="O2" value="10" lower_limit="6.30" upper_limit="15.57"/>
                    <measurement group_id="O3" value="7" lower_limit="2.92" upper_limit="12.71"/>
                    <measurement group_id="O4" value="33" lower_limit="24.44" upper_limit="42.56"/>
                    <measurement group_id="O5" value="6" lower_limit="2.78" upper_limit="12.13"/>
                    <measurement group_id="O6" value="43" lower_limit="34.76" upper_limit="52.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.36" upper_limit="14.08"/>
                    <measurement group_id="O2" value="8" lower_limit="4.61" upper_limit="13.02"/>
                    <measurement group_id="O3" value="6" lower_limit="2.38" upper_limit="11.65"/>
                    <measurement group_id="O4" value="24" lower_limit="16.53" upper_limit="33.10"/>
                    <measurement group_id="O5" value="4" lower_limit="1.30" upper_limit="9.02"/>
                    <measurement group_id="O6" value="33" lower_limit="24.97" upper_limit="41.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="6.62" upper_limit="15.95"/>
                    <measurement group_id="O2" value="9" lower_limit="5.44" upper_limit="14.30"/>
                    <measurement group_id="O3" value="7" lower_limit="2.92" upper_limit="12.71"/>
                    <measurement group_id="O4" value="10" lower_limit="5.01" upper_limit="16.89"/>
                    <measurement group_id="O5" value="49" lower_limit="40.19" upper_limit="58.26"/>
                    <measurement group_id="O6" value="14" lower_limit="8.76" upper_limit="21.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.58" upper_limit="9.56"/>
                    <measurement group_id="O2" value="7" lower_limit="3.79" upper_limit="11.72"/>
                    <measurement group_id="O3" value="6" lower_limit="2.38" upper_limit="11.65"/>
                    <measurement group_id="O4" value="9" lower_limit="4.36" upper_limit="15.81"/>
                    <measurement group_id="O5" value="37" lower_limit="28.12" upper_limit="45.55"/>
                    <measurement group_id="O6" value="7" lower_limit="3.64" upper_limit="13.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Strain ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.85" upper_limit="8.21"/>
                    <measurement group_id="O2" value="5" lower_limit="2.62" upper_limit="9.72"/>
                    <measurement group_id="O3" value="5" lower_limit="1.86" upper_limit="10.57"/>
                    <measurement group_id="O4" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O5" value="26" lower_limit="18.76" upper_limit="34.77"/>
                    <measurement group_id="O6" value="4" lower_limit="1.66" upper_limit="9.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" lower_limit="9.44" upper_limit="20.02"/>
                    <measurement group_id="O2" value="13" lower_limit="8.32" upper_limit="18.65"/>
                    <measurement group_id="O3" value="34" lower_limit="25.25" upper_limit="43.48"/>
                    <measurement group_id="O4" value="8" lower_limit="3.88" upper_limit="15.23"/>
                    <measurement group_id="O5" value="23" lower_limit="15.69" upper_limit="31.19"/>
                    <measurement group_id="O6" value="11" lower_limit="6.40" upper_limit="17.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="5.90" upper_limit="15.02"/>
                    <measurement group_id="O2" value="10" lower_limit="6.07" upper_limit="15.43"/>
                    <measurement group_id="O3" value="23" lower_limit="15.76" upper_limit="32.14"/>
                    <measurement group_id="O4" value="6" lower_limit="2.07" upper_limit="11.70"/>
                    <measurement group_id="O5" value="15" lower_limit="9.56" upper_limit="23.07"/>
                    <measurement group_id="O6" value="6" lower_limit="2.61" upper_limit="11.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.82" upper_limit="11.78"/>
                    <measurement group_id="O2" value="6" lower_limit="2.71" upper_limit="10.03"/>
                    <measurement group_id="O3" value="15" lower_limit="9.10" upper_limit="23.19"/>
                    <measurement group_id="O4" value="4" lower_limit="1.02" upper_limit="9.21"/>
                    <measurement group_id="O5" value="12" lower_limit="6.99" upper_limit="19.32"/>
                    <measurement group_id="O6" value="4" lower_limit="1.22" upper_limit="8.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" lower_limit="57.86" upper_limit="72.07"/>
                    <measurement group_id="O2" value="50" lower_limit="42.72" upper_limit="57.82"/>
                    <measurement group_id="O3" value="24" lower_limit="16.53" upper_limit="33.10"/>
                    <measurement group_id="O4" value="6" lower_limit="2.65" upper_limit="12.90"/>
                    <measurement group_id="O5" value="14" lower_limit="8.26" upper_limit="21.20"/>
                    <measurement group_id="O6" value="50" lower_limit="41.25" upper_limit="58.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="41.49" upper_limit="56.37"/>
                    <measurement group_id="O2" value="39" lower_limit="31.38" upper_limit="46.10"/>
                    <measurement group_id="O3" value="10" lower_limit="5.01" upper_limit="16.89"/>
                    <measurement group_id="O4" value="3" lower_limit="0.58" upper_limit="7.90"/>
                    <measurement group_id="O5" value="11" lower_limit="5.75" upper_limit="17.40"/>
                    <measurement group_id="O6" value="39" lower_limit="30.52" upper_limit="47.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" lower_limit="30.49" upper_limit="44.92"/>
                    <measurement group_id="O2" value="28" lower_limit="22.01" upper_limit="35.70"/>
                    <measurement group_id="O3" value="4" lower_limit="1.47" upper_limit="10.11"/>
                    <measurement group_id="O4" value="3" lower_limit="0.58" upper_limit="7.90"/>
                    <measurement group_id="O5" value="7" lower_limit="3.40" upper_limit="13.44"/>
                    <measurement group_id="O6" value="28" lower_limit="20.24" upper_limit="36.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="11.28" upper_limit="22.45"/>
                    <measurement group_id="O2" value="14" lower_limit="9.25" upper_limit="19.92"/>
                    <measurement group_id="O3" value="9" lower_limit="4.36" upper_limit="15.81"/>
                    <measurement group_id="O4" value="69" lower_limit="58.88" upper_limit="77.12"/>
                    <measurement group_id="O5" value="7" lower_limit="2.85" upper_limit="12.41"/>
                    <measurement group_id="O6" value="72" lower_limit="63.21" upper_limit="79.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="7.65" upper_limit="17.54"/>
                    <measurement group_id="O2" value="7" lower_limit="3.92" upper_limit="12.10"/>
                    <measurement group_id="O3" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O4" value="55" lower_limit="44.76" upper_limit="64.24"/>
                    <measurement group_id="O5" value="6" lower_limit="2.32" upper_limit="11.37"/>
                    <measurement group_id="O6" value="54" lower_limit="45.65" upper_limit="63.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4.22" upper_limit="12.44"/>
                    <measurement group_id="O2" value="6" lower_limit="3.11" upper_limit="10.73"/>
                    <measurement group_id="O3" value="4" lower_limit="0.98" upper_limit="8.89"/>
                    <measurement group_id="O4" value="48" lower_limit="38.43" upper_limit="57.97"/>
                    <measurement group_id="O5" value="5" lower_limit="1.81" upper_limit="10.32"/>
                    <measurement group_id="O6" value="49" lower_limit="39.79" upper_limit="57.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="7.21" upper_limit="16.92"/>
                    <measurement group_id="O2" value="9" lower_limit="5.63" upper_limit="14.77"/>
                    <measurement group_id="O3" value="6" lower_limit="2.55" upper_limit="12.45"/>
                    <measurement group_id="O4" value="10" lower_limit="5.20" upper_limit="17.49"/>
                    <measurement group_id="O5" value="74" lower_limit="65.30" upper_limit="81.48"/>
                    <measurement group_id="O6" value="12" lower_limit="6.98" upper_limit="18.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4.22" upper_limit="12.44"/>
                    <measurement group_id="O2" value="4" lower_limit="1.95" upper_limit="8.62"/>
                    <measurement group_id="O3" value="4" lower_limit="1.47" upper_limit="10.11"/>
                    <measurement group_id="O4" value="7" lower_limit="3.25" upper_limit="14.07"/>
                    <measurement group_id="O5" value="59" lower_limit="50.12" upper_limit="68.11"/>
                    <measurement group_id="O6" value="6" lower_limit="2.61" upper_limit="11.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M14459 Strain ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="184"/>
                    <count group_id="O2" value="179"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.21" upper_limit="6.96"/>
                    <measurement group_id="O2" value="4" lower_limit="1.59" upper_limit="7.89"/>
                    <measurement group_id="O3" value="3" lower_limit="0.56" upper_limit="7.63"/>
                    <measurement group_id="O4" value="6" lower_limit="2.07" upper_limit="11.70"/>
                    <measurement group_id="O5" value="51" lower_limit="42.05" upper_limit="60.33"/>
                    <measurement group_id="O6" value="4" lower_limit="1.66" upper_limit="9.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="11.49" upper_limit="22.58"/>
                    <measurement group_id="O2" value="11" lower_limit="6.63" upper_limit="16.34"/>
                    <measurement group_id="O3" value="20" lower_limit="12.89" upper_limit="28.02"/>
                    <measurement group_id="O4" value="5" lower_limit="1.97" upper_limit="11.20"/>
                    <measurement group_id="O5" value="19" lower_limit="12.45" upper_limit="27.14"/>
                    <measurement group_id="O6" value="8" lower_limit="3.81" upper_limit="13.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="7.92" upper_limit="17.79"/>
                    <measurement group_id="O2" value="7" lower_limit="3.57" upper_limit="11.61"/>
                    <measurement group_id="O3" value="9" lower_limit="4.79" upper_limit="16.20"/>
                    <measurement group_id="O4" value="2" lower_limit="0.22" upper_limit="6.25"/>
                    <measurement group_id="O5" value="12" lower_limit="6.47" upper_limit="18.65"/>
                    <measurement group_id="O6" value="4" lower_limit="1.28" upper_limit="8.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4.53" upper_limit="12.82"/>
                    <measurement group_id="O2" value="5" lower_limit="1.98" upper_limit="8.76"/>
                    <measurement group_id="O3" value="7" lower_limit="3.00" upper_limit="13.03"/>
                    <measurement group_id="O4" value="2" lower_limit="0.22" upper_limit="6.25"/>
                    <measurement group_id="O5" value="9" lower_limit="4.63" upper_limit="15.68"/>
                    <measurement group_id="O6" value="1" lower_limit="0.02" upper_limit="4.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37" lower_limit="29.81" upper_limit="44.02"/>
                    <measurement group_id="O2" value="22" lower_limit="16.26" upper_limit="29.02"/>
                    <measurement group_id="O3" value="11" lower_limit="6.05" upper_limit="18.25"/>
                    <measurement group_id="O4" value="2" lower_limit="0.22" upper_limit="6.25"/>
                    <measurement group_id="O5" value="8" lower_limit="4.03" upper_limit="14.67"/>
                    <measurement group_id="O6" value="21" lower_limit="14.38" upper_limit="29.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="21.40" upper_limit="34.64"/>
                    <measurement group_id="O2" value="12" lower_limit="7.54" upper_limit="17.66"/>
                    <measurement group_id="O3" value="7" lower_limit="3.00" upper_limit="13.03"/>
                    <measurement group_id="O4" value="1" lower_limit="0.02" upper_limit="4.83"/>
                    <measurement group_id="O5" value="5" lower_limit="1.84" upper_limit="10.48"/>
                    <measurement group_id="O6" value="17" lower_limit="11.10" upper_limit="24.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.32" upper_limit="24.93"/>
                    <measurement group_id="O2" value="9" lower_limit="5.29" upper_limit="14.34"/>
                    <measurement group_id="O3" value="4" lower_limit="1.40" upper_limit="9.69"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="3.21"/>
                    <measurement group_id="O5" value="4" lower_limit="1.36" upper_limit="9.38"/>
                    <measurement group_id="O6" value="13" lower_limit="7.93" upper_limit="20.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.32" upper_limit="24.93"/>
                    <measurement group_id="O2" value="13" lower_limit="8.00" upper_limit="18.31"/>
                    <measurement group_id="O3" value="8" lower_limit="3.58" upper_limit="14.10"/>
                    <measurement group_id="O4" value="43" lower_limit="34.07" upper_limit="53.01"/>
                    <measurement group_id="O5" value="4" lower_limit="1.36" upper_limit="9.38"/>
                    <measurement group_id="O6" value="42" lower_limit="33.51" upper_limit="51.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="7.05" upper_limit="16.57"/>
                    <measurement group_id="O2" value="7" lower_limit="3.99" upper_limit="12.30"/>
                    <measurement group_id="O3" value="6" lower_limit="2.44" upper_limit="11.94"/>
                    <measurement group_id="O4" value="31" lower_limit="22.61" upper_limit="40.36"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.52"/>
                    <measurement group_id="O6" value="32" lower_limit="24.06" upper_limit="40.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="4.13" upper_limit="12.18"/>
                    <measurement group_id="O2" value="6" lower_limit="2.76" upper_limit="10.20"/>
                    <measurement group_id="O3" value="3" lower_limit="0.94" upper_limit="8.52"/>
                    <measurement group_id="O4" value="19" lower_limit="12.62" upper_limit="27.98"/>
                    <measurement group_id="O5" value="1" lower_limit="0.02" upper_limit="4.52"/>
                    <measurement group_id="O6" value="22" lower_limit="15.05" upper_limit="30.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="8.35" upper_limit="18.40"/>
                    <measurement group_id="O2" value="11" lower_limit="7.08" upper_limit="17.00"/>
                    <measurement group_id="O3" value="8" lower_limit="3.58" upper_limit="14.10"/>
                    <measurement group_id="O4" value="13" lower_limit="7.62" upper_limit="20.95"/>
                    <measurement group_id="O5" value="41" lower_limit="32.45" upper_limit="50.63"/>
                    <measurement group_id="O6" value="15" lower_limit="9.18" upper_limit="22.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="4.94" upper_limit="13.45"/>
                    <measurement group_id="O2" value="7" lower_limit="3.99" upper_limit="12.30"/>
                    <measurement group_id="O3" value="5" lower_limit="1.90" upper_limit="10.83"/>
                    <measurement group_id="O4" value="9" lower_limit="4.33" upper_limit="15.67"/>
                    <measurement group_id="O5" value="34" lower_limit="25.53" upper_limit="43.05"/>
                    <measurement group_id="O6" value="10" lower_limit="5.52" upper_limit="16.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>M07-0241084 Strain ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="176"/>
                    <count group_id="O3" value="117"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="121"/>
                    <count group_id="O6" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.58" upper_limit="9.56"/>
                    <measurement group_id="O2" value="6" lower_limit="2.76" upper_limit="10.20"/>
                    <measurement group_id="O3" value="4" lower_limit="1.40" upper_limit="9.69"/>
                    <measurement group_id="O4" value="6" lower_limit="2.53" upper_limit="12.35"/>
                    <measurement group_id="O5" value="21" lower_limit="13.84" upper_limit="28.97"/>
                    <measurement group_id="O6" value="6" lower_limit="2.74" upper_limit="11.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" lower_limit="27.61" upper_limit="41.71"/>
                    <measurement group_id="O2" value="29" lower_limit="22.65" upper_limit="36.48"/>
                    <measurement group_id="O3" value="88" lower_limit="81.20" upper_limit="93.47"/>
                    <measurement group_id="O4" value="32" lower_limit="23.63" upper_limit="41.63"/>
                    <measurement group_id="O5" value="31" lower_limit="23.35" upper_limit="40.04"/>
                    <measurement group_id="O6" value="26" lower_limit="18.84" upper_limit="35.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19.68" upper_limit="32.72"/>
                    <measurement group_id="O2" value="20" lower_limit="14.09" upper_limit="26.27"/>
                    <measurement group_id="O3" value="81" lower_limit="72.64" upper_limit="87.44"/>
                    <measurement group_id="O4" value="19" lower_limit="12.00" upper_limit="27.22"/>
                    <measurement group_id="O5" value="18" lower_limit="11.74" upper_limit="25.73"/>
                    <measurement group_id="O6" value="19" lower_limit="12.45" upper_limit="27.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="12.54" upper_limit="24.00"/>
                    <measurement group_id="O2" value="13" lower_limit="8.37" upper_limit="18.76"/>
                    <measurement group_id="O3" value="76" lower_limit="67.17" upper_limit="83.18"/>
                    <measurement group_id="O4" value="12" lower_limit="6.33" upper_limit="19.03"/>
                    <measurement group_id="O5" value="14" lower_limit="8.55" upper_limit="21.31"/>
                    <measurement group_id="O6" value="16" lower_limit="9.73" upper_limit="23.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="93.84" upper_limit="99.12"/>
                    <measurement group_id="O2" value="92" lower_limit="87.16" upper_limit="95.63"/>
                    <measurement group_id="O3" value="85" lower_limit="77.33" upper_limit="90.86"/>
                    <measurement group_id="O4" value="28" lower_limit="19.64" upper_limit="36.93"/>
                    <measurement group_id="O5" value="23" lower_limit="16.41" upper_limit="31.74"/>
                    <measurement group_id="O6" value="91" lower_limit="84.32" upper_limit="95.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="92.40" upper_limit="98.47"/>
                    <measurement group_id="O2" value="89" lower_limit="83.18" upper_limit="93.00"/>
                    <measurement group_id="O3" value="76" lower_limit="67.17" upper_limit="83.18"/>
                    <measurement group_id="O4" value="14" lower_limit="8.39" upper_limit="22.16"/>
                    <measurement group_id="O5" value="17" lower_limit="11.10" upper_limit="24.86"/>
                    <measurement group_id="O6" value="88" lower_limit="81.35" upper_limit="93.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="89.66" upper_limit="97.01"/>
                    <measurement group_id="O2" value="83" lower_limit="76.20" upper_limit="87.85"/>
                    <measurement group_id="O3" value="69" lower_limit="60.09" upper_limit="77.27"/>
                    <measurement group_id="O4" value="11" lower_limit="5.66" upper_limit="17.97"/>
                    <measurement group_id="O5" value="13" lower_limit="7.93" upper_limit="20.41"/>
                    <measurement group_id="O6" value="83" lower_limit="75.63" upper_limit="89.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="74.81" upper_limit="86.53"/>
                    <measurement group_id="O2" value="74" lower_limit="66.48" upper_limit="79.91"/>
                    <measurement group_id="O3" value="64" lower_limit="54.90" upper_limit="72.71"/>
                    <measurement group_id="O4" value="96" lower_limit="91.11" upper_limit="99.02"/>
                    <measurement group_id="O5" value="16" lower_limit="10.45" upper_limit="23.98"/>
                    <measurement group_id="O6" value="97" lower_limit="91.75" upper_limit="99.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73" lower_limit="65.57" upper_limit="78.85"/>
                    <measurement group_id="O2" value="63" lower_limit="55.38" upper_limit="70.03"/>
                    <measurement group_id="O3" value="52" lower_limit="42.37" upper_limit="60.88"/>
                    <measurement group_id="O4" value="96" lower_limit="91.11" upper_limit="99.02"/>
                    <measurement group_id="O5" value="9" lower_limit="4.94" upper_limit="15.80"/>
                    <measurement group_id="O6" value="96" lower_limit="90.62" upper_limit="98.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="53.89" upper_limit="68.33"/>
                    <measurement group_id="O2" value="50" lower_limit="42.43" upper_limit="57.57"/>
                    <measurement group_id="O3" value="42" lower_limit="32.74" upper_limit="51.02"/>
                    <measurement group_id="O4" value="95" lower_limit="88.70" upper_limit="98.01"/>
                    <measurement group_id="O5" value="7" lower_limit="3.27" upper_limit="12.93"/>
                    <measurement group_id="O6" value="94" lower_limit="88.44" upper_limit="97.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" lower_limit="57.73" upper_limit="71.88"/>
                    <measurement group_id="O2" value="54" lower_limit="46.32" upper_limit="61.42"/>
                    <measurement group_id="O3" value="52" lower_limit="42.37" upper_limit="60.88"/>
                    <measurement group_id="O4" value="72" lower_limit="63.07" upper_limit="80.36"/>
                    <measurement group_id="O5" value="96" lower_limit="91.12" upper_limit="98.72"/>
                    <measurement group_id="O6" value="77" lower_limit="68.32" upper_limit="84.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="45.78" upper_limit="60.56"/>
                    <measurement group_id="O2" value="39" lower_limit="32.10" upper_limit="46.91"/>
                    <measurement group_id="O3" value="34" lower_limit="25.76" upper_limit="43.38"/>
                    <measurement group_id="O4" value="54" lower_limit="44.78" upper_limit="63.90"/>
                    <measurement group_id="O5" value="95" lower_limit="89.06" upper_limit="97.77"/>
                    <measurement group_id="O6" value="62" lower_limit="52.71" upper_limit="70.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96217 Strain ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="112"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="28.62" upper_limit="42.82"/>
                    <measurement group_id="O2" value="22" lower_limit="16.57" upper_limit="29.32"/>
                    <measurement group_id="O3" value="28" lower_limit="19.75" upper_limit="36.40"/>
                    <measurement group_id="O4" value="45" lower_limit="35.24" upper_limit="54.33"/>
                    <measurement group_id="O5" value="93" lower_limit="87.07" upper_limit="96.73"/>
                    <measurement group_id="O6" value="51" lower_limit="41.99" upper_limit="60.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="7.72" upper_limit="18.06"/>
                    <measurement group_id="O2" value="23" lower_limit="17.07" upper_limit="29.92"/>
                    <measurement group_id="O3" value="78" lower_limit="68.49" upper_limit="85.07"/>
                    <measurement group_id="O4" value="21" lower_limit="13.62" upper_limit="29.99"/>
                    <measurement group_id="O5" value="38" lower_limit="28.83" upper_limit="46.80"/>
                    <measurement group_id="O6" value="17" lower_limit="10.54" upper_limit="24.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.41" upper_limit="14.67"/>
                    <measurement group_id="O2" value="16" lower_limit="11.19" upper_limit="22.55"/>
                    <measurement group_id="O3" value="64" lower_limit="53.69" upper_limit="72.64"/>
                    <measurement group_id="O4" value="14" lower_limit="8.22" upper_limit="22.47"/>
                    <measurement group_id="O5" value="30" lower_limit="21.98" upper_limit="39.04"/>
                    <measurement group_id="O6" value="13" lower_limit="7.38" upper_limit="19.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="2.82" upper_limit="10.43"/>
                    <measurement group_id="O2" value="11" lower_limit="6.55" upper_limit="16.17"/>
                    <measurement group_id="O3" value="50" lower_limit="39.72" upper_limit="59.37"/>
                    <measurement group_id="O4" value="11" lower_limit="6.05" upper_limit="19.11"/>
                    <measurement group_id="O5" value="20" lower_limit="13.25" upper_limit="28.28"/>
                    <measurement group_id="O6" value="7" lower_limit="3.29" upper_limit="13.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80" lower_limit="72.85" upper_limit="85.40"/>
                    <measurement group_id="O2" value="71" lower_limit="63.52" upper_limit="77.35"/>
                    <measurement group_id="O3" value="61" lower_limit="50.84" upper_limit="70.05"/>
                    <measurement group_id="O4" value="20" lower_limit="12.83" upper_limit="28.93"/>
                    <measurement group_id="O5" value="24" lower_limit="16.82" upper_limit="32.83"/>
                    <measurement group_id="O6" value="74" lower_limit="65.49" upper_limit="81.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="58.09" upper_limit="72.76"/>
                    <measurement group_id="O2" value="52" lower_limit="44.64" upper_limit="59.77"/>
                    <measurement group_id="O3" value="41" lower_limit="31.70" upper_limit="51.05"/>
                    <measurement group_id="O4" value="12" lower_limit="6.76" upper_limit="20.24"/>
                    <measurement group_id="O5" value="18" lower_limit="11.86" upper_limit="26.43"/>
                    <measurement group_id="O6" value="56" lower_limit="46.83" upper_limit="64.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56" lower_limit="48.64" upper_limit="63.93"/>
                    <measurement group_id="O2" value="42" lower_limit="34.79" upper_limit="49.75"/>
                    <measurement group_id="O3" value="31" lower_limit="22.27" upper_limit="40.50"/>
                    <measurement group_id="O4" value="7" lower_limit="2.72" upper_limit="13.25"/>
                    <measurement group_id="O5" value="14" lower_limit="8.47" upper_limit="21.71"/>
                    <measurement group_id="O6" value="40" lower_limit="31.56" upper_limit="49.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="20.82" upper_limit="34.63"/>
                    <measurement group_id="O2" value="28" lower_limit="21.11" upper_limit="34.71"/>
                    <measurement group_id="O3" value="25" lower_limit="17.33" upper_limit="34.55"/>
                    <measurement group_id="O4" value="87" lower_limit="78.64" upper_limit="92.51"/>
                    <measurement group_id="O5" value="8" lower_limit="3.49" upper_limit="13.76"/>
                    <measurement group_id="O6" value="88" lower_limit="81.27" upper_limit="93.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="11.59" upper_limit="23.31"/>
                    <measurement group_id="O2" value="16" lower_limit="11.19" upper_limit="22.55"/>
                    <measurement group_id="O3" value="16" lower_limit="9.54" upper_limit="24.21"/>
                    <measurement group_id="O4" value="76" lower_limit="66.89" upper_limit="83.96"/>
                    <measurement group_id="O5" value="6" lower_limit="2.38" upper_limit="11.65"/>
                    <measurement group_id="O6" value="77" lower_limit="68.88" upper_limit="84.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="6.78" upper_limit="16.71"/>
                    <measurement group_id="O2" value="10" lower_limit="5.66" upper_limit="14.85"/>
                    <measurement group_id="O3" value="13" lower_limit="7.34" upper_limit="20.98"/>
                    <measurement group_id="O4" value="70" lower_limit="60.78" upper_limit="78.98"/>
                    <measurement group_id="O5" value="5" lower_limit="1.86" upper_limit="10.57"/>
                    <measurement group_id="O6" value="70" lower_limit="61.32" upper_limit="77.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="10.61" upper_limit="22.01"/>
                    <measurement group_id="O2" value="12" lower_limit="7.91" upper_limit="18.11"/>
                    <measurement group_id="O3" value="18" lower_limit="11.04" upper_limit="26.33"/>
                    <measurement group_id="O4" value="31" lower_limit="22.72" upper_limit="41.22"/>
                    <measurement group_id="O5" value="85" lower_limit="77.33" upper_limit="90.86"/>
                    <measurement group_id="O6" value="28" lower_limit="20.71" upper_limit="37.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.41" upper_limit="14.67"/>
                    <measurement group_id="O2" value="8" lower_limit="4.37" upper_limit="12.84"/>
                    <measurement group_id="O3" value="11" lower_limit="5.93" upper_limit="18.77"/>
                    <measurement group_id="O4" value="25" lower_limit="16.86" upper_limit="34.14"/>
                    <measurement group_id="O5" value="80" lower_limit="71.72" upper_limit="86.75"/>
                    <measurement group_id="O6" value="15" lower_limit="9.25" upper_limit="22.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A human Serogroup ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="107"/>
                    <count group_id="O4" value="105"/>
                    <count group_id="O5" value="120"/>
                    <count group_id="O6" value="127"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.42" upper_limit="9.70"/>
                    <measurement group_id="O2" value="4" lower_limit="1.60" upper_limit="7.93"/>
                    <measurement group_id="O3" value="9" lower_limit="4.57" upper_limit="16.52"/>
                    <measurement group_id="O4" value="15" lower_limit="8.97" upper_limit="23.56"/>
                    <measurement group_id="O5" value="78" lower_limit="68.98" upper_limit="84.62"/>
                    <measurement group_id="O6" value="7" lower_limit="3.29" upper_limit="13.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="18.23" upper_limit="31.00"/>
                    <measurement group_id="O2" value="64" lower_limit="56.41" upper_limit="70.71"/>
                    <measurement group_id="O3" value="95" lower_limit="89.60" upper_limit="98.17"/>
                    <measurement group_id="O4" value="55" lower_limit="45.66" upper_limit="64.58"/>
                    <measurement group_id="O5" value="73" lower_limit="64.43" upper_limit="80.76"/>
                    <measurement group_id="O6" value="62" lower_limit="52.61" upper_limit="69.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10.24" upper_limit="21.02"/>
                    <measurement group_id="O2" value="50" lower_limit="42.84" upper_limit="57.69"/>
                    <measurement group_id="O3" value="91" lower_limit="84.44" upper_limit="95.41"/>
                    <measurement group_id="O4" value="48" lower_limit="38.79" upper_limit="57.80"/>
                    <measurement group_id="O5" value="59" lower_limit="49.31" upper_limit="67.35"/>
                    <measurement group_id="O6" value="54" lower_limit="44.89" upper_limit="62.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5.00" upper_limit="13.59"/>
                    <measurement group_id="O2" value="42" lower_limit="34.43" upper_limit="49.08"/>
                    <measurement group_id="O3" value="88" lower_limit="80.53" upper_limit="92.95"/>
                    <measurement group_id="O4" value="44" lower_limit="34.58" upper_limit="53.46"/>
                    <measurement group_id="O5" value="50" lower_limit="40.46" upper_limit="58.75"/>
                    <measurement group_id="O6" value="42" lower_limit="32.97" upper_limit="50.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80" lower_limit="73.05" upper_limit="85.12"/>
                    <measurement group_id="O2" value="94" lower_limit="89.61" upper_limit="96.99"/>
                    <measurement group_id="O3" value="93" lower_limit="86.46" upper_limit="96.57"/>
                    <measurement group_id="O4" value="58" lower_limit="48.29" upper_limit="67.08"/>
                    <measurement group_id="O5" value="65" lower_limit="55.92" upper_limit="73.42"/>
                    <measurement group_id="O6" value="98" lower_limit="93.40" upper_limit="99.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" lower_limit="56.63" upper_limit="70.87"/>
                    <measurement group_id="O2" value="90" lower_limit="85.06" upper_limit="94.13"/>
                    <measurement group_id="O3" value="90" lower_limit="83.45" upper_limit="94.81"/>
                    <measurement group_id="O4" value="47" lower_limit="37.94" upper_limit="56.94"/>
                    <measurement group_id="O5" value="50" lower_limit="40.46" upper_limit="58.75"/>
                    <measurement group_id="O6" value="96" lower_limit="91.25" upper_limit="98.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="41.54" upper_limit="56.34"/>
                    <measurement group_id="O2" value="87" lower_limit="81.31" upper_limit="91.51"/>
                    <measurement group_id="O3" value="83" lower_limit="74.90" upper_limit="89.02"/>
                    <measurement group_id="O4" value="41" lower_limit="32.09" upper_limit="50.83"/>
                    <measurement group_id="O5" value="42" lower_limit="33.42" upper_limit="51.51"/>
                    <measurement group_id="O6" value="92" lower_limit="85.36" upper_limit="95.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="22.62" upper_limit="36.12"/>
                    <measurement group_id="O2" value="86" lower_limit="80.70" upper_limit="91.06"/>
                    <measurement group_id="O3" value="89" lower_limit="81.50" upper_limit="93.58"/>
                    <measurement group_id="O4" value="97" lower_limit="92.50" upper_limit="99.45"/>
                    <measurement group_id="O5" value="50" lower_limit="40.46" upper_limit="58.75"/>
                    <measurement group_id="O6" value="98" lower_limit="94.55" upper_limit="99.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="10.70" upper_limit="21.62"/>
                    <measurement group_id="O2" value="80" lower_limit="73.50" upper_limit="85.51"/>
                    <measurement group_id="O3" value="79" lower_limit="70.35" upper_limit="85.58"/>
                    <measurement group_id="O4" value="94" lower_limit="87.76" upper_limit="97.50"/>
                    <measurement group_id="O5" value="37" lower_limit="28.09" upper_limit="45.75"/>
                    <measurement group_id="O6" value="98" lower_limit="94.55" upper_limit="99.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="6.26" upper_limit="15.49"/>
                    <measurement group_id="O2" value="71" lower_limit="64.26" upper_limit="77.75"/>
                    <measurement group_id="O3" value="72" lower_limit="63.29" upper_limit="79.87"/>
                    <measurement group_id="O4" value="92" lower_limit="85.54" upper_limit="96.33"/>
                    <measurement group_id="O5" value="28" lower_limit="19.96" upper_limit="36.43"/>
                    <measurement group_id="O6" value="98" lower_limit="93.40" upper_limit="99.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="13.94" upper_limit="25.77"/>
                    <measurement group_id="O2" value="73" lower_limit="65.97" upper_limit="79.23"/>
                    <measurement group_id="O3" value="74" lower_limit="65.04" upper_limit="81.32"/>
                    <measurement group_id="O4" value="82" lower_limit="73.23" upper_limit="88.22"/>
                    <measurement group_id="O5" value="97" lower_limit="91.88" upper_limit="99.11"/>
                    <measurement group_id="O6" value="92" lower_limit="86.31" upper_limit="96.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="8.89" upper_limit="19.20"/>
                    <measurement group_id="O2" value="64" lower_limit="56.41" upper_limit="70.71"/>
                    <measurement group_id="O3" value="61" lower_limit="52.24" upper_limit="70.14"/>
                    <measurement group_id="O4" value="70" lower_limit="60.89" upper_limit="78.38"/>
                    <measurement group_id="O5" value="96" lower_limit="90.77" upper_limit="98.67"/>
                    <measurement group_id="O6" value="89" lower_limit="82.59" upper_limit="93.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C human Serogroup ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="185"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="5.84" upper_limit="14.86"/>
                    <measurement group_id="O2" value="51" lower_limit="43.91" upper_limit="58.75"/>
                    <measurement group_id="O3" value="53" lower_limit="44.03" upper_limit="62.36"/>
                    <measurement group_id="O4" value="56" lower_limit="46.54" upper_limit="65.42"/>
                    <measurement group_id="O5" value="93" lower_limit="87.59" upper_limit="97.15"/>
                    <measurement group_id="O6" value="85" lower_limit="77.24" upper_limit="90.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="17.71" upper_limit="31.41"/>
                    <measurement group_id="O2" value="32" lower_limit="24.95" upper_limit="39.00"/>
                    <measurement group_id="O3" value="65" lower_limit="55.42" upper_limit="73.24"/>
                    <measurement group_id="O4" value="35" lower_limit="26.24" upper_limit="44.96"/>
                    <measurement group_id="O5" value="50" lower_limit="41.25" upper_limit="59.54"/>
                    <measurement group_id="O6" value="33" lower_limit="25.09" upper_limit="42.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="11.28" upper_limit="23.31"/>
                    <measurement group_id="O2" value="19" lower_limit="13.93" upper_limit="25.99"/>
                    <measurement group_id="O3" value="52" lower_limit="42.75" upper_limit="61.34"/>
                    <measurement group_id="O4" value="25" lower_limit="17.17" upper_limit="34.25"/>
                    <measurement group_id="O5" value="40" lower_limit="31.12" upper_limit="49.05"/>
                    <measurement group_id="O6" value="22" lower_limit="14.99" upper_limit="30.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="6.72" upper_limit="16.99"/>
                    <measurement group_id="O2" value="16" lower_limit="11.06" upper_limit="22.31"/>
                    <measurement group_id="O3" value="42" lower_limit="33.03" upper_limit="51.41"/>
                    <measurement group_id="O4" value="18" lower_limit="10.94" upper_limit="26.10"/>
                    <measurement group_id="O5" value="34" lower_limit="25.84" upper_limit="43.24"/>
                    <measurement group_id="O6" value="18" lower_limit="11.56" upper_limit="25.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67" lower_limit="59.48" upper_limit="74.44"/>
                    <measurement group_id="O2" value="78" lower_limit="71.59" upper_limit="84.12"/>
                    <measurement group_id="O3" value="55" lower_limit="46.07" upper_limit="64.57"/>
                    <measurement group_id="O4" value="34" lower_limit="25.40" upper_limit="44.01"/>
                    <measurement group_id="O5" value="46" lower_limit="37.31" upper_limit="55.56"/>
                    <measurement group_id="O6" value="76" lower_limit="67.93" upper_limit="83.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54" lower_limit="46.32" upper_limit="62.16"/>
                    <measurement group_id="O2" value="65" lower_limit="57.55" upper_limit="71.95"/>
                    <measurement group_id="O3" value="39" lower_limit="29.87" upper_limit="48.02"/>
                    <measurement group_id="O4" value="23" lower_limit="15.57" upper_limit="32.25"/>
                    <measurement group_id="O5" value="34" lower_limit="25.84" upper_limit="43.24"/>
                    <measurement group_id="O6" value="67" lower_limit="58.45" upper_limit="75.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43" lower_limit="34.87" upper_limit="50.59"/>
                    <measurement group_id="O2" value="57" lower_limit="49.09" upper_limit="64.02"/>
                    <measurement group_id="O3" value="30" lower_limit="22.17" upper_limit="39.35"/>
                    <measurement group_id="O4" value="19" lower_limit="12.46" upper_limit="28.17"/>
                    <measurement group_id="O5" value="28" lower_limit="20.69" upper_limit="37.29"/>
                    <measurement group_id="O6" value="56" lower_limit="46.87" upper_limit="65.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31" lower_limit="24.42" upper_limit="39.23"/>
                    <measurement group_id="O2" value="51" lower_limit="43.57" upper_limit="58.62"/>
                    <measurement group_id="O3" value="43" lower_limit="33.83" upper_limit="52.25"/>
                    <measurement group_id="O4" value="90" lower_limit="82.51" upper_limit="94.80"/>
                    <measurement group_id="O5" value="41" lower_limit="31.89" upper_limit="49.88"/>
                    <measurement group_id="O6" value="89" lower_limit="81.64" upper_limit="93.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="15.53" upper_limit="28.74"/>
                    <measurement group_id="O2" value="30" lower_limit="23.41" upper_limit="37.26"/>
                    <measurement group_id="O3" value="29" lower_limit="20.67" upper_limit="37.57"/>
                    <measurement group_id="O4" value="81" lower_limit="71.83" upper_limit="87.54"/>
                    <measurement group_id="O5" value="28" lower_limit="19.96" upper_limit="36.43"/>
                    <measurement group_id="O6" value="80" lower_limit="72.37" upper_limit="87.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="8.21" upper_limit="19.13"/>
                    <measurement group_id="O2" value="21" lower_limit="14.91" upper_limit="27.20"/>
                    <measurement group_id="O3" value="17" lower_limit="10.58" upper_limit="24.76"/>
                    <measurement group_id="O4" value="73" lower_limit="63.76" upper_limit="81.22"/>
                    <measurement group_id="O5" value="20" lower_limit="13.61" upper_limit="28.52"/>
                    <measurement group_id="O6" value="73" lower_limit="64.43" upper_limit="80.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="13.92" upper_limit="26.73"/>
                    <measurement group_id="O2" value="26" lower_limit="19.36" upper_limit="32.58"/>
                    <measurement group_id="O3" value="32" lower_limit="23.69" upper_limit="41.10"/>
                    <measurement group_id="O4" value="56" lower_limit="46.60" upper_limit="66.00"/>
                    <measurement group_id="O5" value="94" lower_limit="88.63" upper_limit="97.68"/>
                    <measurement group_id="O6" value="61" lower_limit="51.77" upper_limit="69.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="4.81" upper_limit="14.07"/>
                    <measurement group_id="O2" value="13" lower_limit="8.28" upper_limit="18.55"/>
                    <measurement group_id="O3" value="17" lower_limit="10.58" upper_limit="24.76"/>
                    <measurement group_id="O4" value="38" lower_limit="28.80" upper_limit="47.81"/>
                    <measurement group_id="O5" value="92" lower_limit="85.56" upper_limit="96.03"/>
                    <measurement group_id="O6" value="46" lower_limit="36.53" upper_limit="54.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>W human Serogroup ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="108"/>
                    <count group_id="O5" value="123"/>
                    <count group_id="O6" value="123"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.44" upper_limit="11.82"/>
                    <measurement group_id="O2" value="11" lower_limit="6.48" upper_limit="15.99"/>
                    <measurement group_id="O3" value="13" lower_limit="7.88" upper_limit="20.91"/>
                    <measurement group_id="O4" value="27" lower_limit="18.78" upper_limit="36.24"/>
                    <measurement group_id="O5" value="89" lower_limit="82.60" upper_limit="94.25"/>
                    <measurement group_id="O6" value="29" lower_limit="21.41" upper_limit="38.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 2-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="2.96" upper_limit="10.23"/>
                    <measurement group_id="O2" value="49" lower_limit="41.38" upper_limit="56.43"/>
                    <measurement group_id="O3" value="74" lower_limit="65.38" upper_limit="81.72"/>
                    <measurement group_id="O4" value="47" lower_limit="37.68" upper_limit="57.02"/>
                    <measurement group_id="O5" value="53" lower_limit="43.70" upper_limit="61.68"/>
                    <measurement group_id="O6" value="51" lower_limit="42.42" upper_limit="59.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 3-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.51" upper_limit="7.52"/>
                    <measurement group_id="O2" value="39" lower_limit="32.25" upper_limit="46.99"/>
                    <measurement group_id="O3" value="64" lower_limit="54.90" upper_limit="72.71"/>
                    <measurement group_id="O4" value="40" lower_limit="30.78" upper_limit="49.78"/>
                    <measurement group_id="O5" value="41" lower_limit="32.30" upper_limit="50.02"/>
                    <measurement group_id="O6" value="43" lower_limit="34.64" upper_limit="51.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 4-fold (At Month 2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.58" upper_limit="5.36"/>
                    <measurement group_id="O2" value="32" lower_limit="25.46" upper_limit="39.58"/>
                    <measurement group_id="O3" value="58" lower_limit="48.15" upper_limit="66.47"/>
                    <measurement group_id="O4" value="33" lower_limit="24.08" upper_limit="42.33"/>
                    <measurement group_id="O5" value="36" lower_limit="27.88" upper_limit="45.22"/>
                    <measurement group_id="O6" value="37" lower_limit="29.13" upper_limit="45.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 2-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="5.77" upper_limit="14.71"/>
                    <measurement group_id="O2" value="84" lower_limit="78.31" upper_limit="89.41"/>
                    <measurement group_id="O3" value="66" lower_limit="56.62" upper_limit="74.24"/>
                    <measurement group_id="O4" value="45" lower_limit="35.93" upper_limit="55.23"/>
                    <measurement group_id="O5" value="46" lower_limit="36.81" upper_limit="54.74"/>
                    <measurement group_id="O6" value="83" lower_limit="75.88" upper_limit="89.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 3-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.73" upper_limit="11.53"/>
                    <measurement group_id="O2" value="80" lower_limit="73.40" upper_limit="85.58"/>
                    <measurement group_id="O3" value="55" lower_limit="45.65" upper_limit="64.09"/>
                    <measurement group_id="O4" value="35" lower_limit="25.74" upper_limit="44.21"/>
                    <measurement group_id="O5" value="35" lower_limit="26.43" upper_limit="43.60"/>
                    <measurement group_id="O6" value="75" lower_limit="67.08" upper_limit="82.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 4-fold (At Month 3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1.85" upper_limit="8.21"/>
                    <measurement group_id="O2" value="68" lower_limit="61.00" upper_limit="75.05"/>
                    <measurement group_id="O3" value="48" lower_limit="39.12" upper_limit="57.63"/>
                    <measurement group_id="O4" value="29" lower_limit="20.82" upper_limit="38.52"/>
                    <measurement group_id="O5" value="31" lower_limit="23.55" upper_limit="40.33"/>
                    <measurement group_id="O6" value="66" lower_limit="57.86" upper_limit="74.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 2-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.21" upper_limit="8.89"/>
                    <measurement group_id="O2" value="60" lower_limit="52.45" upper_limit="67.22"/>
                    <measurement group_id="O3" value="51" lower_limit="41.55" upper_limit="60.07"/>
                    <measurement group_id="O4" value="90" lower_limit="82.81" upper_limit="94.90"/>
                    <measurement group_id="O5" value="39" lower_limit="30.08" upper_limit="47.63"/>
                    <measurement group_id="O6" value="92" lower_limit="86.09" upper_limit="95.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 3-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.18" upper_limit="6.82"/>
                    <measurement group_id="O2" value="48" lower_limit="40.29" upper_limit="55.34"/>
                    <measurement group_id="O3" value="44" lower_limit="35.11" upper_limit="53.52"/>
                    <measurement group_id="O4" value="83" lower_limit="74.35" upper_limit="89.27"/>
                    <measurement group_id="O5" value="28" lower_limit="20.71" upper_limit="37.02"/>
                    <measurement group_id="O6" value="87" lower_limit="80.03" upper_limit="92.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 4-fold (At Month 7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0.87" upper_limit="6.10"/>
                    <measurement group_id="O2" value="41" lower_limit="33.31" upper_limit="48.11"/>
                    <measurement group_id="O3" value="38" lower_limit="29.61" upper_limit="47.65"/>
                    <measurement group_id="O4" value="79" lower_limit="70.30" upper_limit="86.26"/>
                    <measurement group_id="O5" value="23" lower_limit="15.86" upper_limit="31.12"/>
                    <measurement group_id="O6" value="76" lower_limit="67.87" upper_limit="82.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 2-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.21" upper_limit="8.89"/>
                    <measurement group_id="O2" value="43" lower_limit="35.45" upper_limit="50.35"/>
                    <measurement group_id="O3" value="38" lower_limit="29.61" upper_limit="47.65"/>
                    <measurement group_id="O4" value="60" lower_limit="50.22" upper_limit="69.22"/>
                    <measurement group_id="O5" value="94" lower_limit="88.97" upper_limit="97.76"/>
                    <measurement group_id="O6" value="72" lower_limit="63.20" upper_limit="78.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 3-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.18" upper_limit="6.82"/>
                    <measurement group_id="O2" value="34" lower_limit="27.01" upper_limit="41.30"/>
                    <measurement group_id="O3" value="28" lower_limit="20.49" upper_limit="37.28"/>
                    <measurement group_id="O4" value="48" lower_limit="38.55" upper_limit="57.91"/>
                    <measurement group_id="O5" value="91" lower_limit="84.08" upper_limit="95.02"/>
                    <measurement group_id="O6" value="54" lower_limit="45.30" upper_limit="62.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Y human Serogroup ≥ 4-fold (At Month 13)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="188"/>
                    <count group_id="O2" value="180"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="110"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0.58" upper_limit="5.36"/>
                    <measurement group_id="O2" value="25" lower_limit="18.86" upper_limit="31.99"/>
                    <measurement group_id="O3" value="23" lower_limit="16.10" upper_limit="31.93"/>
                    <measurement group_id="O4" value="45" lower_limit="35.93" upper_limit="55.23"/>
                    <measurement group_id="O5" value="89" lower_limit="82.20" upper_limit="93.84"/>
                    <measurement group_id="O6" value="47" lower_limit="38.15" upper_limit="55.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Area Under the Curve (AUC) for Percentage of Subjects With hSBA Titers ≥LLQ for All Serogroups and Strains.</title>
        <description>The area under the curve for percentage of subjects with hSBA titers ≥ LLQ for all serogroups (A, C, W and Y) and for all serogroup B test strains (M14459, 96217, NZ98/254 and M07-0241084) was summarized overall (from Month 0 to Month 13) and by period (from Month 0 to Month 2, Month 2 to Month 3, Month 3 to Month 7 and Month 7 to Month 13) by vaccine groups. It was computed as the sum of the trapezoidal areas and the time unit used was the month. AUC 0_13 = (r0+r2)(2-0)/2 + (r2+r3)(3-2)/2 + (r3+r7)(7-3)/2 + (r7+r13)(13-7)/2 with ri = percentages of subjects with both hSBA titers &gt;= LLQ against N. meningitis for all serogroups A, C, W and Y and for all serogroup B test strains at Month 1.</description>
        <time_frame>From Month 0 to Month 13</time_frame>
        <population>Analysis was done on the FAS Month 13 Over Time. All subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at one month after the last meningococcal vaccination whose result is available for at least one A,C,W,or Y serogroup or serogroup B test strain.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>The Area Under the Curve (AUC) for Percentage of Subjects With hSBA Titers ≥LLQ for All Serogroups and Strains.</title>
          <description>The area under the curve for percentage of subjects with hSBA titers ≥ LLQ for all serogroups (A, C, W and Y) and for all serogroup B test strains (M14459, 96217, NZ98/254 and M07-0241084) was summarized overall (from Month 0 to Month 13) and by period (from Month 0 to Month 2, Month 2 to Month 3, Month 3 to Month 7 and Month 7 to Month 13) by vaccine groups. It was computed as the sum of the trapezoidal areas and the time unit used was the month. AUC 0_13 = (r0+r2)(2-0)/2 + (r2+r3)(3-2)/2 + (r3+r7)(7-3)/2 + (r7+r13)(13-7)/2 with ri = percentages of subjects with both hSBA titers &gt;= LLQ against N. meningitis for all serogroups A, C, W and Y and for all serogroup B test strains at Month 1.</description>
          <population>Analysis was done on the FAS Month 13 Over Time. All subjects in All Enrolled Set who received a study meningococcal vaccination &amp; provided evaluable serum samples at one month after the last meningococcal vaccination whose result is available for at least one A,C,W,or Y serogroup or serogroup B test strain.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="200"/>
                <count group_id="O2" value="196"/>
                <count group_id="O3" value="131"/>
                <count group_id="O4" value="118"/>
                <count group_id="O5" value="132"/>
                <count group_id="O6" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Serogroup A- Month 0-2 (LLQ-22.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="191"/>
                    <count group_id="O2" value="189"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="126"/>
                    <count group_id="O6" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.52"/>
                    <measurement group_id="O2" value="38.01"/>
                    <measurement group_id="O3" value="98.62"/>
                    <measurement group_id="O4" value="38.05"/>
                    <measurement group_id="O5" value="57.12"/>
                    <measurement group_id="O6" value="27.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A- Month 2-3 (LLQ-22.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="125"/>
                    <count group_id="O4" value="118"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="135"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.69"/>
                    <measurement group_id="O2" value="60.98"/>
                    <measurement group_id="O3" value="86.91"/>
                    <measurement group_id="O4" value="33.40"/>
                    <measurement group_id="O5" value="47.00"/>
                    <measurement group_id="O6" value="59.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A- Month 3-7 (LLQ-22.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="191"/>
                    <count group_id="O2" value="194"/>
                    <count group_id="O3" value="124"/>
                    <count group_id="O4" value="118"/>
                    <count group_id="O5" value="127"/>
                    <count group_id="O6" value="136"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="292.53"/>
                    <measurement group_id="O2" value="264.81"/>
                    <measurement group_id="O3" value="243.86"/>
                    <measurement group_id="O4" value="252.54"/>
                    <measurement group_id="O5" value="119.41"/>
                    <measurement group_id="O6" value="370.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup A- Month 7-13 (LLQ-22.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="194"/>
                    <count group_id="O2" value="191"/>
                    <count group_id="O3" value="127"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="136"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="256.04"/>
                    <measurement group_id="O2" value="214.62"/>
                    <measurement group_id="O3" value="217.88"/>
                    <measurement group_id="O4" value="446.58"/>
                    <measurement group_id="O5" value="343.24"/>
                    <measurement group_id="O6" value="436.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M14459- Month 0-2 (LLQ-8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="196"/>
                    <count group_id="O2" value="194"/>
                    <count group_id="O3" value="127"/>
                    <count group_id="O4" value="113"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.10"/>
                    <measurement group_id="O2" value="27.81"/>
                    <measurement group_id="O3" value="67.02"/>
                    <measurement group_id="O4" value="21.09"/>
                    <measurement group_id="O5" value="40.10"/>
                    <measurement group_id="O6" value="18.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M14459- Month 2-3 (LLQ-8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="127"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="129"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.45"/>
                    <measurement group_id="O2" value="46.06"/>
                    <measurement group_id="O3" value="52.36"/>
                    <measurement group_id="O4" value="16.53"/>
                    <measurement group_id="O5" value="30.88"/>
                    <measurement group_id="O6" value="44.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M14459- Month 3-7 (LLQ-8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="192"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="228.61"/>
                    <measurement group_id="O2" value="196.15"/>
                    <measurement group_id="O3" value="117.62"/>
                    <measurement group_id="O4" value="206.84"/>
                    <measurement group_id="O5" value="84.60"/>
                    <measurement group_id="O6" value="325.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M14459- Month 7-13 (LLQ-8.0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="188"/>
                    <count group_id="O3" value="125"/>
                    <count group_id="O4" value="115"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="135"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162.94"/>
                    <measurement group_id="O2" value="141.79"/>
                    <measurement group_id="O3" value="82.51"/>
                    <measurement group_id="O4" value="329.36"/>
                    <measurement group_id="O5" value="309.09"/>
                    <measurement group_id="O6" value="347.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B 96217- Month 0-2 (LLQ-8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="190"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.52"/>
                    <measurement group_id="O2" value="91.00"/>
                    <measurement group_id="O3" value="124.70"/>
                    <measurement group_id="O4" value="88.27"/>
                    <measurement group_id="O5" value="83.08"/>
                    <measurement group_id="O6" value="79.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B 96217- Month 2-3 (LLQ-8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="192"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.03"/>
                    <measurement group_id="O2" value="80.02"/>
                    <measurement group_id="O3" value="95.77"/>
                    <measurement group_id="O4" value="58.55"/>
                    <measurement group_id="O5" value="52.33"/>
                    <measurement group_id="O6" value="74.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B 96217- Month 3-7 (LLQ-8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="199"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="131"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="388.93"/>
                    <measurement group_id="O2" value="373.02"/>
                    <measurement group_id="O3" value="361.75"/>
                    <measurement group_id="O4" value="307.65"/>
                    <measurement group_id="O5" value="172.73"/>
                    <measurement group_id="O6" value="392.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B 96217- Month 7-13 (LLQ-8.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="200"/>
                    <count group_id="O2" value="191"/>
                    <count group_id="O3" value="127"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="545.92"/>
                    <measurement group_id="O2" value="515.49"/>
                    <measurement group_id="O3" value="495.00"/>
                    <measurement group_id="O4" value="561.47"/>
                    <measurement group_id="O5" value="411.36"/>
                    <measurement group_id="O6" value="578.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B NZ98/254- Month 0-2 (LLQ-8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.27"/>
                    <measurement group_id="O2" value="25.84"/>
                    <measurement group_id="O3" value="48.92"/>
                    <measurement group_id="O4" value="22.37"/>
                    <measurement group_id="O5" value="31.33"/>
                    <measurement group_id="O6" value="20.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B NZ98/254- Month 2-3 (LLQ-8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="194"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.56"/>
                    <measurement group_id="O2" value="40.77"/>
                    <measurement group_id="O3" value="37.21"/>
                    <measurement group_id="O4" value="15.89"/>
                    <measurement group_id="O5" value="24.05"/>
                    <measurement group_id="O6" value="42.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B NZ98/254- Month 3-7 (LLQ-8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="196"/>
                    <count group_id="O2" value="194"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="227.81"/>
                    <measurement group_id="O2" value="162.89"/>
                    <measurement group_id="O3" value="92.78"/>
                    <measurement group_id="O4" value="156.65"/>
                    <measurement group_id="O5" value="65.46"/>
                    <measurement group_id="O6" value="282.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B NZ98/254- Month 7-13 (LLQ-8.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="200"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142.59"/>
                    <measurement group_id="O2" value="105.40"/>
                    <measurement group_id="O3" value="90.34"/>
                    <measurement group_id="O4" value="242.66"/>
                    <measurement group_id="O5" value="257.90"/>
                    <measurement group_id="O6" value="277.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M07-0241084- Month 0-2 (LLQ-8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="196"/>
                    <count group_id="O2" value="191"/>
                    <count group_id="O3" value="127"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.74"/>
                    <measurement group_id="O2" value="43.20"/>
                    <measurement group_id="O3" value="53.67"/>
                    <measurement group_id="O4" value="42.74"/>
                    <measurement group_id="O5" value="58.93"/>
                    <measurement group_id="O6" value="47.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M07-0241084- Month 2-3 (LLQ-8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="189"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="128"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.46"/>
                    <measurement group_id="O2" value="37.16"/>
                    <measurement group_id="O3" value="34.01"/>
                    <measurement group_id="O4" value="28.33"/>
                    <measurement group_id="O5" value="34.47"/>
                    <measurement group_id="O6" value="41.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M07-0241084- Month 3-7 (LLQ-8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="118"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="213.53"/>
                    <measurement group_id="O2" value="151.20"/>
                    <measurement group_id="O3" value="111.63"/>
                    <measurement group_id="O4" value="190.79"/>
                    <measurement group_id="O5" value="110.94"/>
                    <measurement group_id="O6" value="251.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B M07-0241084- Month 7-13 (LLQ-8.9)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="190"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="136"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="217.26"/>
                    <measurement group_id="O2" value="159.73"/>
                    <measurement group_id="O3" value="145.97"/>
                    <measurement group_id="O4" value="301.71"/>
                    <measurement group_id="O5" value="282.69"/>
                    <measurement group_id="O6" value="320.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C- Month 0-2(LLQ-5.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="118"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.82"/>
                    <measurement group_id="O2" value="129.30"/>
                    <measurement group_id="O3" value="148.03"/>
                    <measurement group_id="O4" value="126.63"/>
                    <measurement group_id="O5" value="135.79"/>
                    <measurement group_id="O6" value="128.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C- Month 2-3(LLQ-5.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="194"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="136"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.78"/>
                    <measurement group_id="O2" value="91.97"/>
                    <measurement group_id="O3" value="99.22"/>
                    <measurement group_id="O4" value="82.97"/>
                    <measurement group_id="O5" value="88.21"/>
                    <measurement group_id="O6" value="92.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C- Month 3-7(LLQ-5.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="199"/>
                    <count group_id="O2" value="196"/>
                    <count group_id="O3" value="131"/>
                    <count group_id="O4" value="118"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="331.60"/>
                    <measurement group_id="O2" value="390.80"/>
                    <measurement group_id="O3" value="390.79"/>
                    <measurement group_id="O4" value="360.70"/>
                    <measurement group_id="O5" value="339.12"/>
                    <measurement group_id="O6" value="398.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup C- Month 7-13(LLQ-5.2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="196"/>
                    <count group_id="O2" value="192"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="382.55"/>
                    <measurement group_id="O2" value="567.41"/>
                    <measurement group_id="O3" value="574.69"/>
                    <measurement group_id="O4" value="589.70"/>
                    <measurement group_id="O5" value="545.04"/>
                    <measurement group_id="O6" value="595.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W-Month 0-2(LLQ-39.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="199"/>
                    <count group_id="O2" value="195"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.66"/>
                    <measurement group_id="O2" value="93.12"/>
                    <measurement group_id="O3" value="124.89"/>
                    <measurement group_id="O4" value="85.71"/>
                    <measurement group_id="O5" value="103.94"/>
                    <measurement group_id="O6" value="84.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W-Month 2-3(LLQ-39.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="190"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="114"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="137"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.51"/>
                    <measurement group_id="O2" value="81.75"/>
                    <measurement group_id="O3" value="90.33"/>
                    <measurement group_id="O4" value="65.66"/>
                    <measurement group_id="O5" value="75.19"/>
                    <measurement group_id="O6" value="78.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W-Month 3-7(LLQ-39.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="195"/>
                    <count group_id="O2" value="195"/>
                    <count group_id="O3" value="131"/>
                    <count group_id="O4" value="118"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="293.42"/>
                    <measurement group_id="O2" value="359.84"/>
                    <measurement group_id="O3" value="327.79"/>
                    <measurement group_id="O4" value="331.64"/>
                    <measurement group_id="O5" value="297.71"/>
                    <measurement group_id="O6" value="392.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup W-Month 7-13(LLQ-39.6)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="194"/>
                    <count group_id="O2" value="192"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="130"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="305.31"/>
                    <measurement group_id="O2" value="444.54"/>
                    <measurement group_id="O3" value="434.34"/>
                    <measurement group_id="O4" value="543.61"/>
                    <measurement group_id="O5" value="512.92"/>
                    <measurement group_id="O6" value="550.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y-Month 0-2(LLQ-14.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="199"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="115"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.25"/>
                    <measurement group_id="O2" value="76.31"/>
                    <measurement group_id="O3" value="99.44"/>
                    <measurement group_id="O4" value="67.83"/>
                    <measurement group_id="O5" value="84.92"/>
                    <measurement group_id="O6" value="67.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y-Month 2-3(LLQ-14.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="195"/>
                    <count group_id="O3" value="128"/>
                    <count group_id="O4" value="116"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.51"/>
                    <measurement group_id="O2" value="79.32"/>
                    <measurement group_id="O3" value="83.26"/>
                    <measurement group_id="O4" value="58.88"/>
                    <measurement group_id="O5" value="67.70"/>
                    <measurement group_id="O6" value="75.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y-Month 3-7(LLQ-14.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="199"/>
                    <count group_id="O2" value="194"/>
                    <count group_id="O3" value="131"/>
                    <count group_id="O4" value="118"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.05"/>
                    <measurement group_id="O2" value="339.26"/>
                    <measurement group_id="O3" value="339.26"/>
                    <measurement group_id="O4" value="303.62"/>
                    <measurement group_id="O5" value="234.85"/>
                    <measurement group_id="O6" value="373.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serogroup Y-Month 7-13(LLQ-14.7)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="199"/>
                    <count group_id="O2" value="191"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="117"/>
                    <count group_id="O5" value="131"/>
                    <count group_id="O6" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="125.13"/>
                    <measurement group_id="O2" value="425.13"/>
                    <measurement group_id="O3" value="389.69"/>
                    <measurement group_id="O4" value="520.64"/>
                    <measurement group_id="O5" value="454.48"/>
                    <measurement group_id="O6" value="537.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Any Solicited Local or Systemic AEs and Other Indicators of Reactogenicity Within 30 Minutes After Vaccination.</title>
        <description>Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity within 30 minutes after each vaccination. Assessed solicited symptoms were Pain, erythema and induration. Assessed solicited systemic symptoms were Fatigue, headache, myalgia, arthralgia, loss of appetite, nausea, chills, and fever (body temperature ≥38.0°C).</description>
        <time_frame>Within 30 minutes after vaccination</time_frame>
        <population>Analysis was done on subjects in Solicited Safety Set - all screened subjects who provided informed consent &amp; provided demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status in the trial, received a subject ID,provided post-vaccination reactogenicity data &amp; received a study vaccination</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Solicited Local or Systemic AEs and Other Indicators of Reactogenicity Within 30 Minutes After Vaccination.</title>
          <description>Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity within 30 minutes after each vaccination. Assessed solicited symptoms were Pain, erythema and induration. Assessed solicited systemic symptoms were Fatigue, headache, myalgia, arthralgia, loss of appetite, nausea, chills, and fever (body temperature ≥38.0°C).</description>
          <population>Analysis was done on subjects in Solicited Safety Set - all screened subjects who provided informed consent &amp; provided demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status in the trial, received a subject ID,provided post-vaccination reactogenicity data &amp; received a study vaccination</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="228"/>
                <count group_id="O2" value="232"/>
                <count group_id="O3" value="155"/>
                <count group_id="O4" value="134"/>
                <count group_id="O5" value="151"/>
                <count group_id="O6" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Induration(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="217"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="143"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Induration(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="217"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="143"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="215"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Induration(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="215"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Induration(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Induration(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Induration(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="217"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="143"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Erythema(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="217"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="143"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="215"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Erythema(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="215"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Erythema(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Erythema(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Erythema(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Myalgia(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Myalgia(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Myalgia(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Myalgia(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Myalgia(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Arthralgia(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Arthralgia(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Arthralgia(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Arthralgia(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Arthralgia(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Headache(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Headache(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Headache(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Headache(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Headache(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gradec3 Chills(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Appetite Loss(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Appetite Loss(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Appetite Loss(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Appetite Loss(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Appetite Loss(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Appetite Loss(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Appetite Loss(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Appetite Loss(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyAppetiteLoss(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Appetite Loss(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="232"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="218"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="137"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="232"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(1st vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="232"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(2nd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="216"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="129"/>
                    <count group_id="O5" value="145"/>
                    <count group_id="O6" value="153"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(3rd vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="219"/>
                    <count group_id="O3" value="146"/>
                    <count group_id="O4" value="126"/>
                    <count group_id="O5" value="141"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(4th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(5th vaccination)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="207"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="122"/>
                    <count group_id="O5" value="134"/>
                    <count group_id="O6" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Any Unsolicited AEs Within 30 Minutes After Vaccination.</title>
        <description>An unsolicited adverse event is an adverse event that was not solicited and that was spontaneously communicated by a participant and/or parent/legal guardian who has signed the informed consent. Number of participants reporting any unsolicited AE within 30 minutes after each vaccination.</description>
        <time_frame>Within 30 minutes after vaccination</time_frame>
        <population>Analysis was done on subjects in the Unsolicited Safety Set-all screened subjects who provided informed consent &amp; demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status, received a subject ID, received a study vaccination &amp; have either post-vaccination reactogenicity data or records.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Unsolicited AEs Within 30 Minutes After Vaccination.</title>
          <description>An unsolicited adverse event is an adverse event that was not solicited and that was spontaneously communicated by a participant and/or parent/legal guardian who has signed the informed consent. Number of participants reporting any unsolicited AE within 30 minutes after each vaccination.</description>
          <population>Analysis was done on subjects in the Unsolicited Safety Set-all screened subjects who provided informed consent &amp; demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status, received a subject ID, received a study vaccination &amp; have either post-vaccination reactogenicity data or records.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
                <count group_id="O2" value="228"/>
                <count group_id="O3" value="151"/>
                <count group_id="O4" value="129"/>
                <count group_id="O5" value="147"/>
                <count group_id="O6" value="157"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dizziness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Presyncope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asthenia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dyspnoea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypoaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site bruising</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site warmth</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paraesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pruritus allergic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Unsolicited AEs From Day 1 to Day 30 After Any Vaccination.</title>
        <description>The number of participants reporting unsolicited AEs and possibly or probably related unsolicited AEs were assessed.</description>
        <time_frame>Day 1 through Day 30 after any vaccination</time_frame>
        <population>Analysis was done on subjects in the Unsolicited Safety Set -all screened subjects who provided informed consent &amp; provided demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status, received a subject ID, received a study vaccination &amp; have either post-vaccination reactogenicity records.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Unsolicited AEs From Day 1 to Day 30 After Any Vaccination.</title>
          <description>The number of participants reporting unsolicited AEs and possibly or probably related unsolicited AEs were assessed.</description>
          <population>Analysis was done on subjects in the Unsolicited Safety Set -all screened subjects who provided informed consent &amp; provided demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status, received a subject ID, received a study vaccination &amp; have either post-vaccination reactogenicity records.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
                <count group_id="O2" value="228"/>
                <count group_id="O3" value="151"/>
                <count group_id="O4" value="129"/>
                <count group_id="O5" value="147"/>
                <count group_id="O6" value="157"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any AE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                    <measurement group_id="O2" value="148"/>
                    <measurement group_id="O3" value="93"/>
                    <measurement group_id="O4" value="76"/>
                    <measurement group_id="O5" value="97"/>
                    <measurement group_id="O6" value="104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Possibly or Probably Related AE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Any Solicited Local or Systemic Adverse Events (AEs) and Other Indicators of Reactogenicity From Day 1 to Day 7.</title>
        <description>Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity from Day 1 (6 hours) to Day 7 after any meningococcal vaccination is reported.</description>
        <time_frame>At Day 1 (6 hours) to Day 7 after vaccination</time_frame>
        <population>Analysis was done on all subjects in the Solicited Safety Set-all screened subjects who provided informed consent &amp; provided demographic &amp;/ other baseline screening measurements,regardless of the subject's randomization &amp; vaccination status in the trial,received a subject ID,provided post-vaccination reactogenicity data &amp; received study vaccination</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Solicited Local or Systemic Adverse Events (AEs) and Other Indicators of Reactogenicity From Day 1 to Day 7.</title>
          <description>Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity from Day 1 (6 hours) to Day 7 after any meningococcal vaccination is reported.</description>
          <population>Analysis was done on all subjects in the Solicited Safety Set-all screened subjects who provided informed consent &amp; provided demographic &amp;/ other baseline screening measurements,regardless of the subject's randomization &amp; vaccination status in the trial,received a subject ID,provided post-vaccination reactogenicity data &amp; received study vaccination</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="228"/>
                <count group_id="O2" value="231"/>
                <count group_id="O3" value="155"/>
                <count group_id="O4" value="134"/>
                <count group_id="O5" value="151"/>
                <count group_id="O6" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any AE</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="225"/>
                    <measurement group_id="O2" value="228"/>
                    <measurement group_id="O3" value="153"/>
                    <measurement group_id="O4" value="131"/>
                    <measurement group_id="O5" value="151"/>
                    <measurement group_id="O6" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Local AE</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="224"/>
                    <measurement group_id="O2" value="227"/>
                    <measurement group_id="O3" value="148"/>
                    <measurement group_id="O4" value="129"/>
                    <measurement group_id="O5" value="148"/>
                    <measurement group_id="O6" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Systemic AE</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="201"/>
                    <measurement group_id="O2" value="201"/>
                    <measurement group_id="O3" value="143"/>
                    <measurement group_id="O4" value="117"/>
                    <measurement group_id="O5" value="134"/>
                    <measurement group_id="O6" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="213"/>
                    <measurement group_id="O2" value="223"/>
                    <measurement group_id="O3" value="142"/>
                    <measurement group_id="O4" value="126"/>
                    <measurement group_id="O5" value="80"/>
                    <measurement group_id="O6" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="122"/>
                    <measurement group_id="O4" value="41"/>
                    <measurement group_id="O5" value="135"/>
                    <measurement group_id="O6" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="193"/>
                    <measurement group_id="O2" value="185"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="77"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="106"/>
                    <measurement group_id="O5" value="44"/>
                    <measurement group_id="O6" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                    <measurement group_id="O2" value="80"/>
                    <measurement group_id="O3" value="58"/>
                    <measurement group_id="O4" value="48"/>
                    <measurement group_id="O5" value="119"/>
                    <measurement group_id="O6" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Pain (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="226"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="150"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Erythema (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="226"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="150"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="215"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Erythema(2ndvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="215"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Erythema(3rdvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="202"/>
                    <count group_id="O2" value="209"/>
                    <count group_id="O3" value="137"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Erythema(4thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="202"/>
                    <count group_id="O2" value="209"/>
                    <count group_id="O3" value="137"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="203"/>
                    <count group_id="O2" value="203"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="129"/>
                    <count group_id="O6" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Erythema(5thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="203"/>
                    <count group_id="O2" value="203"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="129"/>
                    <count group_id="O6" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyInduration(1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="226"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="150"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Induration(1vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="226"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="150"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyInduration(2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="215"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Induration(2vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="215"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyInduration(3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Induration(3vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="211"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyInduration(4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="202"/>
                    <count group_id="O2" value="209"/>
                    <count group_id="O3" value="137"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Induration(4vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="202"/>
                    <count group_id="O2" value="209"/>
                    <count group_id="O3" value="137"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="133"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyInduration(5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="203"/>
                    <count group_id="O2" value="203"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="129"/>
                    <count group_id="O6" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Induration(5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="203"/>
                    <count group_id="O2" value="203"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="129"/>
                    <count group_id="O6" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126"/>
                    <measurement group_id="O2" value="121"/>
                    <measurement group_id="O3" value="84"/>
                    <measurement group_id="O4" value="68"/>
                    <measurement group_id="O5" value="68"/>
                    <measurement group_id="O6" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="64"/>
                    <measurement group_id="O3" value="64"/>
                    <measurement group_id="O4" value="40"/>
                    <measurement group_id="O5" value="64"/>
                    <measurement group_id="O6" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106"/>
                    <measurement group_id="O2" value="96"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="32"/>
                    <measurement group_id="O5" value="32"/>
                    <measurement group_id="O6" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Garde 3 Fatigue(3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="51"/>
                    <measurement group_id="O5" value="35"/>
                    <measurement group_id="O6" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Fatigue(4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="41"/>
                    <measurement group_id="O5" value="51"/>
                    <measurement group_id="O6" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Fatigue(5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103"/>
                    <measurement group_id="O2" value="92"/>
                    <measurement group_id="O3" value="65"/>
                    <measurement group_id="O4" value="52"/>
                    <measurement group_id="O5" value="63"/>
                    <measurement group_id="O6" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Headache(1stvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                    <measurement group_id="O2" value="47"/>
                    <measurement group_id="O3" value="70"/>
                    <measurement group_id="O4" value="36"/>
                    <measurement group_id="O5" value="63"/>
                    <measurement group_id="O6" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Headache(2ndvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                    <measurement group_id="O2" value="76"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="30"/>
                    <measurement group_id="O6" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Headache(3rdvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="44"/>
                    <measurement group_id="O5" value="26"/>
                    <measurement group_id="O6" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Headache(4thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                    <measurement group_id="O2" value="40"/>
                    <measurement group_id="O3" value="33"/>
                    <measurement group_id="O4" value="33"/>
                    <measurement group_id="O5" value="52"/>
                    <measurement group_id="O6" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Headache(5thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="39"/>
                    <measurement group_id="O4" value="34"/>
                    <measurement group_id="O5" value="33"/>
                    <measurement group_id="O6" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Myalgia(1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="37"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Myalgia(2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="40"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Myalgia(3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Myalgia(4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Myalgia(5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyAppetite Loss(1vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3AppetiteLoss(1vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyAppetiteLoss(2vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3AppetiteLoss(2vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyAppetiteLoss(3vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3AppetiteLoss(3vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyAppetiteLoss(4vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3AppetiteLoss(4vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AnyAppetiteLoss(5vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3AppetiteLoss(5vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="26"/>
                    <measurement group_id="O6" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(1stvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="221"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="26"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Nausea(5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="226"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="150"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="27"/>
                    <measurement group_id="O6" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(1stvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="226"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="150"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="215"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="32"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(2ndvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="213"/>
                    <count group_id="O2" value="215"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills(3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(3rdvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills(4thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(4thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 Chills(5vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever (1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="133"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="158"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="149"/>
                    <count group_id="O4" value="127"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever (3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="143"/>
                    <count group_id="O4" value="124"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever (4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="138"/>
                    <count group_id="O4" value="119"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever (5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="24"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(4)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="155"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention(5)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="26"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="45"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="32"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="29"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(3)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(4)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment(5)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="29"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(1st vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Arthralgia(1stvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="227"/>
                    <count group_id="O2" value="231"/>
                    <count group_id="O3" value="154"/>
                    <count group_id="O4" value="134"/>
                    <count group_id="O5" value="151"/>
                    <count group_id="O6" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (2nd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Arthralgia(2ndvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="216"/>
                    <count group_id="O3" value="150"/>
                    <count group_id="O4" value="128"/>
                    <count group_id="O5" value="144"/>
                    <count group_id="O6" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(3rd vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Arthralgia(3rdvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="217"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="125"/>
                    <count group_id="O5" value="138"/>
                    <count group_id="O6" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(4th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Arthralgia(4thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="211"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="120"/>
                    <count group_id="O5" value="136"/>
                    <count group_id="O6" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia(5th vacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade3Arthralgia(5thvacc)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="206"/>
                    <count group_id="O2" value="206"/>
                    <count group_id="O3" value="140"/>
                    <count group_id="O4" value="121"/>
                    <count group_id="O5" value="132"/>
                    <count group_id="O6" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Any Serious AE (SAE), Medically Attended AEs (MAAEs), AEs Leading to Premature Withdrawal</title>
        <description>The number of participants reporting any SAE, possibly or probably related SAE(s), medically-attended AEs, AEs leading to premature withdrawal, AEs leading to death, AEs leading to hospitalization and AEs leading to dose reduction, interruption and delay in study vaccination during the entire study period is reported.</description>
        <time_frame>During the entire study period (Month 0 to Month 13)</time_frame>
        <population>Analysis was done on all subjects in the Unsolicited Safety Set-all screened subjects who provided informed consent &amp; provided demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status, received a subject ID, received a study vaccination and have post-vaccination unsolicited AE records.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB_0_2 Group</title>
            <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O2">
            <title>ABCWY_ 0_2 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
          </group>
          <group group_id="O3">
            <title>ABCWY_0_1 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
          </group>
          <group group_id="O4">
            <title>ABCWY_0_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O5">
            <title>ABCWY_0_11 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
          </group>
          <group group_id="O6">
            <title>ABCWY_0_2_6 Group</title>
            <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Serious AE (SAE), Medically Attended AEs (MAAEs), AEs Leading to Premature Withdrawal</title>
          <description>The number of participants reporting any SAE, possibly or probably related SAE(s), medically-attended AEs, AEs leading to premature withdrawal, AEs leading to death, AEs leading to hospitalization and AEs leading to dose reduction, interruption and delay in study vaccination during the entire study period is reported.</description>
          <population>Analysis was done on all subjects in the Unsolicited Safety Set-all screened subjects who provided informed consent &amp; provided demographic &amp;/or other baseline screening measurements, regardless of the subject's randomization &amp; vaccination status, received a subject ID, received a study vaccination and have post-vaccination unsolicited AE records.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
                <count group_id="O2" value="228"/>
                <count group_id="O3" value="151"/>
                <count group_id="O4" value="129"/>
                <count group_id="O5" value="147"/>
                <count group_id="O6" value="157"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any SAE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Possibly or Probably Related SAE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Medically Attended AE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103"/>
                    <measurement group_id="O2" value="97"/>
                    <measurement group_id="O3" value="68"/>
                    <measurement group_id="O4" value="57"/>
                    <measurement group_id="O5" value="67"/>
                    <measurement group_id="O6" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AE(s) leading to premature withdrawal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AE(s) leading to Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AE(s) leading to Hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AE(s)leadingtodosereduction,interruption,vaccdelay</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Solicited AEs were collected from day 1 to day 7, Unsolicited AEs were collected from day 1 to day 30, SAEs were collected throughout the entire study period.</time_frame>
      <desc>Solicited AEs were collected by Systematic assessment; Unsolicited AEs were collected by non-systematic assessment.</desc>
      <group_list>
        <group group_id="E1">
          <title>rMenB_0_2 Group</title>
          <description>Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
        </group>
        <group group_id="E2">
          <title>ABCWY_ 0_2 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.</description>
        </group>
        <group group_id="E3">
          <title>ABCWY_0_1 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.</description>
        </group>
        <group group_id="E4">
          <title>ABCWY_0_6 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.</description>
        </group>
        <group group_id="E5">
          <title>ABCWY_0_11 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.</description>
        </group>
        <group group_id="E6">
          <title>ABCWY_0_2_6 Group</title>
          <description>Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Infectious mononucleosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Pelvic inflammatory disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Peritonsillar abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Carbon monoxide poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Connective tissue disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Torticollis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Fibroadenoma of breast</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion incomplete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Testicular torsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="226" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="229" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="153" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="131" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="151" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="158" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="74" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="51" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="47" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="56" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="62" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="80" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="76" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="61" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="40" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="62" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="70" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="169" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="165" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="119" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="98" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="105" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="120" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="131" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="131" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="80" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="80" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="89" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="97" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" subjects_affected="110" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="98" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="67" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="53" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="70" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="85" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="221" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="225" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="148" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="129" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="148" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="154" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="25" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="26" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="21" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="24" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="25" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="15" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="58" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="31" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="35" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="37" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="69" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="64" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="45" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="43" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="45" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="52" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="103" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="99" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="69" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="54" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="65" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="81" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="31" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="27" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="38" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="165" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="149" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="114" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="93" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="110" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="117" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="159"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="231"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="134"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>GSK Response Center</name_or_title>
      <organization>GlaxoSmithKline</organization>
      <phone>866-435-7343</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT02212457
org study id: 205215
secondary id: V102_15
secondary id: 2013-002451-15
nct id: NCT02212457
lead sponsor: 
The main purposes for conducting the study are firstly to assess immunological
      non-inferiority of the MenABCWY vaccine, administered according to 0, 2 month schedule to
      healthy adolescents 10 to 18 years of age, to those of the licensed rMenB+OMV vaccine
      (Bexsero™) in terms of hSBA GMTs at one month after the second vaccination, secondly to give
      the flexibility for the national vaccination program by showing the safety and immunogenicity
      of MenABCWY administrated according to four different vaccination schedules and additionally
      to evaluate a potential benefit of the 3-dose vaccination series.
allocation: Randomized
intervention model: Parallel Assignment
primary purpose: Other
masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
measure: Human Serum Bactericidal Assay (hSBA) Geometric Mean Titers (GMTs) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.
time frame: At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3)
description: The non-inferiority of the Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant (MenABCWY) vaccine to Meningococcal (group B) multicomponent recombinant adsorbed (Bexsero) vaccine, administered according to 0, 2 month schedule, as measured by hSBA GMTs against N.meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, is reported. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the rMenB_0_2 and ABCWY_ 0_2 Groups.
measure: hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.
time frame: At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3 for ABCWY_ 0_2 Group and Month 7 for ABCWY_0_2_6 Group)
description: The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 2 months schedule, as measured by hSBA GMTs against N. meningitidis serogroup B test strains and serogroups A,C, W and Y at 1 month after the last meningococcal vaccination. The B test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab. This outcome measure was evaluated in the ABCWY_ 0_2 and ABCWY_0_2_6 Groups. 1 month post last meningococcal vaccination corresponds to Month 3 for ABCWY_0_2 Group and Month 7 for ABCWY_0_2_6 Group.
measure: Percentages of Subjects With hSBA Titers ≥LLQ Against N. Meningitidis Serogroups A, C, W and y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_2 Month Schedule.
time frame: At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3 for ABCWY_ 0_2 Group and Month 7 for ABCWY_0_2_6 Group)
description: The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 2 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination.
measure: hSBA GMTs Against Each of N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0, 11 Month Schedule.
time frame: At 1 Month after the last vaccination (Month 2 for ABCWY_0_1 Group, Month 3 for ABCWY_0_2 Group, Month 7 for ABCWY_0_6 Group and Month 13 for ABCWY_0_11 Group)
description: The immunogenicity of MenABCWY vaccine, administered according to 0, 2 months schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.
measure: Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against N. Meningitidis Serogroup B Test Strains When Administered According to 0_2 Month Schedule.
time frame: At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 3)
description: A sufficient immune response following Bexsero vaccine, administered according to 0, 2 month schedule, as measured by the percentage of subjects with hSBA titers ≥ Lower Limit of Quantitation (LLQ) against N. meningitidis serogroup B test strains at 1 month after the last meningococcal vaccination, was to be demonstrated. Criterion: the immune response was to be considered sufficient if the lower limit of the two-sided 95% CI for the percentage of subjects with hSBA titers ≥ LLQ was greater than 75% for each of the four serogroup B test strains. The test strains assessed were Meningitis B NZ98/254 Ab, Meningitis B M14459 Ab, Meningitis B M07-0241084 Ab and Meningitis B 96217 Ab.
measure: hSBA GMTs Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.
time frame: At 1 month after last vaccination (Month 7)
description: The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 months schedule was compared with those administered according to 0, 6 months schedule, as measured by hSBA GMTs against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.
measure: Percentages of Subjects With hSBA Titers ≥ Lower Limit of Quantitation (LLQ) Against Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_2_6 Month and 0_6 Month Schedule.
time frame: At baseline (Month 0) and 1 month after the last meningococcal vaccination (Month 7)
description: The immunogenicity of MenABCWY vaccine, administered according to 0, 2, 6 month schedule, was compared with those, administered according to 0, 6 month schedule, as measured by the percentages of subjects with hSBA titers ≥ LLQ against serogroups A, C, W and Y and serogroup B test strains at 1 month after the last meningococcal vaccination.
measure: Percentages of Subjects With hSBA Titers ≥ LLQ Against N. Meningitidis Serogroups A, C, W and Y and Serogroup B Test Strains When Administered According to 0_1 Month, 0_2 Month, 0_6 Month and 0_11 Month Schedule.
time frame: At 1 month after second vaccination (Month 2 for ABCWY_0_1 Group, Month 3 for ABCWY_0_2 Group , Month 7 for ABCWY_0_6 Group and Month 13 for ABCWY_0_11 Group)
description: The immunogenicity of MenABCWY vaccine, administered according to 0, 2 month schedule, was compared with those, administered according to 0, 1 month, 0, 6 month and 0, 11 month schedules, as measured by the percentages of subjects with hSBA titers ≥ LLQ against N. meningitidis serogroups A, C, W and Y and serogroup B test strains at 1 month after the second meningococcal vaccination.
measure: hSBA GMTs Against Serogroups A, C, W and Y and Serogroup B Test Strains at All the Relevant Time Points for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the adjusted hSBA GMTs against serogroups A,C, W and Y and serogroup B test strains was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against NZ98/254 B Strain for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against NZ98/254 B strain was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M14459 B Strain for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M14459 B strain was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against M07-0241084 B Strain for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against M07-0241084 B strain was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against 96217 B Strain for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against 96217 B strain was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against A Human Serogroup for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against A human serogroup was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against C Human Serogroup for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against C human serogroup was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against W Human Serogroup for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against W human serogroup was assessed.
measure: Percentages of Subjects With hSBA Titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 Against Y Human Serogroup for All Schedules.
time frame: At Month 0, Month 2, Month 3, Month 7 and Month 13.
description: The kinetic of immune response (at Months 0, 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with hSBA titers ≥LLQ, ≥5, ≥8, ≥16, ≥32, ≥64, ≥128 against Y human serogroup was assessed.
measure: Percentages of Subjects With Two-, Three- and Four-fold Titer Rise Against Serogroups A, C, W and Y and Serogroup B Test Strains for All Schedules.
time frame: At Month 2, Month 3, Month 7 and Month 13
description: The kinetic of immune response (at Months 2, 3, 7 and 13) following different vaccination schedules as measured by the percentages of subjects with two-, three- and four-fold titer rise against serogroups A, C, W and Y and serogroup B test strains was assessed. The two/three/four fold titer rise is defined as: a) for subjects with prevaccination hSBA titers ≤ LLQ, a postvaccination hSBA ≥ 2/3/4 LLQ; b) for subjects with a prevaccination hSBA titers ≥ LLQ, an increase of at least 2/3/4 times of the prevaccination hSBA titer.
measure: The Area Under the Curve (AUC) for Percentage of Subjects With hSBA Titers ≥LLQ for All Serogroups and Strains.
time frame: From Month 0 to Month 13
description: The area under the curve for percentage of subjects with hSBA titers ≥ LLQ for all serogroups (A, C, W and Y) and for all serogroup B test strains (M14459, 96217, NZ98/254 and M07-0241084) was summarized overall (from Month 0 to Month 13) and by period (from Month 0 to Month 2, Month 2 to Month 3, Month 3 to Month 7 and Month 7 to Month 13) by vaccine groups. It was computed as the sum of the trapezoidal areas and the time unit used was the month. AUC 0_13 = (r0+r2)(2-0)/2 + (r2+r3)(3-2)/2 + (r3+r7)(7-3)/2 + (r7+r13)(13-7)/2 with ri = percentages of subjects with both hSBA titers >= LLQ against N. meningitis for all serogroups A, C, W and Y and for all serogroup B test strains at Month 1.
measure: Number of Participants Reporting Any Solicited Local or Systemic AEs and Other Indicators of Reactogenicity Within 30 Minutes After Vaccination.
time frame: Within 30 minutes after vaccination
description: Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity within 30 minutes after each vaccination. Assessed solicited symptoms were Pain, erythema and induration. Assessed solicited systemic symptoms were Fatigue, headache, myalgia, arthralgia, loss of appetite, nausea, chills, and fever (body temperature ≥38.0°C).
measure: Number of Participants Reporting Any Unsolicited AEs Within 30 Minutes After Vaccination.
time frame: Within 30 minutes after vaccination
description: An unsolicited adverse event is an adverse event that was not solicited and that was spontaneously communicated by a participant and/or parent/legal guardian who has signed the informed consent. Number of participants reporting any unsolicited AE within 30 minutes after each vaccination.
measure: Number of Participants Reporting Unsolicited AEs From Day 1 to Day 30 After Any Vaccination.
time frame: Day 1 through Day 30 after any vaccination
description: The number of participants reporting unsolicited AEs and possibly or probably related unsolicited AEs were assessed.
measure: Number of Participants Reporting Any Solicited Local or Systemic Adverse Events (AEs) and Other Indicators of Reactogenicity From Day 1 to Day 7.
time frame: At Day 1 (6 hours) to Day 7 after vaccination
description: Number of participants reporting any solicited local or systemic AEs and other indicators of reactogenicity from Day 1 (6 hours) to Day 7 after any meningococcal vaccination is reported.
measure: Number of Participants Reporting Any Serious AE (SAE), Medically Attended AEs (MAAEs), AEs Leading to Premature Withdrawal
time frame: During the entire study period (Month 0 to Month 13)
description: The number of participants reporting any SAE, possibly or probably related SAE(s), medically-attended AEs, AEs leading to premature withdrawal, AEs leading to death, AEs leading to hospitalization and AEs leading to dose reduction, interruption and delay in study vaccination during the entire study period is reported.
arm group label: rMenB_0_2 Group
arm group type: Experimental
description: Subjects received two injections of Bexsero vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.
arm group label: ABCWY_ 0_2 Group
arm group type: Experimental
description: Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 2, Havrix vaccine at Visit Month 6 and Visit Month 12 and saline placebo at Visit Month 1.
arm group label: ABCWY_0_1 Group
arm group type: Experimental
description: Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 1, Havrix vaccine at Visit Month 2 and Visit Month 12 and saline placebo at Visit Month 6.
arm group label: ABCWY_0_6 Group
arm group type: Experimental
description: Subjects received MenABCWY vaccine at Visit Month 0 and Visit Month 6, Havrix vaccine at Visit Month 1 and Visit Month 12 and saline placebo at Visit Month 2.
arm group label: ABCWY_0_11 Group
arm group type: Experimental
description: Subjects received MenABCWY vaccine at Visit Month 1 and Visit Month 12, Havrix vaccine at Visit Month 0 and Visit Month 6 and saline placebo at Visit Month 2.
arm group label: ABCWY_0_2_6 Group
arm group type: Experimental
description: Subjects received MenABCWY vaccine at Visit Month 0, Visit Month 2 and Visit Month 6 and Havrix vaccine at Visit Month 1 and Visit Month 12.
intervention type: Biological
intervention name: Bexsero
description: Two doses administered intramuscularly into the deltoid area at Months 0 and 2 in rMenB_0_2 Group.
arm group label: rMenB_0_2 Group
intervention type: Other
intervention name: Saline Placebo
description: One dose administered intramusculary in the deltoid muscle at Month 1 in ABCWY_ 0_2 Group and rMenB_0_2 Group, Month 2 in ABCWY_0_6 Group and ABCWY_0_11 Group and Month 6 in ABCWY_0_1 Group.
arm group label: ABCWY_ 0_2 Group
arm group label: ABCWY_0_1 Group
arm group label: ABCWY_0_11 Group
arm group label: ABCWY_0_6 Group
arm group label: rMenB_0_2 Group
intervention type: Biological
intervention name: Havrix
description: Two doses administered in the deltoid muscle at Month 2 and 12 in ABCWY_0_1 Group, Month 1 and 12 in Group ABCWY_0_6 Group and ABCWY_0_2_6 Group , Month 0 and 6 in ABCWY_0_11 Group and Month 6 and 12 in ABCWY_ 0_2 Group and rMenB_0_2 Group.
arm group label: ABCWY_ 0_2 Group
arm group label: ABCWY_0_1 Group
arm group label: ABCWY_0_11 Group
arm group label: ABCWY_0_2_6 Group
arm group label: ABCWY_0_6 Group
arm group label: rMenB_0_2 Group
intervention type: Biological
intervention name: MenABCWY
description: Two to three doses administered in the deltoid muscle at Month 0 and 1 in ABCWY_0_1 Group, Month 0 and 6 in ABCWY_0_6 Group, Month 1 and 12 in ABCWY_0_11 Group, Month 0, 2 and 6 in ABCWY_0_2_6 Group, Month 0 and 2 in ABCWY_ 0_2 Group and rMenB_0_2 Group.
arm group label: ABCWY_ 0_2 Group
arm group label: ABCWY_0_1 Group
arm group label: ABCWY_0_11 Group
arm group label: ABCWY_0_2_6 Group
arm group label: ABCWY_0_6 Group
criteria: 
gender: All
minimum age: 10 Years
maximum age: 18 Years
healthy volunteers: Accepts Healthy Volunteers
last name: GSK Clinical Trials
role: Study Director
affiliation: GlaxoSmithKline
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
country: Finland
country: Poland
country: United States
responsible party type: Sponsor
mesh term: Meningococcal Infections
participant flow: 
baseline: 
outcome list: 
reported events: 
certain agreements: 
point of contact: 